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CHAPTER I
POTYVIRUSES
Introduction
Characteristics of the Potyviridae
The Potyviridae family of plant viruses consists of a large number of
plant viral pathogens which share common structural and biological
properties. Structurally, members of this virus family are flexuous rod-
shaped viruses. Virion particles are composed of a single stranded RNA of
plus (or message) sense polarity, helically encapsidated by multiple copies of
a single coat protein monomer. The RNA genome is covalently linked to a
virus-encoded protein (VPg) at its 5' end and has a 3' polyadenylate
sequence (review, Riechmann et al., 1992). All members of the Potyviridae
induce the formation of characteristic cylindrical or pinwheel-shaped
inclusion bodies in the cytoplasm of infected plant cells (Edwardson and
Christie, 1991).Infections by certain members of the Potyviridae also results
in the formation of nuclear inclusion and/or amorphous cytoplasmic
inclusion bodies (Edwardson and Christie, 1991).2
Organization of the Potyviridae
Several taxonomic methods have been proposed for the Potyviridae
based on host range, ability to cross protect, inclusion body morphology, coat
protein amino acid sequence homology, nucleotide sequence homology, or
serological relationships. However, with the limited number of Potyviridae
examined and the continuum of variation observed, it has been difficult to
arrive at a consensus which adequately distinguishes a "strain" from a
"virus". As such, controversy still remains regarding their taxonomic
status.It has been recently suggested that the Potyviridae be divided into
three genera (Barnett, 1992), based upon their natural vectors:
Genus 1:Aphid-transmitted members (Potyvirus).
Genus 2:Fungus-transmitted members (Bymovirus).
Genus 3:Mite-transmitted members (Rymovirus).
This introduction will focus on members of the aphid-transmitted
Potyvirus genus, especially tobacco etch virus (TEV).
Transmission
Potyviruses are transmitted by aphids in a non-persistent, non-
circulative (stylet-borne) manner (review, Pirone, 1991). Aphids can acquire
virus by probing infected tissue for only a few seconds, retain the ability to
transmit virus for several hours, and can transmit virus to healthy plants
with short probes lasting less than one minute. Because aphids do not
retain the ability to transmit virus for extended periods of time, in field
conditions virus usually comes from nearby inoculum sources. A typical
potyvirus is often transmissible by several different aphid species. Given
the promiscuous feeding behavior of aphids and the characteristics of stylet-3
borne transmission, potyviruses can be spread in a field by aphids simply
passing through, and not colonizing, a crop.
Aphid transmission of potyviruses involves at least two viral
encoded proteins:(1) the "helper component" (the 56 kDa HC-PRO in TEV)
and (2) the virus capsid protein. Nucleotide sequence comparisons between
non-aphid and aphid transmissible virus isolates have been used to predict
which amino acids in these two proteins may be important for aphid
transmissibility. Infectious transcripts from a full-length cDNA clone of the
potyvirus tobacco vein mottling virus (TVMV) have been used to confirm
the importance of specific amino acids in both the capsid protein and HC-
PRO in aphid transmissibility (review, Pirone, 1991).
Genome structure
The following discussion on genome organization and expression is
based largely on experimentation with the potyviruses TEV, TVMV, and
plum pox virus (PPV). The TEV system will be used to illustrate proteolytic
processing and gene expression. In the following discussion, protein sizes
mentioned are for TEV. Other potyviruses will not necessarily have
identically-sized proteins.
The RNA genome of potyviruses is a single strand message-sense
RNA of about 9,600 nucleotides (nt).It is organized as a single large open
reading frame (ORF), encompassing about 95% (>9,100 nt) of the RNA
molecule. A viral encoded protein (VPg) is covalently linked to the 5'
terminal nucleotide and a polyadenylate sequence is present at the 3'
terminus. At least nine gene products are encoded in this large ORF and are
initially expressed as a large polyprotein which is proteolytically processed
into mature viral protein products (review, Dougherty and Carrington,4
1988). The various TEV gene products and their identities/functions are
presented in Fig I.1. and discussed below.
Gene expression
Three distinct proteolytic activities have been associated with TEV
gene products. The first identified proteolytic activity was ascribed to the
TEV 49 kDa NIa polyprotein (Carrington and Dougherty, 1987), one of the
components of the nuclear inclusion body which forms in TEV-infected
plant tissue (Dougherty and Hiebert, 1980b). The 49 kDa polyprotein is
further processed into two proteins of ca. 21 and 27 kDa (Dougherty and
Parks, 1991). The amino-terminal 21 kDa of the NIa polyprotein is the VPg
of the virus (Murphy et al., 1990). The proteolytic activity of the NIa
polyprotein resides in the carboxy-terminal 27 kDa portion (Dougherty and
Parks, 1991). The NIa proteinase of TEV has been identified as a trypsin-like
cysteine proteinase similar to the 3C proteinase of picornaviruses
(Dougherty et al., 1989). The proteolytic specificities associated with the 27
and 49 kDa proteins appear to be identical in cell-free studies (Dougherty
and Parks, 1991). It is uncertain whether the 49 or 27 kDa form of this
proteinase is responsible for in vivo cleavage of the polyprotein (review,
Dougherty and Carrington, 1988).
The TEV NIa proteinase cleaves at a highly conserved site which
spans the seven amino acid sequence:
Ile GluSer
Glu-Xaa-Leu-Tyr-Xaa-Gln / Gly
Val5
Figure I.1. Genome organization and protein products of the potyvirus
tobacco etch virus (TEV). Sizes of proteins are deduced from predicted
amino acid sequence derived from the TEV genomic nucleotide sequence.
Other potyviruses have similar, but not identically sized, protein products.
In the genome map (A), the solid circle represents the VPg, the thin
horizontal lines represent the TEV genome 5' and 3' untranslated sequences
and the long open rectangular box denotes the open reading frame. Vertical
lines are used to show locations of proteolytic cleavage of the polyprotein.
Molecular weights (in kDa) of the various processed TEV gene products are
presented above the diagram. Proteins which aggregate to form the various
inclusion bodies during infection are identified: AI and CI represent the
proteins which form the amorphous cytoplasmic inclusion and cylindrical
inclusion bodies, respectively. The NIa polyprotein and NIb protein
together make up the nuclear inclusion body co-crystal. (B) Predicted
protein function and experimentally determined activities (in parenthesis)
are listed in the right hand column. The symbol, ??, denotes proteins for
which no function is known. The 49 kDa NIa polyprotein is processed into
21 and 27 kDa proteins. The proteolytic activity is associated with the 27 kDa
protein. Either the 21 or the 49 kDa protein can function as the VPg moiety.A
B
6
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TEV
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Figure I.1.7
Cleavage occurs between the Glu (Gin) and Gly (Ser) residues. Positions
represented by Xaa are occupied by neutral or hydrophobic amino acids. In
cell-free studies, various amino acids in the Xaa positions affect the
rate of cleavage (Dougherty et al., 1989; Dougherty and Parks, 1989).
Cleavage sites composed of strictly and loosely conserved amino acids have
been found in other potyviruses also.
The two other proteolytic activities described for TEV have only been
demonstrated to function in a mono-molecular fashion (i.e. cis). The 52
kDa protein, referred to as HC-PRO, is a papain-like cysteine proteinase (Oh
and Carrington, 1989) which cleaves at its carboxy-terminal end to release
itself from the polyprotein. Cleavage is between a Gly/Gly dipeptide
(Carrington et al., 1989). A recently described proteolytic activity involves
the 35 kDa protein (P1) of TEV (Carrington et al., 1990; Verchot et al., 1991).
This proteinase, located at the N-terminus of the genome derived
polyprotein, also cleaves at its carboxy-terminus to release itself from the
polyprotein. Sequence homology and mutagenesis studies suggest the P1
proteinase resembles cellular serine-type proteinases (Verchot et al., 1991,
1992). In TEV the P1 catalyzed cleavage is between a Tyr-Ser dipeptide
(Verchot et al., 1992).
Gene regulation
It has been proposed that potyviruses may regulate their gene
expression at a post-translational level via differential processing rates at
various cleavage sites. Potyviruses may also use differential protein
stabilities and/or the shunting of proteins into inclusion bodies as a means
of regulating gene activity in a post-translational manner. A proposed8
pathway of proteolytic processing in potyviruses is presented in schematic
form in Fig 1.2.
Replication
Because of their genome structure and gene expression mechanism,
potyviruses have been placed in the super group of "picorna-like" viruses
(review, Goldbach, 1987). As such, it is likely potyvirus replication will be
similar to picornavirus replication. Replication of picornaviruses occurs in
the cytoplasm of infected cells and involves a membrane bound replicase
complex. The picornaviral proteins 2B, 2C, 3A, 3C and 3D are involved in
replication (review, Kuhn and Wimmer, 1987). Sequence homology studies
have revealed regions of homology between picornavirus 2C, 3C, and 3D
proteins and the 71, 27 and 58 kDa proteins of TEV (review, Goldbach, 1990).
Structural and functional similarities have been observed between
picornavirus and potyvirus proteins as well. On a functional level, the
picornavirus 2BC protein and potyvirus 71 kDa protein both induce the
formation of smooth walled vesicles in the cytoplasms of infected cells
(Calder and Ingerfeld, 1990). The picornavirus 3A and TEV 6 kDa proteins
do not show sequence homology, though they appear to be biochemically
similar in that both are small proteins with hydrophobic core sequences.
The 3A protein is a component of the picornavirus replicase complex
(review, Kuhn and Wimmer, 1987). The 3B and 21kDa proteins both
function as VPgs (although in a portion of TEV virions, a 49 kDa
polyprotein is linked to the TEV genome) (Murphy et al., 1990). The 3C and
27 kDa proteins both have proteolytic activities, and the 3D and 58 kDa
proteins both have amino acid sequences conserved among RNA-
dependent RNA-polymerases. Helicase and ATPase activities have recently9
Fig 1.2. Putative proteolytic processing scheme of the potyvirus tobacco etch
virus (TEV). Shown is a map of the TEV genome (see Fig I.1 for details), its
translation products, and a proposed scheme of proteolytic processing. The
solid circle in the genome map represents the VPg. Proteolytic activities
have been mapped to three proteins in TEV: (1) the 35 kDa protein, (2) the
carboxy-terminal half of the 52 kDa HC-PRO, and (3) the 27 kDa NIa protein.
Those regions with identified proteolytic activities are shaded. Arrows
indicate the proteinase responsible for cleavage at the dipeptide sequences
(single letter amino acid code) indicated. A series of autocatalytic events
occur rapidly (above dotted line in diagram ) and possibly co-translationally.
Subsequent cleavage reactions (below the dotted line) may be mono- or bi-
molecular. The 49 kDa protein is autocatalytically processed at a Glu-Gly
dipeptide to form a 21 and 27 kDa sized protein. The 27 kDa portion retains
proteolytic activity.87 50 71 6 49 58 30
35 52
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2127
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been demonstrated for the PPV 71 kDa protein in vitro (Lain et a/., 1990,
1991) implicating this protein in virus replication. A completely functional
"replicase complex" has not been isolated from potyvirus infected tissue.
This discussion has briefly touched on several of the nine identified
gene products encoded by the TEV genome. Activities and roles in the viral
replication cycle have been described, but do not preclude other functions
associated with partially processed polyproteins containing these gene
products. A putative function(s) for the TEV 50 kDa protein product has not
been proposed.
Virus-host relationship
The formation of large distinctive inclusion bodies is a hallmark of
potyvirus-infected tissue. Potyvirus infected cells contain cylindrical or
pinwheel shaped cytoplasmic inclusion (CI) bodies comprised of viral
encoded protein. Initially the CI's are associated with the infected cell
membrane and later are found free in the cytoplasm. The CI protein has
helicase and ATPase activities (Lain et al., 1990, 1991). These cytological and
biochemical observations have lead to speculation that the CI inclusion
protein may function both in virus replication and cell-to-cell movement.
Sequence homology studies suggest that the 35 kDa proteinase may also be
involved in movement of virus infection from cell-to-cell within a plant.
Limited sequence homology has been detected between the TVMV 35 kDa
proteinase and the TMV 30 kDa movement protein (Domier et al., 1987).
A few potyviruses also form nuclear inclusions (NI) and/or
amorphous cytoplasmic inclusions (AI). NI bodies are distinctively shaped
crystals composed of two virus-encoded proteins, the 49 kDa polyprotein (21
kDa VPg and 27 kDa proteinase) and the putative RNA-dependent-RNA12
polymerase of ca. 58 kDa. The AI, when formed, is an aggregate of the HC-
PRO protein. In addition to its proteolytic function, HC-PRO is also required
for aphid transmission. The relationship between these two functions is
not understood. All potyvirus-induced inclusions can be readily viewed in
stained epidermal strips by light microscopy. Purification schemes to obtain
inclusion bodies also have been established.
On a whole plant level, systemic symptoms usually appear within 6-8
days post inoculation (mechanically- or aphid-vectored inoculum).
Symptoms on systemically infected leaves often include mosaic and
mottling, vein clearing, chlorosis, streaking, necrosis, leaf distortion, etc.
Tens of milligrams of virions can usually be obtained from a
kilogram of infected plant tissue. Such purified virus preparations are often
used to generate antibodies to potyvirus coat proteins for use in serological
based detection schemes (enzyme-linked immunosorbent assay, etc.).
Recent serological and structural analysis of potyvirus coat proteins has
revealed that the amino- and carboxy-termini of the coat protein reside on
the exterior of the virion (Allison et al., 1985a; Shukla and Ward, 1989).
These termini greatly differ in both sequence and length among
potyviruses. The internal amino acids of the coat protein, however, are
relatively conserved between potyviruses. Antibodies directed toward the
coat protein amino- or carboxy-terminus can be virus specific, whereas
antibodies directed toward the internal, conserved amino add residues are
usually cross-reactive with different potyviruses (Dougherty et al., 1985).13
Economic importance
Several factors contribute to potyviruses being an economically
important virus group, including the following: (1) Although the host
range of most potyviruses is narrow, there is virtually no agricultural crop
which one or more potyviruses cannot infect.(2) Symptoms on infected
plants are often quite visible. Vein clearing, leaf chlorosis, necrosis, leaf
distortion, stunting, and distorted fruits and seeds can result in considerable
crop losses in yield and/or quality. (3) Potyviruses arereadily transmitted
from infected to healthy plants. Aphid transmitted potyviruses are
transmitted in a non-persistent, non-circulative (stylet-borne) manner.
Aphids can acquire and transmit virus with short feeding probes lasting
only a few seconds. (4) Potyviruses are found in a wide range of
environments. They are especially prevalent in sub-tropical or tropical
regions where virus can overwinter in weeds, alternate crops, or volunteer
plants. (Though some potyviruses may also enter a field via contaminated
seed). Tropical, sub-tropical and temperate climates also support insect
populations which may vector the virus.
The economic impact of the group as a whole is difficult to estimate.
The extent of crop loss depends upon a complex interaction of growing
conditions, cultivars, virus strains, cultural practices, time and extent of
infection in the field, etc. Chronic losses due to viral infection may often go
undetected, but epidemics can cause complete crop loss. Financial
investments in virus control measures such as resistance breeding
programs and seed certification programs also represent one aspect of the
economic impact of potyviruses.14
Control schemes
In addition to cultural practices to remove primary sources of
inoculum, seed certification and traditional breeding programs have been
implemented to control potyviruses. Resistance phenotypes are often
inherited in a recessive manner and therefore difficult to identify
(Provvidenti and Hampton, 1992). Also, resistant germplasm is often not
available for every crop and viruses rapidly mutate to overcome deployed
resistance genes.
Because of their economic importance and the inaccessibility or
ineffectiveness of many naturally occuring virus resistance genes, it is of
interest to develop alternative, effective means of virus control. Virus
resistant plants have been genetically engineered by deriving resistance
genes from the virus itself (reviews, Beachyet al.,1990; Gadaniet al.,1990).
It has been demonstrated that transgenic host plants which express the coat
protein nucleotide sequence of a particular plant virus are resistant to
subsequent infection by that virus. Although the mechanism of this
resistance is not entirely understood, this approach has been applied, with
varying degrees of sucess, to a wide variety of plant viruses, including
potyviruses (review, Lindboet al.,1993).
Conclusions
Potyviruses are a very large group of plant viruses which can have
significant economic impact on a wide variety of agriculturally important
crops. This work was initiated to examine genetically engineered resistance
to potyviruses. At the onset of this work no plant species had yet been
genetically engineered for resistance to a potyvirus. The specific goals were
to develop a model (transgenic) plant-potyvirus system with which to15
examine "genetically engineered resistance". Experiments were conducted
to ask several questions:
Are transgenic plants which express the coat protein (CP) gene of TEV
resistant to TEV?
Are transgenic plants which accumulate truncated forms of the TEV
CP resistant to TEV?
Is virus resistance due to the CP or its RNA?
If resistance is found, what is the mechanism of resistance?
To address these questions the well studied potyvirus TEV and a
TEV-susceptible commercially grown tobacco cultivar (Nicotiana tabacum
cv. B49) were selected as a model system. The following chapters
summarize the current status of genetically engineered resistance to
potyviruses, and describe in detail my efforts to develop a transgenic plant
system with which to examine this phenomenon. A series of transgenic
plant lines have been generated, screened for transgene expression at the
RNA and protein level and assayed for virus resistance phenotypes.
Experiments were also performed to examine virus resistance at the cellular
level to determine if resistance was due to an inhibition of virus replication,
or virus movement. These studies have provided data which suggests an
unexpected phenomenon is at work which may provide insight into aspects
of basic gene regulation, and virus resistance strategies.16
CHAPTER II
PATHOGEN DERIVED RESISTANCE TO POTYVIRUSES:
WORKING, BUT WHY?
Abstract
The theory of pathogen derived resistance suggests that pathogen
resistance genes can be developed from a pathogen's own genetic material. For
example, transgenic plants expressing plant virus coat protein genes are often
virus resistant. Non-structural virus genes also have been expressed in plants,
with mixed results. Recent experiments suggest that, at least in some cases,
resistance may be RNA mediated. In all cases the exact mechanism of this
resistance remains a mystery. This review discusses examples of pathogen
derived resistance for members of the Potyviridae family of plant viruses and
offers some possible mechanisms to account for this intriguing phenomenon.17
Introduction
The Potyviridae is a large, agronomically important family of plant
viruses which share common structural, biochemical, and biological properties.
The family is composed of three genera, the Potyvirus genus containing the
most members (Barnett, 1992). Potyviruses are flexuous rod-shaped plant
viruses approximately 12-15 nm in diameter and 700 to 900 nm in length.
Virions are composed of a single-strand of plus sense RNA nearly 10,000
nucleotides in length, encapsidated by approximately 2000 copies of a coat
protein (CP) monomer. The RNA genome is covalently linked to a virus-
encoded protein (VPg) at its 5' end and has a 3' polyadenylate sequence. A
potyvirus genome contains a single open reading frame encompassing over
95% of the genome (Fig. II.1.). All virus-encoded proteins are expressed
initially as a large polyprotein that is proteolytically processed into mature viral
products. No subgenomic RNAs are produced during the replication cycle
(Dougherty, 1983).
Potyviruses are significant agricultural pathogens for several reasons.
First, there are over 100 members in this genus. Although each individual
member has a fairly limited host range, the large number of potyviruses insures
that few, if any, agricultural crop species cannot be infected by one or more
members of this genus. Second, potyviruses are transmitted by aphids in a
non-persistent, non-circulative (stylet borne) manner. This mode of
transmission enables aphids to efficiently vector the virus and makes control of
potyvirus transmission difficult (review, Pirone, 1991). Finally, potyviral
infection can result in necrosis, chlorosis, and/or stunting of the infected plant,
adversely affecting the quantity and quality of the leaves, fruits, or seeds
produced.NIa
5' AI CI NIb CP 3'
11-135I52I50
HC-PRO
I
18
70 16121 127I58 I30--poly A
Figure II. 1. Schematic representation of the genome organization and protein
products of tobacco etch virus (TEV), a typical potyvirus. In the TEV genome
map, the solid circle represents the VPg; the thin horizontal lines represent the
TEV genomic 5' and 3' untranslated sequences; and the long rectangular box
represents the open reading frame. Vertical lines dissecting the box are used to
show locations of proteolytic cleavage of the polyprotein. Approximate sizes of
proteins (in kilodaltons) are listed in the open boxes. Selected protein identities
are shown above or below the corresponding box. Abbreviations used are as
follows: HC-PRO, helper component-proteinase; AI, amorphous inclusion
protein; CI, cylindrical inclusion protein; NIa, nuclear inclusion body protein a;
Mb, nuclear inclusion body protein b; CP, coat protein. Other potyviruses
have similar but not identically sized proteins.19
Because plant viruses can have devastating effects on marketable crop
yield, a significant amount of effort has been devoted to plant virus control.
Using virus resistant cultivars is an effective way to control plant viruses.
Traditional breeding practices have been successful in incorporating potyvirus
resistance genes into commercially important cultivars (Provvidenti and
Hampton, 1992). However, virus resistant germplasm can be unavailable or
difficult to identify. Additionally, a continually mutating virus population
often renders resistance genes ineffective after a few growing seasons.
The theory of pathogen derived resistance (PDR) (Sanford and Johnston,
1985) proposed that virus resistance genes may be developed from a virus' own
genetic material. PDR has predicted that selected genes, when removed from a
virus, inserted into and expressed from a host plant genome, may render that
plant resistant to virus infection. Such "genetic engineering" offers the
potential to expand the repertoire of resistance genes which can then be
deployed through traditional breeding methods. In 1986, it was first
demonstrated that transgenic plants which express the tobacco mosaic virus
(TMV) CP were resistant to TMV (Powell-Abel et a/., 1986). This phenomenon
has since been tested for a wide variety of plant virus groups (Beachy et al.,
1990; Gadani et al.,1990) and is often referred to as "coat protein meditated
resistance" (CPMR).
To date, several examples of "genetically engineered" potyvirus
resistance have been demonstrated. This review chapter will summarize the
various results obtained and speculate on possible mechanisms of resistance.
In this review "virus-specific resistance" refers to those cases where a transgenic
plant expressing a viral cistron is resistant to the virus from which the
transgene was derived. "Broad spectrum resistance" refers to those cases in20
which a transgenic plant is resistant to a virus other than the virus from which
the transgene was derived.
Coat protein mediated resistance (CPMR)
The first example of CPMR to a potyvirus was presented by Stark and
Beachy (1989). They reported that transgenic tobacco plants expressing the CP
of soybean mosaic virus (SMV) were resistant to the potyviruses tobacco etch
virus (TEV) and potato virus Y (PVY). Stark and Beachy referred to the ability
of a potyvirus CP to confer resistance to a distantly related (heterologous)
potyvirus as "broad spectrum" resistance. Shortly thereafter, Lawson and co-
workers (Lawson et al., 1990) published the first report of virus-specific CPMR
to a potyvirus. Since these two initial reports, numerous examples of both
virus-specific and broad spectrum potyvirus CPMR have been described
(summarized in Table II.1.). Select examples are discussed in this section.
In the report of Stark and Beachy (1989), transgenic tobacco (N. tabacum
cv. Xanthi) plants expressing the CP of SMV were challenged with various
dilutions of purified preparations of TEV and PVY. Since tobacco is a non-host
for SMV, virus-specific CPMR could not be tested with this system. Six
transgenic plant lines were analyzed for virus resistance. Transgenic plant line
1052, while not the highest CP accumulating line (SMV CP= 0.15% total soluble
protein), was the most resistant of the six lines examined. Resistance was
manifested as a delay in the appearance of symptoms and an attenuation of
symptoms. To examine the effect of SMV CP levels on protection, plants of line
1052 (heterozygous or homozygous for the CP gene) were generated. Plants of
line 1052, homozygous for the CP gene, express 2-3 times more SMV CP than21
Table ILL aAbbreviations used are: (high)= high virus inoculum levels;
(low)= low virus inoculum levels; S= wild type susceptibility; R= resistance
characterized by one or more of the following : delay in appearance of
syptoms, symptom attenuation, ability to outgrow infection or a reduction in
virus titer; HR= highly resistant--resistance is typified as described in R, only
to a greater degree; CR= complete resistance, no detectable symptoms or virus
after challenge. Note: R and HR designations are relative and should only be
compared when the same transgenic plant line has been inoculated with
different viruses.
Other abbreviations used are as follows: SMV, soybean mosaic virus;
PVY, potato virus Y; TEV, tobacco etch virus; TVMV, tobacco vein mottling
virus; TVBMV, tobacco vein banding mosaic virus; PRV, papaya ringspot virus;
PeMV, pepper mottle virus; ZYMV, zucchini yellow mosaic virus; PPV, plum
pox virus; WMV H, watermelon mosaic virus II; CYVV, clover yellow vein
virus; BYMV, bean yellow mosaic virus; PeaMV, pea mosaic virus; TuMV,
turnip mosaic virus. PC= personal communication.Table II.1. Examples of Coat Protein Mediated Resistance:
Expression of full length potyviral coat proteins in transgenic plantsa
Host plant
CP
expressed
ChallengingResistance
virus phenotypeReference
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N. tabacum SMV PVY (low)
cv. Xanthi nc PVY (high)
TEV(low)
TEV (high)
TVMV
TVBMV
N. tabacum PRV TEV
cv. Xanthi nc PVY
PeMV
N.tabacum ZYMV TEV
cv. Samsun
Cucumis melo ZYMV ZYMV
S. tuberosum PVY PVY
N. tabacum PVY PVY
PPV PPV
PRV PRV
TEV
N. tabacum TVMV TVMV
cv. Burley 21 TEV
PVY
N. benthamiana
and N. clevelandii
Carica papaya
N. tabacum
cv. Burley 49
TEV
PVY
TVMV
N. benthamiana WMV II WMV II
Or CYVV
ZYMV BYMV
TEV
PeMV
PVY
PeaMV
N. benthamiana BYMV BYMV
PeMV
TuMV
R
S
R
R
S
S
Stark and Beachy, 1989;
Thompson et al., 1992
R to HR Ling et al., 1991
R
R
R Fang and Grumet, 1993
CR Fang and Grumet, 1993
S to HR Lawson et al.,1990;
Kaniewski et al., 1990;
Farinelli et a1.,1992
S to R van der Vlugt et a1.,1992;
Woloshuk et a1.,1992
R Regner et al., 1992
S to CR Fitch et al.,1992
R to HRLindbo and Dougherty,
S 1992a
S
S Hunt, A. (PC)
R
R
HR Namba et a1.,1992
R
R
R
R
R
R
R
S
S
Hammond and Kamo,
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heterozygous (CP gene) plants and displayed a higher level of resistance to
TEV or PVY challenge. They also noted that the degree of resistance could be
reduced by challenging plants with higher inoculum levels and that older
plants were more resistant than younger plants.
Thompson and colleagues recently re-examined the resistance of line
1052 by challenging the plants with high inoculum levels (infected plant sap) of
TEV, PVY, tobacco vein mottling virus (TVMV), or tobacco vein banding
mosaic virus (TVBMV) (Thompson et ai., 1992). Line 1052 again showed some
resistance to TEV, but displayed little resistance to the other potyviruses tested.
This work confirmed the earlier observation by Stark and Beachy that challenge
inoculum dose could affect resistance.
The first report of virus-specific CPMR to a potyvirus involved
transgenic potato plants transformed with the PVY CP gene alone, or co-
introduced with the potato virus X (PVX) CP gene (Lawson et a1.,1990). The
PVY gene construct inserted into the potato genome consisted of the entire PVY
CP coding sequence and PVY 3' untranslated sequence (UTS). This construct
resulted in the production of a PVY CP with minor amino acid changes at the
N-terminus. Four transgenic lines were selected and tested for resistance
against PVY and PVX. One line (303) showed apparent immunity to both PVY
and PVX when challenged with these viruses. The three remaining lines
showed varying degrees of resistance to PVY and PVX challenge. These
transgenic potato lines also were shown to be resistant to aphid-vectored PVY
inoculum. Field studies of these four transgenic lines have been performed
(Kaniewski et a1.,1990). These studies resulted in observations similar to those
obtained with plants grown under controlled conditions. Interestingly, as was
observed in the study with SMV CP-expressing tobacco, there was no24
correlation between accumulation of potyviral CP and the level of resistance
observed; in fact, the most PVY-resistant line (line 303) accumulated little to no
detectable PVY CP.
The Gonsalves research group (Cornell University, USA) has studied
several examples of CPMR, investigating virus-specific and broad spectrum
resistance (Ling et al., 1991; Namba, et al., 1992; Fitch et al., 1992). A chimeric
gene composed of cucumber mosaic virus- (CMV) and papaya ringspot
potyvirus- (PRV) derived sequences was generated and inserted into the
genome of N. tabacum cv. Havana 423 (Ling et al., 1991). This gene produced a
chimeric protein of 16 CMV amino acids (aa) fused to the amino terminus of the
PRV CP. As tobacco is not a host for PRV, transgenic plant lines were
challenged with TEV, PVY, or pepper mottle potyvirus (PeMV). Most of the
eight tested transgenic plant lines displayed resistance to TEV, exhibited as a
delay in symptom expression, attenuated symptoms, and lower virus titers as
assayed by enzyme-linked immunosorbent assay (ELISA). The best protected
line (I-26) did not display symptoms until 25-30 days after all controls were
symptomatic. Plants of line 1-26, however, tested positive for TEV by ELISA
several days before symptoms appeared. Infected plants of line 1-26 were
observed to "outgrow" TEV-induced symptoms; that is, newly emerging leaves
would demonstrate progressively fewer and fewer symptoms, until new
growth appeared asymptomatic. Line 1-26 also was demonstrated to be
resistant to PeMV and PVY, showing a delay in symptoms of ca. 10 days for
PeMV and ca. 5 days for PVY. As observed by Stark and Beachy (1989) and
Lawson and co-workers (1991), plant lines accumulating the most CP were not
the most resistant.25
In an effort to compare the efficacy of virus-specific and broad spectrum
CPMR, the Gonsalves group generated transgenic N. benthamiana plants
expressing either the watermelon mosaic virus II (WMV II) CP- or zucchini
yellow mosaic virus (ZYMV) CP-gene (Namba et al., 1992). Transgenic plants
were obtained that accumulated WMV II CP at levels of 0.1% to 0.7% of the
total soluble protein. None of the ZYMV CP transgenic plants accumulated CP
at a level greater than 0.1% total soluble protein. Three selected (R1 generation)
lines of each of the two types of transgenic plants were challenged with WMV
II. The best protected WMV II CP- and ZYMV CP-accumulating transgenic
lines were analyzed further. These two transgenic plant lines were challenged
with a battery of potyviruses including WMV II, bean yellow mosaic potyvirus
(BYMV), PVY, pea mosaic potyvirus (PeaMV), clover yellow vein potyvirus
(CYVV), PeMV, and TEV. The WMV II CP gene-expressing line showed delays
in symptom expression with all potyviruses examined, but the extent of the
delay and percentage of escapes (asymptomatic plants) varied with the
particular virus and inoculum titer. In general, the plants were most resistant
to challenge by WMV II; followed by the potyviruses BYMV, TEV, and PeMV;
with the least resistance to PVY and PeaMV. In general, the WMV II CP
transgenics displayed better resistance than transgenic plants accumulating
ZYMV CP.
The ability of ZYMV CP to participate in CPMR also has been examined
by Fang and Grumet (1993). Transgenic melon (Cucumis melo L. Hale's Best
Jumbo) and tobacco plants (N. tabacum cv. Samsun) were generated which
expressed the ZYMV CP gene sequence. The transgenic melons were protected
against ZYMV challenge, while the transgenic tobacco only showed a slight
delay in symptom development and reduction in virus titer (by ELISA analysis)
when challenged with TEV or PVY.26
Transgenic tobacco (N. tabacum cv. Burley 49) plants accumulating the
TEV CP have been constructed and challenged with TEV, PVY, and TVMV
(Lindbo and Dougherty, 1992a). In these studies, plants were challenged with
high inoculum levels (1:10 dilutions of infected plant sap) of virus. Inoculation
with TEV resulted in plants that developed symptoms at wild-type rates, but
then "outgrew" the infection ca. 3-5 weeks post inoculation. These same plant
lines were completely sensitive to infection with PVY and TVMV.
Transgenic tobacco (N. tabacum cv. Burley 21) expressing the TVMV CP
gene have been generated and challenged with 1 gg/ ml of purified virus of
TVMV, PVY, or TEV (A. Hunt, personal communication). Interestingly, such
plants were more resistant to both TEV and PVY challenge than to TVMV
challenge. This is one of the few cases where broad spectrum resistance
appears more robust than virus-specific resistance.
Recently, two perennial plant species have been engineered to express
potyvirus CP gene sequences. Transgenic papaya expressing PRV CP (Fitch et
al., 1992) and transgenic apricot expressing plum pox potyvirus (PPV) CP
(Laimer da Camara Machado et al., 1992) have been generated. In the case of
papaya, wild type sensitivities, intermediate, and high levels of resistance have
been identified in separate transgenic plant lines. The resistance phenotype of
transgenic apricot plants has not yet been reported.
CPMR with truncated or chimeric coat proteins
This section deals with transgenic plants which express altered forms of
potyvirus CPs (Table 11.2.). To date, only a limited number of plants expressing
truncated or chimeric CPs have been described.27
Table 11.2. Examples of Coat Protein Mediated Resistance: Expression of
truncated or chimeric potyvirus coat proteins in transgenic plantsa
Host plant CP form expressed
Challenging
virus
Response to
challenging virusReference
N. tabacum TEV AN29
TEV AC18
TEV AN/C
ZYMV AN41
ZYMV AN41
BYMV/ZYMV
BYMV/PeMV
'TEV
PVY
TVMV
TEV
PVY
TVMV
TEV
PVY
TVMV
TEV
PVY
ZYMV
BYMV
TuMV
PVY
BYMV
TuMV
PVY
R
S
S
R
R
R
R
S
R
S
R
Lindbo and
Dougherty,
1992a
Fang and
Grumet, 1993
Fang and
Grumet, 1993
Hammond and
Kamo, 1992
Hammond and
Kamo, 1992
cv. Burley 49
N. tabacum
cv. Samsun
Cucumis melo L.
Hate's Best
junbo
N.benthamiana
N.benthamiana
a Abbreviations used are as described for Table II.1.
Other abbreviations used are as follows: BYMV/ZYMV, BYMV-ZYMV
chimeric coat protein(CP); BYMV/PeMV, BYMV-PeMV chimeric coat protein;
Thy AN29, amino (N)-terminal 29 amino acids (aa) deleted from TEV CP; TEV
AC18, carboxy(C)-terminal 20 aa deleted from TEV CP; TEV AN/C, N- and C-
terminally truncated TEV CP; ZYMV AN41, ZYMV CP lacking the 41 N-
terminal aa. Other abbreviations used are as described in Table 11.1.28
Potyvirus CPs contain an internal "core" sequence of amino acids (aa)
which are highly conserved among the group (Shulda and Ward, 1989). The
most variable regions of potyvirus CPs are adjacent to the amino- (N-) and
carboxy- (C-) termini. In an effort to examine the ability of mutated forms of a
potyvirus CP to confer resistance, we have generated transgenic plant lines
which express one of several different forms of the TEV CP gene (Lindbo and
Dougherty, 1992a), including truncations which flank the conserved "core"
sequence of amino acids. Transgenic tobacco (N. tabacum cv. Burley 49) plants
have been constructed which express the full length TEV CP (FL lines) or one of
the following truncated forms of CP:(1) a CP lacking the N-terminal 29 aa
(AN29 lines); (2), a CP form in which the C-terminal 20 aa were replaced by 7
non-TEV encoded amino acids (AC18 lines), or (3) a CP lacking both the N- and
C- terminal sequences (AN/C lines).
We have examined 8 to 10 individual transformants of each line
homozygous for the CP gene sequence (Lindbo and Dougherty, 1992a;
unpublished results). Mechanical inoculation of these lines with high titers of
TEV (1:10 dilution of TEV-infected plant sap) resulted in distinct symptoms for
different lines. Transgenic plant lines that accumulated the AN29 form of TEV
CP were similar to lines that express the FL version of the TEV CP gene in that
they showed little or no delay in the initial appearance and severity of TEV-
induced symptoms. However, TEV-infected plants from these lines eventually
recovered (outgrew) and new growth was devoid of symptoms and virus.
Transgenic plant lines expressing either AC18 or AN/C truncated forms of the
TEV CP gene showed a significant delay in the appearance of TEV-induced
symptoms. Additionally, in AC and AN/C lines, some plants never developed
symptoms, and symptoms, when present, were attenuated. Symptomatic
plants were systemically infected with TEV while asymptomatic tissue was29
determined by ELISA and bioassay procedures to be free of virus. Protoplasts
derived from all of these various TEV CP transgenic plant lines supported viral
replication at levels similar to untransformed N. tabacum cv. Burley 49
protoplasts. This suggested that the various versions of the TEV CP were
effective at interfering with virus movement inside the plant and not with virus
replication per se.
Fang and Grummet (1993) have generated transgenic plants expressing a
ZYMV CP lacking the amino terminal 41 amino acids. This truncated CP
construct was not as effective as full length ZYMV CP in conferring resistance
to ZYMV in transgenic melon, or to TEV or PVY in transgenic tobacco.
Hammond and Kamo have generated transgenic plants expressing
chimeric CP genes composed of BYMV and PeMV (BYMV-PeMV) sequences,
or BYMV and ZYMV sequences (BYMV-ZYMV) (Hammond and Kamo, 1992).
Transgenic plants expressing the BYMV-ZYMV fusion protein had a resistance
phenotype similar to transgenic plants which produced BYMV CP (i. e. BYMV
resistant, TuMV and PVY sensitive). However, the BYMV-PeMV transgenic
plant lines, while sensitive to TuMV, were resistant to both BYMV and to PVY.
Upon DNA sequence analysis of the PeMV transgene component, the
possibility was raised that the BYMV-PeMV chimera is actually a BYMV-PVY
chimera. Resistance to PVY in these transgenic plants was possibly due to the
"PeMV"-derived amino acids in the coat protein fusion, or the 3' UTS of the
chimeric gene. This experiment raises the possibility of extending the spectrum
of broad spectrum resistance through the construction of chimeric potyvirus CP
genes.30
Characteristics of CPMR
It is clear that virus CPs can be effective in conferring virus specific and
broad spectrum resistance to potyviruses. Although the results are somewhat
confusing, the following generalizations of CPMR can be made:
1. The resistance phenotype can be expressed as:
a) a temporal delay in the development of symptoms.
b) an attenuation of normal virus-induced symptoms.
c) lower virus titer in infected transgenic tissue.
d) the ability of infected plants to "outgrow" infection.
e) a percentage of plants which escape infection.
2. Resistance phenotypes usually can be overcome by high levels of
virus inoculum.
3. Resistance is more effective in older plants than in younger plants.
4. Virus-specific CPMR tends to be more effective than broad spectrum
CPMR.
5. Truncated or chimeric forms of CPs can (in some cases) be used to
increase the effectiveness and/or spectrum of CPMR.
6. There does not appear to be a correlation between CP accumulation
and resistance.
7. Many lines which accumulate CP showed virus susceptibilities
identical to untransformed parental tissue.31
Transgenic plants accumulating nonstructural proteins
Although CP sequences have been the most thoroughly investigated for
their ability to confer resistance, other potyviral genes have been examined as
well. This section will discuss some of the results obtained with transgenic
plants expressing nonstructural potyviral proteins (Table II.3.).
N. tabacum cv. Xanthi plants were generated by Berger and co-workers
(Berger et a1.,1989) to express a polyprotein of the first three genes of TVMV
[P1, helper component-proteinase (HC-PRO), and 42 K genes (see Fig. II.1)].
The P1 and HC-PRO proteins of potyviruses contain proteolytic activities
which self-cleave at their carboxyl termini. As a result of these proteolytic
activities, the transgenic plants accumulated fully processed HC-PRO which
had biologically active helper component activity. These plants were not
analyzed for steady state levels of the P1 or 42K proteins. Challenge inoculation
of these transgenic plants with TVMV resulted in no protection, and symptom
formation similar to untransformed controls (J. Shaw, personal
communication).
Transgenic plants expressing the TVMV nuclear inclusion protein a
(NIa) or cytoplasmic inclusion (CI) protein (see Fig II.1.) have been generated
and preliminary screening for resistance to PVY, TEV, and TVMV performed
(A. Hunt, personal communication). Transgenic N. tabacum cv. Burley 21 plants
expressing the TVMV NIa protein or a fusion protein of NIa and the bacterial
glnH (glutamine H) gene (NIa-glnH) were highly resistant to TVMV, but were
susceptible to PVY and TEV. Only one transgenic plant line producing TVMV
CI has been examined to date and has not displayed resistance to TVMV. N.
tabacum cv. Xanthi nc expressing the TEV 49K (NIa), 58 K (NIb), or HC-Pro
genes have been generated and accumulated the expected viral proteins
(Carrington et a1.,1990; Restrepo-Hartwig and Carrington, 1992). ChallengeTable 11.3. Examples of potyvirus nonstructural protein genes
expressed in transgenic plants'
Host plant
Non-structural
protein gene
expressed
Challenging
virus
Response to
challenging virusReference
N. tabacum TVMV NIa or TVMV HR A. Hunt (PC)
cv. Burley 21TVMV NIa-glnH TEV S
PVY S
N. tabacum TVMV HC-PRO TVMV S J. Shaw (PC)
cv. Xanthi
N. tabacum TVMV CI TVMV S A. Hunt (PC)
cv. Burley 21
N. tabacum TEV HC-PRO TEV S J. Carrington
cv. Havana 425TEV NIa TEV S (PC)
TEV NIb TEV S
32
a Abbreviations used are as described for Tables 11.1 and 11.2. Other
abbreviations used are as follows; NIa, nuclear inclusion protein a; NIa-glnH,
NIa-glnH fusion protein; glnH, bacterial glutamine H gene; NIb, nuclear
inclusion protein b; HC-PRO, helper component-proteinase, CI, cytoplasmic
inclusion protein. See Fig II.1. for genomic location of these coding regions.
(PC)= personal communication.33
inoculation with TEV revealed these plants were susceptible to TEV at a level
nearly identical to untransformed control plants (J.C. Carrington, unpublished
observations).
Transgenic plants expressing potyviral RNA sequences
Untranslatable sense-stranded RNAs of the TEV coat protein gene
sequence have been shown to confer TEV resistance (Table 11.4.) in transgenic
N. tabacum cv. Burley 49 plants (Lindbo and Dougherty, 1992a; 1992b). A single
nucleotide insertion (frameshift mutation) and four point mutations were
introduced in the TEV CP gene. These mutations introduced stop codons at the
5th, 6th, and 9th codons in the gene. The resulting mutated form of the TEV CP
gene (called an RNA Control, or RC form) did not direct the synthesis of
detectable levels of TEV CP in planta. Approximately 40% of the transgenic
plant lines examined displayed a resistance phenotype which was absolute; no
virus was detectable after challenge inoculation with TEV. The remaining RC
lines, all expressing the untranslatable RNA, behaved as untransformed
tobacco and displayed typical virus symptoms when inoculated. Protected
transgenic lines withstood high inoculum doses of all isolates of TEV tested,
but were susceptible to the potyviruses PVY and TVMV. Resistance was virus-
specific, but not isolate specific. The resistance in RC transgenic plants was
quite durable, as it was effective against mechanically- or aphid-transmitted
TEV and also was effective in transgenic plants 2-3 weeks old (the youngest
age tested). Protoplasts from resistant RC transgenic plants were transfected
with TEV RNA. These cells did not support the production of detectable levels
of TEV protein or infectious particles. However, as observed with coat protein
expressing transgenic lines, a correlation between steady state RNA levels and
protection could not be established.34
Table 11.4. RNA-mediated resistance to Potyvirusesa
Host plant RNA expressed
Challenge
virus
Response to
challenge virusReference
N. tabacum TEV-CP AS RNA TEV S or R Lindbo and
cv. Burley 49 PVY
TVMV
S
S
Dougherty,
1992a; 1992b
N. tabacum TEV-CP RNA Control TEV S or CR Lindbo and
cv. Burley 49(RC) PVY
TVMV
S
S
Dougherty,
1992a; 1992b
N. tabacum PVY-CP RNA (-ATG) PVY S or R van der Vlugt
et a1..,1992 cv. SR1
N. benthamiana BYMV-CP AS RNA BYMV S. R or CRHammond and
TEV S Kamo, 1992
TuMV S
Cucumis melo ZYMV-CP AS RNA ZYMV R Fang and
L. 'Hales Best Grumet, 1993
Jumbo'
N. tabacum ZYMV-CP AS RNA TEV R Fang and
cv. Samsun PVY R Grumet, 1993
aAbbreviations used are as described for Table III Other abbreviationsare as
follows: AS, antisense; RC, RNA Control (untranslatable sense RNA); (-ATG),
CP gene lacking an ATG start codon.35
Transgenic tobacco (N. tabacum cv. SR1) plants expressing the PVY CP
gene lacking an AUG start codon (PVY CP"ATG) have also been generated.
Such transgenic plant lines express a sense strand PVY CP RNA but no CP.
Approximately 20% of the transgenic plant lines tested were reported to be
resistant to PVY (van der Vlugt et al., 1992).
Selected transgenic plants accumulating potyvirus complimentary, or
antisense (AS), RNA sequences have been shown to exhibit a virus-resistant
phenotype. Antisense RNA-mediated resistance has been reported for the
potyviruses ZYMV, BYMV, and TEV (Fang and Grumet, 1993; Lindbo and
Dougherty, 1992a; Hammond and Kamo, 1992) (Table 11.4.). In some cases the
transgenic constructs have included viral-derived 3' UTS (Fang and Grumet,
1993; Hammond and Kamo, 1992), though the effect of expressing this portion
of the potyvirus genome is not known. When challenged with virus, transgenic
plants expressing AS sequences responded to virus infection by displaying
phenotypes which ranged from wild-type sensitivities to apparent complete
resistance. Only in plants expressing ZYMV CP AS RNA, was a low level of
broad spectrum resistance detected; BYMV and TEV CP AS RNA plants
displayed only virus specific resistance. In these studies there was no
consistent correlation between steady state levels of antisense transcripts and
resistance. These observations are reminiscent of the results observed for
transgenic plant lines expressing potyviral CP sense mRNA and CP.36
Summary and Discussion
The disparate results obtained for PDR with potyviruses make it difficult
to hypothesize a single unifying mechanism for resistance. Interpretation of
results is further complicated by the wide variety of systems and genetic
constructs used. In general, experiments designed to investigate the
mechanism(s) of resistance are limited. Below, I detail some working models
which may explain some results summarized in this chapter.
In its simplest form, virus resistance could be due to the transgene
product directly interfering with one (or more) of several viral processes such
as replication, assembly, or movement. In our studies (Lindbo and Dougherty,
1992a) with transgenic plants expressing a FL TEV CP, TEV-challenged plants
initially developed symptoms and virus titers similar to wild-type plants.
Similarly, protoplasts from these transgenic plants appeared to support virus
replication at wild-type levels. However, these transgenic plants consistently
outgrew infection and young emerging leaf tissue was asymptomatic and
devoid of virus. Untransformed control plants never were observed to
outgrow TEV infection. Collectively, these results suggest virus movement
might have been impaired, especially as the infected plant grew older.
However, some recent preliminary studies could require modification of this
simplistic model. In a study in which the upper virus-free leaves of a
"recovered" FL transgenic plant were challenged with TEV, a systemic or
localized infection could not be established (WGD, unpublished observations).
Thus it appears as though a "virus resistant" state had been achieved in these
leaves. This virus resistant state may be host-encoded and induced by the
interaction of the transgene, viral, and host genomes. A similar phenomenon
occurs in transgenic plants which express AN29 truncated forms of the TEV CP.37
Perhaps most perplexing in the phenomenon of CPMR is the lack of
correlation between CP gene expression level and resistance. In many of the
examples cited in this review, transgenic plants expressing potyvirus CPs
showed little or no resistance in response to challenge with virus. All gene
expression estimates, however, have been made at a very gross level (i.e.
expression levels of a piece of tissue have been extrapolated to represent
expression on a per cell or whole plant basis). This may not be entirely
appropriate. Due to "position effects," different gene expression levels and
patterns (Barnes, 1990) (cell-specific expression patterns) can exist in different
transgenic plants containing the same transgene. It may be that all cells (or
only a specific subset of cells) of a plant or tissue need to express a certain basal
level of transgene product to confer resistance. Since transgene expression
analysis has not yet been performed on a cellular level, it is currently
impossible to determine if this is the case.
Therefore, we are left with a variety of CPMR studies in which no dear
mechanistic theme can be definitively applied to all examples. It is conceivable
that no one single mechanism dominates or exists. Rather, multiple
mechanisms may be in effect and operate with different efficiencies in different
transgenic plants and different host-pathogen systems. Since potyvirus
genomes are small (compared to other biotic pathogens), it is reasonable to
expect that their proteins are often multifunctional. Therefore, expression of
one virus gene product could theoretically alter multiple viral and/or host
processes. Much work remains to be done on elucidating the mechanism of
CPMR toward potyviruses. A central question to be initially addressed is
whether the coat protein is directly or indirectly responsible for the resistance
phenotype in transgenic plants.38
Most transgenic plants expressing a potyvirus non-structural gene were
not virus resistant. The exception to this was transgenic tobacco plants
expressing the TVMV NIa gene. These lines were resistant to TVMV, while
similar plants expressing TEV NIa genes were not resistant to TEV. The TEV
NIa protein is known to be directed to the nucleus (Restrepo-Hartwig and
Carrington, 1992) when expressed in planta, whereas it is not known if the
TVMV NIa protein has this characteristic. The nuclear localization of the TEV
NIa protein may prohibit it from interfering with cytoplasmically localized
viral functions. Although results with transgenic plants expressing potyvirus
non-structural proteins have been, in most cases, disappointing, these
observations do not necessarily infer that these proteins will be unable to confer
resistance. These negative results may instead be a result of small sample size
and the preliminary nature of these studies. Alternatively, mutated forms of
these genes could be effective in conferring viral resistance.
A remarkably high degree of (virus specific) resistance has been
obtained with plants expressing untranslatable sense or antisense CP RNAs. It
has been proposed that these untranslatable RNAs interfere with virus
replication, perhaps by hybridizing to plus or minus sense virusgenomes. In
transgenic plants expressing an untranslatable plus-sense RNA (RC), resistance
was dramatic. In the TEV system, the resistance was TEV-specific and
independent of plant age or virus inoculum levels. No TEV replication could
be detected in resistant transgenic plants or protoplasts. Complicating this
system, however, was the observation that not all plant lines expressing an RC
CP RNA sequence were resistant. Approximately 40% of the independent
selections of the various RC-producing transgenic lines display resistance. I
have proposed that the RC molecule inhibits replication by hybridizing to
minus sense TEV RNA genomes. I have also suggested that the failure ofsome39
lines to display the resistant phenotype was attributable to tissue specific
expression patterns. However, in light of preliminary data regarding the
apparent virus resistant state in "recovering" CP-producing transgenic plants
(see discussion above), I believe it prudent to ask if the untranslatable RNA
actually is the molecule in the host cell which arrests virus replication. For
example, could the RC or AS RNAs induce a host-mediated virus resistant state
similar to what may be happening in CP-expressing plants that "outgrow"
infection? Perhaps, RC or AS gene constructs can interfere with the expression
of host or virus genes, by a phenomenon similar to "co-suppression" reported
for some transgenic plants (Napoli et a1.,1990; van der Krol et a1.,1990; de
Carvalho et al., 1992). A better understanding of these phenomena could lead
to important improvements in the generation (and understanding) of virus
resistance in plants.
In addition to providing effective resistance, RNA-mediated resistance
has a number of advantages over protein-mediated resistance strategies.
Concerns have been raised as to the possibility of "new" viable viruses being
formed through transencapsidation of viral genomes with CPs expressed from
transgenic plants, or by RNA-recombination between a virus genome and a
transgene mRNA (de Zoeten, 1991). It has been recently demonstrated that
transencapsidation can occur in transgenic plants (Farinelli et al., 1992) Both of
these concerns could be alleviated by expressing dysfunctional viral genes
(such as untranslatable RNA sequences) in transgenic plants. Additionally,
regulatory approval of plants expressing a mutated RNA may be less
problematic than a plant expressing both a viral RNA and protein. Finally, the
RNA-mediated resistance rendered the plant highly resistant to virus
replication and, as a result, may be very difficult for a virus to overcome. I
suggest the virus will not have the opportunity to replicate and adapt to the40
RC-producing cells. Over time this may be a limitation of CPMR since it does
allow a reduced level of virus replication.
In conclusion, it is encouraging that, in addition to the well established
phenomenon of CPMR, alternative effective resistance strategies are appearing.
These strategies include the expression of mutated (dysfunctional?) CPs,
chimeric CPs, non-structural proteins, and RNA (sense or antisense) mediated
resistance. Further studies performed on each of these different strategies may
lead to our understanding of the mechanism(s) involved in virus resistance
allowing for a more rational approach in designing virus resistant plants.41
CHAPTER III
PATHOGEN DERIVED RESISTANCE TO A POTYVIRUS:
IMMUNE AND RESISTANT PHENOTYPES IN TRANSGENIC TOBACCO
EXPRESSING ALTERED FORMS OF A
POTYVIRUS COAT PROTEIN NUCLEOTIDE SEQUENCE
Abstract
Transgenic Nicotiana tabacum cv. Burley 49 plants containing one of
six different forms of the Tobacco Etch Virus (TEV) coat protein (CP)
nucleotide sequence have been generated. In whole plant studies, R1 and R2
progeny were inoculated mechanically with TEV and the appearance and
severity of symptoms recorded. Symptom phenotype was altered, ranging
from near wild-type susceptibility to apparent immunity. Protoplasts
derived from wild-type and transgenic Burley 49 plant lines were transfected
with TEV RNA. Protoplasts from transgenic plants expressing full-length or
truncated forms of TEV CP supported virus replication. Protoplasts from
certain transgenic plants, producing plus- or minus-sense CP transcripts but
no CP, did not support virus replication at wild-type levels. A model is
proposed to account for these observations.42
Introduction
The theory of pathogen derived resistance (Sanford and Johnston,
1985) predicts that a "normal" host-pathogen relationship can be disrupted if
the host organism expresses certain pathogen derived genes. It has been
proposed that host organisms expressing pathogen gene products in excess
amounts, at the inappropriate developmental stage, or in a dysfunctional
form may disrupt the normal replicative cycle of the pathogen and result in
an attenuated or aborted infection of the host.
It has been demonstrated that transgenic plants expressing a plant
virus coat protein can be resistant to infection by the homologous virus.
This type of pathogen derived resistance has come to be known as coat
protein-mediated resistance and has been demonstrated for the tobamo-,
potex-, cucumo-, tobra-, carla-, poty- and alfalfa mosaic virus groups (for
review see Beachy et al., 1990) and more recently for the luteovirus group
(Kawchuk et al., 1990, 1991).I have undertaken experiments to investigate
the efficacy and mechanism of this form of pathogen derived resistance for
the potyvirus group.
The potato virus Y, or Potyvirus genus, contains a large number of
plant viral pathogens which collectively can infect most crop species and
compromise crop yield and/or quality (Hollings and Brunt, 1981; Matthews,
1982; Francki et al., 1985). Potyviruses have a single-stranded, "plus sense"
RNA (of about 10,000 nucleotides) which has a viral-encoded protein linked
to the 5' end and a 3' polyadenylate region. A single open reading frame
(ORF) codes for a 351,000 dalton (351 kDa) polyprotein which is
proteolytically processed into mature viral gene products (Allison et al.,
1985b, 1986b; Dougherty and Carrington, 1988). The RNA is encapsidated by43
approximately 2000 copies of a coat protein monomer to form a virion
(Hollings and Brunt, 1981). The capsid protein is encoded by the sequence
present at the 3' end of the large ORF (Allison et al., 1985b)
I have generated a series of transgenic plants expressing either full-
length or truncated forms of the coat protein (CP) of the potyvirus tobacco
etch virus (TEV). Additionally, transgenic plants were generated which
expressed either an antisense (AS) form of the CP RNA sequence or a
"sense" stranded CP RNA molecule (RC) with a frameshift mutation,
rendering it untranslatable. R1 and R2 progeny plants were screened by
Western and/or Northern blot analysis for expression of the transgene.
Expressing plant lines were inoculated mechanically with TEV and
symptoms recorded. Truncated forms of the TEV CP tended to confer greater
protection than the full-length CP. Select plant lines expressing either AS or
RC transcripts were highly resistant. In protoplast transfection studies, all
lines which produced CP supported viral replication, while those lines
which expressed high levels of AS or RC RNA did not support replication at
wild-type levels. These results suggest that the resistant phenotypes
observed function via at least two different mechanisms in these transgenic
plant lines.44
Materials and Methods
All restriction enzymes were purchased from New England Biolabs,
unless specified, and used according to manufacturers instructions. Plasmids
were maintained in E. coli strains HB101 or TG1. Radioactive isotopes were
purchased from New England Nuclear. T7 and SP6 RNA polymerases were
purchased from Bethesda Research Laboratories. Rabbit reticulocyte lysate
was purchased from Green Hectares, Oregon, WI. Plasmid pCGN 2113 was a
kind gift from Calgene (Davis, California). Agrobacterium tumefaciens
strain A136/pCIB 542, pRK2013, pCIB 710, and pCIB 200 were kind gifts of
Ciba Geigy Corporation (Research Triangle Park, North Carolina).
Mutagenesis of pTL 37/8595
Plasmid pTL 37/8595 (Carrington and Dougherty, 1987; Carrington et
al., 1987) contains a cDNA copy of the genomic sequence of the highly aphid
transmissible (HAT) isolate of TEV corresponding to nucleotides (nt) 1-200
and nt 8,462-9,495. The first and last codons of the CP coding region in the
TEV genome are nt 8,518-8,520 (Ser) and 9,307-9,309 (opal), respectively. (For
numbering of TEV nucleotides, see Allison et al., 1986). pTL 37/8595 was
subjected to in vitro site-directed mutagenesis using the method developed
by Taylor et al. (1985 a,b). In all cases, nucleotide changes were confirmed by
dideoxy-nucleotide sequencing (Sanger et al., 1977).
TEV nt 9,312-9,317 were first mutated (Fig. III.1) to generate a BamHI
restriction site. TEV nt 8,516-8,521 were then altered to generate an NcoI site,
changing the first codon of the TEV CP coding region from AGT (Ser), to
ATG (Met). A single oligonucleotide was then used to mutate TEV nt 133-45
Fig. HU. Schematic representation of pTC: FL and its construction.
Restriction endonuclease sites were introduced into pTL 37/8595 at positions
A, B and C in diagram. Following these nucleotide changes the mutated pTL
37/8595 was digested with the restriction enzyme Ncol, the DNA fragment
delineated by the restriction enzyme sites at B and C was removed, and the
plasmid religated to generate pTC: FL. pTC:FL contains the tobacco etch
virus (TEV) coat protein nucleotide sequence flanked by BamHI restriction
sites and the TEV 5' and 3' untranslated sequences (UTS). T7 and SP6
promoters are also shown. Abbreviations used in this diagram are as
follows: T7, T7 RNA polymerase promoter sequence; SP6, SP6 RNA
polymerase promoter sequence; ori, origin of replication; M13 ori,
bacteriophage M13 single-stranded origin of replication; ampr,11-lactamase
gene. Lightly stippled areas are TEV 5' and 3' untranslated sequences; solid
black area, TEV genome cDNA nucleotides 144 to 200; striped area, a portion
of the TEV NIb gene (TEV nt 8,462-8,517); heavily stippled areas, cDNA of
TEV CP nucleotide sequence (TEV nt 8,518-9,309).46
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138 to a BamHI restriction site, nt 143-148 to an NcoI restriction site and nt
142 to a deoxyadenylate residue. These mutations generated an NcoI site
centered on the first codon of the TEV ORF and in a good translational start
context as described by Kozak (1984). Digestion of the resulting plasmid with
the restriction enzyme NcoI, removing TEV nt 143-200/8,462-8,516, and
religation generated plasmid pTC:FL. pTC:FL contained the TEV CP gene
flanked by BamHI restriction sites and TEV 5' and 3' untranslated sequences
(see Fig III.1).
Plasmid pTC:AN29 was constructed as follows: TEV nt 8,600-8,605 in
pTC:FL were mutated to an NcoI restriction site. Digestion of the resulting
plasmid with the restriction enzyme NcoI, removal of TEV nt 8,517-8,601,
and religation generated pTC:AN29, a plasmid lacking the nucleotides which
coded for the N-terminal 29 amino acids of the TEV CP gene.
pTC:FL and pTC:AN29 were modified further to generate plasmids
pTC:LC18 and pTC:AN/C, respectively. Originally these two plasmids were
mutated to create a premature stop codon at TEV nt 9,253-9,255, such that the
18 carboxy-terminal codons would not be translated. However, subsequent
nucleotide sequence analysis of the mutagenized region revealed that a
single nucleotide deletion (TEV nt 9,249) and three point mutations (at TEV
nt 9,250-9,252) had also occurred. The resulting frameshift, 20 codons
upstream of the wild type TEV CP stop codon, negated the introduced TAG
stop codon at TEV nt 9,253-9,255 and created an in-frame TGA stop codon
eight codons downstream of the frameshift. Translation of these genes
resulted in a truncated TEV CP with the addition of seven non-TEV amino
acids (EPRQRTM) after TEV CP amino acid number 243.48
Plasmid pTC: RC (RNA control) was generated by insertion of a single
deoxythymidylate residue after TEV nt 8,529, and point mutations of TEV nt
8,522 (G-C), 8,534 (C-A), 8,542 (G-A),and 8,543(A-G) to create a frameshift
mutation immediately followed by three stop codons. An NheI restriction
site was simultaneously generated, for screening purposes, at nt 8,539-8,544.
All plasmids described above were linearized with Hind111, transcribed
with 17 RNA polymerase (Melton et al. 1984), and translated in a rabbit
reticulocyte lysate containing 35S methionine (Dougherty and Hiebert,
1980a). Radio labeled translation products were analyzed by electrophoretic
separation on a 12.5% acrylamide gel containing SDS (Laemmli, 1970) and
detected by autoradiography. Transcripts of plasmid pTC:RC produced no
detectable protein products while transcripts from all other plasmids
produced proteins of the expected sizes (data not shown).
The various forms of the CP nucleotide sequence were then inserted
as BamHI cassettes into the plant expression vector pPEV (See below and Fig.
111.2). The full length TEV CP ORF was inserted in the reverse orientation to
make the antisense (AS) construct.
Construction of pPEV
The vector pPEV is part of a binary vector system for Agrobacterium
tumefaciens mediated plant cell transformation. Plasmid pPEV was
constructed from the plasmids pCGN 2113 (Calgene), pCIB 710 and pCIB 200
(Ciba Geigy Corp.). pCGN 2113 contains the "enhanced" Cauliflower Mosaic
Virus (CaMV) 35S promoter (CaMV sequences -941 to -90/-363 to +2, relative
to the transcription start site) in a pUC derived plasmid backbone. pCIB 710
has been described (Rothstein et al., 1987) and pCIB 200 is a derivative of the49
Fig 111.2. Forms of the TEV coat protein gene inserted into Nicotiana
tabacum cv. Burley 49. All constructs contained the enhanced CaMV 35S
(Enh 35S) promoter, CaMV 35S 5' untranslated sequence (UTS) of 50 by and
the CaMV 35S 3' UTS/polyadenylation site of 110 bp. The nomenclature
used to describe the transgenic plant lines is presented along with the gene
products produced in those plant lines (far right column). Abbreviations
used are as follows: 35S, transgenic plants containing the CaMV 35S
promoter and 5' and 3' UTS only; FL, \N29, AC18, AN/C, transgenic plants
containing the transgene coding for full length TEV CP, TEV CP lacking the
amino-terminal 29 amino acids (aa), TEV CP lacking the carboxy-terminal 20
aa, or TEV CP lacking both the amino-terminal 29aa and carboxy-terminal 20
aa, respectively. AS and RC transgenic plants contain the transgene
expressed as an antisense form of the TEV CP gene, or an untranslated sense
form of the TEV CP gene, respectively. Arrowheads denote the presence of
in-frame stop codons. The various forms of the TEV CP nucleotide sequence
are shaded.TEV Coat Protein Gene Constructs Inserted Product in
into Nicotiana tabacum cv. Burley 49
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wide host range plasmid pTJS 75 (Schmidhauser and Helinski, 1985) which
contains left and right A. tumefaciens T37 DNA borders, the plant selectable
NOS/NPT II chimeric gene from the plasmid Bin 6 (Bevan, 1984) and part of
a pUC polylinker. The small EcoRI-EcoRV DNA fragment of pCIB 710
(Rothstein et al., 1987) was ligated into EcoRI-EcoRV digested pCGN 2113.
This regenerated the enhanced CaMV 35S promoter (Kay et al., 1987) of
pCGN 2113 and introduced the CaMV 35S 5' and 3' untranslated sequences
into pCGN 2113. The CaMV 35S promoter-terminator cassette of the
resulting plasmid was isolated as an EcoRI-XbaI DNA fragment and ligated
into EcoRI-XbaI digested pCIB 200 to generate pPEV. TEV CP ORFs were
cloned as BamHI cassettes into BamHI digested pPEV and orientation of
inserts confirmed by digestion with appropriate restriction endonucleases.
Plant Transformation
pPEV plasmids containing TEV CP ORFs were mobilized from E. coli
HB101 into A. tumefaciens A136 containing plasmid pCIB 542 (Ciba Geigy),
using the helper plasmid pRK 2013 in E. coli HB101 and the tri-parental
mating system of Ditta et a/.(1980). Plasmid pCIB 542 supplied vir functions
necessary for T-DNA transfer.
Leaf discs of Nicotiana tabacum cv. Burley 49 were transformed and
whole plants regenerated according to Horsch et al. (1985). Transformed
tissue was selected by culturing callus on MS plates (Murashige and Skoog,
1962) containing 111.g/m1 6-benzylaminopurine (Sigma Corp.), 0.1 µg /ml a-
naphthaleneacetic acid (Sigma Corp.), 500 1.1g/m1 carbenicillin and 100 µg /ml
kanamycin sulfate (Sigma Corp.). Shoots were rooted on MS plates52
containing 500 µg /ml carbenicillin and 100 1.1.g/m1 kanamycin sulfate and
plantlets were transplanted into soil and transferred directly into the
greenhouse approximately 2-3 weeks after rooting.
RO, R1 and R2 plants were screened by Western and/or Northern blot
analyses. R2 seeds (ca. 100 seeds per R2 plant) are screened for Kanr
phenotype by surface sterilizing seed in 10% bleach for 5 min., washing twice
in sterile water and germinating on MS plates containing 100 µg /ml
kanamycin sulfate. R2 seed lines which were 100 % kanamycin resistant
were screened by Western blot analysis for expression of TEV coat protein.
Those transgenic plant lines generated and their nomenclature are presented
in Fig. 111.2.
Western Blot Analysis
Tissue samples of transgenic plants were ground in 10 volumes of 2X
Laemmli (Tris-glycine) running buffer (Laemmli, 1970) and clarified by
centrifugation in a microcentrifuge for 10 min at 10,000xg. Protein
concentration was estimated by the dye binding procedure of Bradford (1976)
using BSA as a standard. Protein samples (50 .tg total protein) were
separated on a 12.5% polyacrylamide gel containing SDS and subjected to the
immunoblot transfer procedures described by Towbin et al. (1979). Anti -TEV
coat protein polyclonal primary antibodies, alkaline phosphatase conjugated
secondary antibodies and the chromogenic substrates NBT (para-nitro blue
tetrazolium chloride) and BCIP (5-bromo-4-chloro-3-indoyl phosphate para-
toluidine salt) were used to detect bound antigen.53
Northern Blot Analysis
Total nucleic acids were isolated from tissue and RNA precipitated
with LiC1 as described by Verwoerd et al. (1989). RNAs were
electrophoretically separated on 1.2 % agarose gels containing 6% (v/v)
formaldehyde and transferred to nitrocellulose. Prehybridization and
hybridization conditions were as described in Sambrook et a/. (1989). Strand
specific riboprobes were generated from SP6 or T7 DNA dependent RNA
polymerase transcription reactions of pTL 37/8595 linearized with the
restriction enzymes Asp718 (Boehringer Mannheim) or Hindul, respectively.
Probes were labelled with a-32P-CTP ribonucleotide and suggested
procedures (Promega).
Inoculation of transgenic plants
Eight week old (ca. 15 cm tall) R1 and R2 plants were inoculated with
either purified virus preparations or infected plant sap. Inoculum was
applied with sterile, premoistened cotton swabs. Infected plant sap
inoculum was prepared by grinding TEV-infected N. tabacum Burley 21 leaf
tissue (2 weeks post-inoculation) in carborundum and 50 mM sodium
phosphate buffer (pH 7.8) at a ratio of 1gm:0.2gm:10m1s, respectively, and
filtering the homogenate through cheesecloth. TEV virions were purified as
described by Dougherty and Hiebert (1980b). One leaf per plant was dusted
lightly with carborundum (320 grit) and inoculated at two interveinal
locations with 50 pl (total) of inoculum. Inoculated plants were examined
daily and the appearance and severity of systemic symptoms recorded.
Symptoms on any leaf above the inoculated leaf were considered to be
systemic. Ten R2 expressing plants of each of the CP expressing lines were
inoculated with infected plant sap and 20 R1 plants of lines AS #3 and RC #554
were inoculated with 50 1.11 of a 51.1g/m1 solution of purified TEV. Identical
results were obtained when AS #3 and RC #5 R1 plants were inoculated with
TEV-infected plant sap, as described above.
Preparation, inoculation and analysis or protoplasts
Protoplasts were prepared from transgenic plants and electroporated
according to the procedure of Lucianoeta/. (1987). Protoplasts (1 X 106) were
resuspended in 450 gl electroporation buffer (330 mM mannitol, 1 mM
potassium phosphate, pH 7.0, 150 mM KC1) and electroporated using a BTX
Transfector 300 (San Diego, USA) (950 microFarads, 130 volt pulse
amplitude, 3.5 mm electrode gap) in the presence or absence of 6 gg of
purified TEV RNA. After electroporation, protoplasts were incubated for 96
hours in incubation medium as described in Lucianoet al.(1987).
Protoplasts were extracted in 2X Laemmli (Tris-glycine) running buffer and 5
x104 extracted protoplastswere then subjected to Western blot analysis as
described above. Protoplast viability was measured by dye exclusion as
described in Lucianoet al.(1987). All electroporated protoplast samples had
equivalent viability counts.55
Results
Analysis of transgenic plants
I first sought to determine if the resulting transgenic Burley 49 tobacco
plants were producing the expected RNA and protein products. Total RNA
samples isolated from the various transgenic lines were analyzed in
Northern blot hybridization studies. An RNA transcript of approximately
1,000 nt was expected with all transgenic plant lines. Such a TEV CP
transcript was detected in CP expressing plant lines by using a "minus"
sense-stranded riboprobe containing the TEV CP sequence (Fig. 111.3, A and B,
lanes 1-5). A similar transcript was detected in AS plants by using a "plus"
sense-stranded riboprobe containing the TEV CP sequence (Fig. I11.3B, lane 9).
However, the transcript in the RC line (Fig. 111.3B, lane 3), while detected
with a "minus" sense riboprobe, may have migrated as a slightly larger (ca.
1100-1200 nt) RNA species, possibly due to termination at an alternately
selected site and/or a longer poly-A tail on the transcript. Differing levels of
CP transcript accumulation were observed among different transgenic plant
lines (Fig. 111.3.)
Transgenic plant lines expressing either full-length or truncated TEV
CP were identified by Western blot analysis using polyclonal antisera to TEV
CP. The various CP products produced in plants were stable and
accumulated to different levels in individual transgenic plant lines.It was
estimated by Western blot analysis that between 0.01% to 0.001 % of total
extracted protein was TEV CP. Full-length and the three truncated forms of
TEV CP could be readily distinguished in this analysis. Additionally, the
antisera cross-reacted with two high molecular weight proteins present in56
Fig. 111.3. Northern blot analysis of total RNA extracted from transgenic
plants.Samples (10 .tg) of total RNA from R2 (coat protein [CP] lines) or R1
(AS #3 and RC #5) transgenic plants were separated on a 1.2% agarose gel
containing 6% formaldehyde. RNAs were transferred to nitrocellulose
membranes and hybridized with either minus-sense TEV CP riboprobe (A
and lanes 1-5 of B) or with plus-sense TEV CP riboprobe (B, lanes 6-10). After
washing under stringent conditions, filters were exposed to Kodak X-Omat
film at -70° C. Plus or minus sense transcripts of pTL 37/8595 were used as
markers. RNA present in each lane is as follows:A. Total RNA from 35S
#4 leaf tissue with marker transcripts derived from T7 polymerase
transcription of pTL 37/8595 added (Lane 1), total RNA samples from leaf
tissue of R2 transgenic plants from lines 35S #4 (lane 2), FL #3 (lane 3), FL
#24 (lane 4), AC18 #7 (lane 5), AC18 #15 (lane 6), .N29 #1(lane 7), \N29 #2
(lane 8), AN29 #8 (lane 9), LN /C #69 (lane 10), and AN/C #61 (lane 11).
Marker transcript sizes are presented on the left side of the figures. B. Total
RNA from leaf tissue of the following transgenic plant lines: 35S #4 with
sense strand transcripts derived from pTL 37/8595 added (lanes 1 and 6), 35S
#4 (lanes 2 and 7), RC #5 (lanes 3 and 8), AS #3 (lanes 4 and 9), 35S #4 with
antisense strand transcripts (from SP6 transcription of pTL 37/8595) added
(lanes 5 and 10). The sizes of the marker RNAs are presented on the left and
right sides of the figure.A
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Burley 49. No CP was detected in extracts of the AS or RC transgenic plant
lines screened. The results from selected lines are presented in Fig. 111.4.
In general, the expected RNA and protein products were detected in
the various transgenic plant lines examined. Transcript expression levels
generally correlated with protein expression levels as determined by
Western blot analysis. Different expression levels between different
transgenic plant lines were also noted.
Inoculation of transgenic plants with virus. To estimate virus
resistance in transgenic plants expressing different forms of the TEV CP, I
challenged plants with TEV. Typically, inoculation of Burley 49 plants with
TEV (either purified virus or plant sap) resulted in severe chlorosis and
mosaic and mottle on systemically infected leaves approximately 6-7 days
after inoculation. Severe etching of the leaf followed withina few days. I
observed that transgenic plants containing only the CaMV promoter and
untranslated sequences ( i.e. the 35S plant line) responded to challenge
inoculation in a manner similar to wild type Burley 49, developing
extensive chlorosis and etching at the same rate (Fig. 111.5 and Fig. 111.6, B and
C). Plant lines that expressed either FL or AN29 forms of TEV CP showed
little, or no delay in the appearance of symptoms when inoculated with
infected plant sap (Fig. 111.5, A and C). However, FL and AN29 transgenic
plants did show a slight attenuation of symptoms and eventually (2-4 weeks
after initial appearance of symptoms) younger leaf tissue emerged devoid of
symptoms and virus as demonstrated by back inoculation experiments (data
not shown). Typically chlorosis and etching on older systemic leaves was
limited (Fig. 111.6 E and F). In contrast transgenic plant lines which expressed
AC18 or AN /C forms of TEV CP showed significant delays in theappearance59
Fig. 111.4. Western blot analysis of transgenic plants. Protein samples (50 1.1g
per lane) from leaf tissue of transgenic plants were separated on a 12.5%
polyacrylamide gel containing SDS, and transferred to nitrocellulose. After
blocking with 3% gelatin, bound antigen was detected with rabbit anti-TEV
polyclonal antisera, goat anti-rabbit (alkaline phosphatase conjugate)
antibody and the chromogenic substrates NBT and BCIP. Ten nanograms
(ng) of purified TEV was used as a size marker (lanes 2 and 15, labeled on left
and right sides of the Figure). Specific degradation of TEV CP occurs during
virus purification and repeated freezing/thawing resulting in a doublet of 30
and 27 kDa and a smaller, fainter band of about 24 kDa. Lanes 1-15 contain
protein samples from the following transgenic plant lines: 35S #4 (lane 1),
35S #4 plus 10 ng TEV (lane 2), FL #3 (lane 3), FL #24 (lane 4), AC18 #7 (lane
5), AC18 # 15 (lane 6), AN29 #1 (lane 7), AN29 #2 (lane 8), 0N29 #8 (lane 9),
AN/C #69 (lane 10), AN/C #61 (lane 11), AS #3 (lane 12), RC #5 (lane 13), 35S
#4 (lane 14), 35S #4 plus 10 ng TEV (lane 15).TEV Cp
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Fig. 111.5. Time of appearance of systemic symptoms in transgenic plants.
Ten B49 (wild-type) plants and ten R2 plants of transgenic plant lines 35S #4,
FL #3, FL #24 (A), AC18 #7, AC18 #15 (B), AN29 #1, AN29 #2, AN29 #8 (C),
AN/C #69, and AN/C #61 (D), homozygous for the inserted TEV gene, were
mechanically inoculated with 50 IA of 1:10 dilution of infected plant sap.
Twenty 1349 plants and 20 R1 plants of lines AS #3 and RC #5 were
mechanically inoculated with 50 p.1 of 5 1.1g/m1 TEV (E). Plants were
evaluated daily and any plants displaying systemic symptoms (attenuated or
wild-type) were recorded as symptomatic.10
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Fig. 111.6. Photographs of individual leaves of transgenic and wild type
Nicotiana tabacum cv. Burley 49 uninoculated or inoculated with TEV.
Individual leaves were removed from plants which had been inoculated
with TEV 14 days earlier (or uninoculated Burley 49 plant) and
photographed on a light box with transmitted light to illustrate symptom
attenuation in transgenic plants. Symptoms in (D), (G), and (H) were not
readily apparent without the use of transmitted light. Leaf samples were
from (A) uninoculated Burley 49; (B) TEV-infected Burley 49; C through H
show a TEV infected leaf from transgenic plant lines: (C) 35S #4; (D) AS #3;
(E) FL #3; (F) AN29 #2;(G) AC18 #7; and (H) AN/C #69.C
)
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of systemic symptoms (Fig. 111.5, B and D). AC18 and \N /C plant lines also
showed a pronounced modification of symptoms in systemically infected
leaves as only a mild mosaic was observed (note lack of etching in Fig. 111.6 G
and H). However, AC18 and AN/C plants did not completely outgrow
symptoms and a mild mosaic was detected on most leaf tissue.
Transgenic Burley 49 plant lines AS#3 and RC#5, expressing only TEV
CP related RNA sequences, showed a delay in the appearance of symptoms,
(Fig. 111.5, E) and a modification of symptoms when inoculated with TEV.
Since the 20 R1 plants were not screened for expression of CP RNA prior to
inoculation, some of the symptomatic plants represented non-expressing
plants in which the gene of interest had been lost during Mendelian
segregation. Modified symptoms on AS#3 plants appeared as small chlorotic
lesions often associated with a vein (see arrows in Fig. 111.6, D). Most of the
leaves were devoid of symptoms and virus (determined by back inoculation
experiments). Approximately 15% of RC#5 plants showed symptoms which
were identical to those of infected Burley 49.However, the remaining RC
#5 plants were entirely asymptomatic and virus was not detected in back
inoculation studies (data not shown).
Analysis of TEV replication in protoplasts derived from transgenic plant
lines
I was surprised by the results obtained when AS and RC transgenic
plants were challenged with TEV and by the alteration of symptoms
observed with the different CP expressing plants. In my initial attempt to
explain these results, I sought to determine if all of the transgenic plant lines
I investigated would support virus replication at a level comparable to
Burley 49. Accumulation of viral encoded proteins was used as an indirect66
indicator of viral replication. Protoplasts were derived from leaf tissue of
homozygous CP expressing plants and electroporated with TEV RNA. Four
days after electroporation, protoplast proteins were extracted and assayed for
the presence of TEV-encoded protein, indicative of TEV gene expression and
replication, by Western blot analysis. These results, presented in Fig. III.7,
indicated that protoplasts from all CP-expressing plant lines (full length and
truncated versions) supported virus replication at levels comparable to wild
type Burley 49 protoplasts. R1 transgenic plants from lines AS#3 and RC#5
were initially screened by Northern analysis and leaves from positive
expressors were used in the production of protoplasts. Transfected
protoplasts derived from AS#3 plants supported TEV replication, albeit at a
reduced level. Protoplasts derived from RC #5 transgenic plant leaf tissue
did not support TEV replication at a detectable level. These results (Fig. III.7),
and those presented in the whole plant inoculation series (Fig. 111.5, E),
suggested AS and RC plants interfere with TEV replication.67
Fig. 111.7. Western blot analysis of tobacco etch virus (TEV) RNA transfected
protoplasts. Protoplasts (1 x 10 6) were electroporated in the presence (lanes
marked +) or absence (lanes unmarked) of 6 .tg of purified TEV RNA. After
94 hours, protoplasts were collected and extracted by grinding in 2X Laemmli
(1970) Tris-glycine running buffer. The equivalent of 5 x 104 viable
protoplasts were loaded per lane. Proteins were separated by electrophoresis
and TEV proteins detected by Western blotting conditions identical to those
described in Fig. 111.2. Migration of TEV CP in this analysis, indicated on the
left and right, was determined by adding 10 ng of purified TEV to a sample
of 5 x 104 B49 protoplasts (lanes 1 and 30). Electroporated protoplasts were
derived from the following tobacco lines: B49 (lanes 2, 3, 24 and 25), FL #3
(lanes 4 and 5), FL #24 (lanes 6 and 7), AC18 #7 (lanes 8 and 9), AC18 #15
(lanes 10 and 11), AN29 #1 (lanes 12 and 13), AN29 #2 (lanes 14 and 15), AN29
#8 (lanes 16 and 17), AN/C #69 (lanes 18 and 19), AN/C #61 (lanes 20 and 21),
35S #4 (lanes 22 and 23), AS #3 (lanes 26 and 27), and RC #5 (lanes 28 and 29).TEV CP -OP
+
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Figure 111.769
Discussion
I have generated transgenic plants expressing either full-length CP,
amino-terminal truncated CP, carboxy-terminal truncated CP, or amino- and
carboxy-terminal truncated CP of TEV. The amino- and carboxy-termini of
potyvirus CPs reside on the exterior of intact virions. Comparisons between
different potyvirus CP nucleotide sequences has revealed that the amino-
and carboxy- termini are highly variable in size and sequence while the
internal "core" CP amino acids tend to be very conserved. Our AN29, AC18,
and AN/C truncations maintain the highly conserved TEV CP core (Allison
et al., 1985a; Dougherty et al., 1985; Shukla et al., 1988).I sought to determine
if these truncated versions of the CP gene would be functional in CP-
mediated resistance.
My studies suggested that transgenic plants expressing mutated TEV
CPs (either AC18 or AN/C forms, in particular) were more effective in CP-
mediated resistance to TEV than transgenic plants which expressed FL TEV
CP. I speculate that the truncated CPs are in some way dysfunctional and are
more effective at disrupting the normal virus-host relationship than FL CP.
This disruption may be at the level of virus movement throughout the
plant. There have been reports of CP deletions in tobamovirus systems
which affect virus movement (Dawson et al., 1988). In these studies, viral
genomes encoding truncated CPs are dysfunctional in the process of systemic
(long distance) movement. Perhaps in the TEV system, truncated CP
molecules are dysfunctional in the process of long distance movement and,
as a consequence of being incorporated into virions, generated defective
virus or ribonucleoprotein complexes inhibited in systemic movement. I
have not yet investigated the affect of truncated CPs on short distance70
movement. The reported "broad spectrum resistance" (Stark and Beachy,
1989; Ling et al., 1991) for potyviruses may also involve this phenomenon.
CPs from heterologous potyviruses may protect because they are
dysfunctional in the heterologous system, resulting in limited systemic
movement of the virus.
This study represented my initial analysis of transgenic plant lines.
My goal is to select 12-15 independent lines of each construct to complete our
germplasm bank. Although a limited number of transgenic plants have
been tested to date, in general it appears as though AC18 coat proteins (either
AC18 or AN/C forms) confer more effective resistance to virus than
transgenic plants which express either full-length or AN29 truncated coat
proteins. To my knowledge this was the first report of CP-mediated
resistance in which truncated CP forms demonstrate significant virus
resistance. Since protoplasts from all CP expressing transgenic plants
examined support virus replication, subsequent efforts to unravel the
mechanism involved in the observed resistance will focus on how CP
expressing transgenic lines might primarily interfere with systemic
movement of the replicating virus.
Transgenic plants expressing AS RNAs showed a delay in symptoms
and a reduction in symptom severity (AS #3 plants). Transgenic plant line
RC #5 was apparently immune to TEV. Protoplasts derived from AS#3
transgenic leaf tissue did not support TEV replication at wild-type levels,
while protoplasts from RC #5 did not support detectable TEV replication
(Fig. 111.7).I suggest that TEV resistance in these plants was due primarily to
interference with a step in viral replication. My results with these two
transgenic plant lines appear to be similar to those reported by Golemboski et
al. (1990). They have reported that plants which express an RNA sequence71
from the 3' end of the 180 kDa gene of tobacco mosaic virus (TMV), but no
detectable protein, were highly resistant to TMV infection. There are other
examples reported in which transgenic plant lines are highly resistant to
challenge virus inoculation, yet the expected protein product is not observed
(Kawchuk et al., 1990, 1991). It may be that in these instances, as with the AS
#3 and RC#5 plant line, the resistant phenotype is mediated through a
defective RNA species and not the expected translation product, as
demonstrated in the extensively studied TMV-transgenic tobacco system
(Powell et al., 1990). In the AS and RC plant lines, AS and RC RNA
molecules may be interfering with viral replication by (1) hybridizing to + or
- sense genomelength TEV RNA (respectively), thereby interfering with
transcription and/or translation; (2) binding to an essential host or viral
factor (e.g. replicase); or (3) interfering with virion assembly. Further studies
will focus on these questions. From these preliminary studies it appears that
transgenic plants expressing defective RNAs or proteins will be among the
most effective potyvirus control strategies.
At present, literature regarding CP-mediated resistance to potyviruses
is limited. Two previous studies have investigated the ability of a potyvirus
CP to confer resistance to a heterologous potyvirus (referred to as "broad
spectrum resistance") (Stark and Beachy, 1989; Ling et al., 1991). The only
other report of potyvirus CP-mediated resistance involved transgenic potato
plants expressing PVY CP (Lawson et al., 1990). In this study a transgenic line
(303) which expressed little, if any, PVY CP was highly resistant to PVY
infection, while other transgenic lines expressing higher levels of PVY CP
were more sensitive, showing only mild protection. In the experiments I
have observed that transgenic lines expressing FL TEV CP show little or no
protection to TEV challenge while plant lines which accumulate RNA, but72
no CP, are highly resistant (AS#3 and RC#5 lines ).It may have been that in
the study of Lawson et al. (1990) a spontaneous mutant which resulted in an
untranslatable PVY CP RNA was responsible for the high degree of PVY
resistance observed in the absence of PVY CP.
In summary, I have developed a series of transgenic plant lines which
express various forms of the TEV CP gene sequence. Delay in symptom
formation and altered symptom phenotype correlated with the TEV
sequence being expressed. AS and RC transgenic plant lines displayed a high
level of resistance and in one case, immunity. The level of protection
achieved in these plants may represent a new and effective way of generating
potyvirus resistant germplasm. Collectively, this work would appear to
validate the concept of pathogen-derived resistance (Sanford and Johnston,
1985) as a viable approach to the development of potyvirus resistant plants.73
CHAPTER IV
UNTRANSLATABLE TRANSCRIPTS OF THE TOBACCO ETCH VIRUS
COAT PROTEIN GENE SEQUENCE CAN INTERFERE WITH TOBACCO
ETCH VIRUS REPLICATION IN TRANSGENIC PLANTS AND
PROTOPLASTS
Abstract
Transgenic tobacco plants which express untranslatable sense or
antisense forms of the tobacco etch virus potyvirus (TEV) coat protein (CP)
gene sequence have been generated. One of seven transgenic plant lines
expressing a CP gene antisense transcript showed an attenuation of
symptoms when inoculated with TEV. Three of 10 transgenic plant lines
expressing untranslatable sense stranded transcripts did not develop
symptoms when inoculated with TEV. These lines were resistant to either
aphid- or mechanically-transmitted TEV. In contrast to CP-mediated
resistance reported for other viruses, resistance was (1) mediated by an
RNA molecule; (2) TEV specific (i.e. "broad-spectrum resistance" was not
observed); (3) independent of inoculum levels; (4) not dependent on plant
size and; (5) due to decreased levels of virus replication. Protoplast
experiments were used to demonstrate that resistant plant lines did not
support the production of virus protein and progeny virus at wild-type
levels.74
Introduction
Potyviruses are members of the picornavirus-like supergroup of
viruses (Strauss et a/., 1990). Members of this supergroup contain similarly
organized RNA genomes and employ a gene expression strategy involving
proteolytic processing of viral polyproteins. Potyviruses are flexuous rod-
shaped viruses with an RNA genome of ca. 10,000 nt with a 5' covalently
linked viral encoded protein (VPg) and a 3' polyadenylate sequence
(reviews, see Dougherty and Carrington, 1988; Riechmann et al., 1992). The
RNA contains a single, large open reading frame (ORF) coding for a
polyprotein of ca. 350,000 daltons. No subgenomic mRNAs are produced
during the virus replication cycle (Dougherty, 1983).
It has been proposed that a normal host-pathogen relationship can be
disrupted, leading to resistance, if the host organism expresses a pathogen-
derived gene product which interferes with the pathogen's normal
replicative cycle (Sanford and Johnston, 1985). This phenomenon, termed
pathogen derived resistance (PDR), has been demonstrated for numerous
plant virus groups. Transgenic plants accumulating a plant virus CP
frequently are resistant to infection by the homologous virus. This form of
PDR is termed CP-mediated resistance and has been demonstrated for a
large number of plant viruses (reviews, see Beachy et al.,1990; Gadani et al.,
1990). Most examples of CP-mediated resistance constitute a delay in the
appearance of symptoms (Beachy et a/., 1990). Interference with virus
uncoating or cell-to-cell movement may be at least partly responsible for
this phenomenon (Register and Beachy, 1988; Osbourn et al., 1989; Wu et al.,
1990). Other examples of PDR directed at plant viruses involve the
expression of nonstructural protein gene sequences (Golemboski et al., 1990;75
Carr and Zaitlin, 1991), sequences present in untranslated regions (Morch et
al., 1987) or various antisense RNAs (Hemenway et al., 1988; Rezaian et a/.,
1988; Cuozzo et al., 1988; Powell et al., 1989; Kawchuck et al., 1991).
I have recently generated and described a series of transgenic plants
which express either full-length or truncated forms of the TEV CP (Lindbo
and Dougherty, 1992a). Attenuation and alteration of symptoms, following
infection with TEV, was dependent on the particular form of CP-derived
transgene expressed in planta.I have also noted, in preliminary studies,
that certain transgenic plant lines expressing untranslated versions of the
TEV CP gene sequence were resistant.
In this chapter I report the results of my analysis of a group of
transgenic plants which express untranslatable sense (RNA Control, RC
plant lines) or antisense (AS plant lines) CP transcripts. Only one of seven
AS transgenic plant lines studied showed an attenuation of TEV replication
in protoplasts and virus resistance in whole plants. Three of ten RC
transgenic plant lines examined did not display symptoms when inoculated
with TEV. Protected plant lines were resistant to both aphid- and
mechanically-transmitted TEV, but were sensitive to the closely related
potyviruses potato virus Y (PVY) and tobacco vein mottling virus (TVMV).
Protoplasts from resistant RC lines did not support the production of TEV
antigen or infectious particles. A model is proposed to account for these
observations.76
Materials and Methods
Restriction enzymes and T4 DNA ligase were purchased from New
England Biolabs and used according to manufacturer's instructions.
Plasmids were maintained in Escherichia coli strain HB101. Radio labelled
CTP [a-32P] was purchased from New England Nuclear, Westwood, MA. 17
and SP6 RNA polymerases were purchased from Promega, Madison, WI.
Virus isolates used were obtained from the following sources:
tobacco vein mottling virus (TVMV) and the TEV-H (highly aphid-
transmissible) isolate were obtained from Dr. Tom Pirone, University of
Kentucky; TEV-N (non aphid-transmissible) isolate was obtained from Dr.
E. Heibert, University of Florida; TEV-S (severe) isolate and potato virus Y
(PVY-N) were obtained from Dr. Guy Gooding, North Carolina State
University. The TEV-OX isolate, originally isolated from infected pepper in
Oxnard, CA, was obtained from Dr. Dan Purcifull, University of Florida. All
viruses were maintained in Nicotiana tabacum cvs. Burley 49 (B49) or
Burley 21.
Generation of AS and RC gene constructs
The construction of transgenic plant lines expressing AS, RC, or full
length (FL) TEV CP gene constructs has been described in detail (Lindbo and
Dougherty, 1992). Pertinent features of the transgene constructs in 35S, FL,
AS, RC and 2RC plant lines and the nomenclature of the generated
transgenic plants are presented in Fig. IV.1.77
Fig. IV.1. TEV coat protein (CP) coding sequences used in generating
transgenic plants. A cDNA sequence of the TEV CP gene was cloned into
wide host range (WHR) vectors in either of two orientations. The resulting
WHR plasmids were used in generating transgenic plants which would
express either an antisense form of the TEV CP RNA (AS plant lines) or a
translatable sense form of the CP RNA (FL plant lines). A mutated form of
the TEV CP sequence, which would express an untranslatable sense form of
the TEV CP RNA (as in RC and 2RC plant lines), was also cloned into the
WHR vector. Transgenic plants transformed with WHR vector sequences
only were generated as controls (35S plant lines). The nucleotide sequence
in the region of the mutations is shown. Mutated nucleotides are in bold,
enlarged type and the frameshift mutation is shown in superscript form.
Four of the mutations generate stop codons, and one mutation changes the
second codon from GGC to GCC. The arrow heads represent the location of
the stop codons (underlined) generated in the CP open reading frame (ORF)
in RC constructs.Abbreviations used in this diagram are as follows:
CaMV, cauliflower mosaic virus; Enh 35S, "enhanced" CaMV 35S promoter;
UTS, untranslated sequence; TEV, tobacco etch virus; TML, tumor
morphology large.Gene constructs inserted into Transgenic Plant
Nicotiana tabacum cv. Burley 49 nomenclature
--IEnh 35S
Enh 35S
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Figure IV.1.
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Wide host range plasmids containing T-DNA borders, TEV CP
sequences (Fig. IV.1.) and a neomycin phosphotransferase II (kanamycin
resistance) selectable marker were mobilized from E. coli into
Agrobacterium tumefaciens A136 as described (Lindbo and Dougherty,
1992a).
Plant transformation
Leaf discs of Nicotiana tabacum cv. B49 were transformed and whole
plants regenerated according to the procedures of Horsch and co-workers
(1985). Transformed tissue was selected in the presence of 100 µg /ml
kanamycin sulfate. Callus, shooting, and rooting media were as described
(Lindbo and Dougherty, 1992a).
Analysis of transgene expression
Selected R1 and R2 generation transgenic plants were analyzed for
expression of the transgene. Total nucleic acids were isolated from leaf
tissue and RNA precipitated with LiC1 as described in Verwoerd et al. (1989).
Northern blotting conditions were as described in Lindbo and Dougherty
(1992a). Strand specific 32P-labeled RNA probes generated from a cDNA
done of the TEV CP region were used to detect plus or minus sense
transcripts.
RNA slot blot analysis (Sambrook et al., 1989) was used to estimate
levels of transgene expression in R2 generation transgenic plants. Plus or
minus sense TEV CP transcripts were used in generating a standard curve.
Duplicate slot blots were probed with a strand specific TEV CP RNA probe or
an actin specific RNA probe as an internal standard. Nitrocellulose filters80
were scanned using an Ambis Radioanalytic Imaging System (AMBIS
Systems Inc., San Diego, CA) to quantitate the amount of bound label.
In vitro transcription reactions
Both plus and minus sense TEV CP transcripts were generated from
plasmid pTI., 37/8595 (Carrington and Dougherty, 1987). Plasmid pTL
37/8595 contains a cDNA copy of the TEV CP gene flanked by 17 and SP6
RNA polymerase promoters. T7 or SP6 in vitro transcription reactions
(Melton et al., 1984) of linearized pTL 37/8595 as templates were used to
synthesize unlabeled marker transcripts or 32P-labeled RNA probes as
described in Lindbo and Dougherty (1992a). The actin specific RNA probe
was generated from a partial actin cDNA sequence (obtained from Dr. Russ
Meints, Oregon State University) cloned into the vector pGEM-3 (Promega
Corp., Madison, WI). RNA probes were synthesized using suggested
procedures (Promega Corp., Madison, WI).
DNA Isolation and Southern Blot Analysis
Genomic DNA was isolated from leaf tissue using the procedure of
Rogers and Bendich (1988). Purified DNA was digested with selected
restriction enzymes and 10 mg of digested DNA analyzed by Southern
blotting procedures (Southern, 1975), using TEV CP specific RNA probes.
Inoculation of Transgenic Plants
Generally, five to ten R2 generation plants per line per test were
inoculated mechanically with infected plant sap. Plants were inoculated as
seedlings (two true leaves ca. 2 cm in diameter) or when 5, 10 or 15 cm in
height with various TEV isolates or with TVMV or PVY. Preparation of81
inoculum and inoculation conditions were as described (Lindbo and
Dougherty, 1992a). The TEV inoculum used could be diluted 1:5000 and still
established a systemic infection on N. tabacum (B49 or B21). Inoculated
plants were observed daily for symptoms.
Plants were also inoculated using viruliferous aphids (Myzus
persicae). Aphids were fasted for 2 hr and acquired TEV by feeding for 3 min
through stretched parafilm membranes on a mixture of purifed PVY helper
component and purified TEV-H in a buffered sucrose solution (Govier et al.,
1977). PVY helper component was prepared as described by Govier and co-
workers (1977) and TEV-H was purified using the method of Mohgal and
Francki (1976). Ten feeding aphids were then transferred to each test plant
and allowed to feed for ca. 12 hr. Alternatively, fasted aphids were allowed a
2-5 min access time on TEV-H infected B49 leaf tissue. Four feeding aphids
were transferred to each test plant. Seedlings and plants 5 cm in height were
used in these studies. Inoculated plants were observed daily for symptoms.
Preparation, inoculation and analysis of protoplasts
Protoplasts were prepared from transgenic tobacco plants and
electroporated according to the procedure of Luciano et al. (1987) as modified
in Lindbo and Dougherty (1992a). Protoplasts (1 x 106) were electroporated in
the presence or absence of 6 ug of purified TEV RNA. Following
electroporation, protoplasts were incubated for 96 hr in incubation media
(Luciano et al., 1987).
After a 96 hr incubation period, protoplasts were stained with
fluoroscein diacetate to estimate viability (Widholm, 1972) and used in
Western blot or back inoculation experiments. Protoplasts (2.5 x 104, viable)
were extracted in 2X Laemmli (Tris-glycine, SDS) runningbuffer (Laemmli,82
1970) and analyzed by Western blot analysis (Towbin et al., 1979) as described
in Lindbo and Dougherty (1992a). For back inoculation studies, 1 x 105 viable
transfected protoplasts were ground in the presence of 100111 of 100 mM
sodium phosphate buffer (pH 7.8) and the resulting extract used to inoculate
two N. tabacum cv. B49 plants (50 .tl per plant). Plants were observed daily
for the appearance of symptoms.83
Results
Production and analysis of transgenic plants
R1 generation AS and RC transgenic plants initially were screened by
RNA dot blot analysis. Strand-specific RNA probes were used to identify
transgenic plants expressing TEV specific RNA sequences (data not shown).
Selected R1 generation transgenic plants were selfed and the resulting R2
progeny screened for expression of the kanamycin resistance(Kanr) marker
and the TEV CP transgene sequence. R2 seedlings were screened for Kanr
(50 to 200 R2 seedlings per line) and for RNA expression (10 R2 plants per
line) by dot blot analysis (data not shown). R2 generation plant lines which
gave 100% positives in both of these tests were considered to be
homozygous and used in subsequent experiments. This initial screening
resulted in the identification of 7 AS and 10 RC lines (nine RC- and one
2RC-type transgenic plant lines) as homozygotes to be used in this study.
I asked if the transgenic plant lines generated were the result of single
or multiple insertion events during Agrobacterium-mediated
transformation. Transgene copy number was estimated by segregation of
the Kanr phenotype in R2 seed samples (see above), or by Southern blot
analysis of transgenic plant genomic DNA. Genomic DNA was isolated
from AS and RC transgenic plants, digested with various restriction
enzymes, and analyzed by Southern blot procedures (Southern, 1975) to
estimate copy number of the transgene in the genome. Most lines appeared
to contain a single copy of the gene, although multiple copies were detected
in six transgenic plant lines. The data are summarized in Table IV.1.84
Table IV.1. Estimated Gene Copy Number and Expression
Level in Transgenic Plantsa
Sample copy #
expression level
(pg/pg)
AS #3 1 6.6
AS #4 1 1.8
AS #5 1 11.6
AS #6 1 4
AS #7 2 10.6
AS #9 2 20.6
AS #10 1 6.6
RC #1 1 1.4
RC #2 1 3
RC #3 ND 5.6
RC #4 1 3
RC #5 2 3
RC #7 3 3.8
RC #8 ND 9.4
RC #9 2 2.8
RC #10 ND 1.2
2RC #6 2 5.8
aGene copy number was estimated by segregation of the kanamycin
resistance phenotype and/or Southern blot analysis of genomic DNA
isolated from transgenic plants. RNA expression levels were estimated by
slot blot analysis of total RNA isolated from transgenic plants. Slot blots
were probed with a strand specific TEV RNA probe. The expression levels
presented are an average of two trials and are expressed as pg of transgene
transcript /µg of total RNA. ND = not determined.85
I also sought to characterize the RNA product of the introduced gene.
Total RNA samples, isolated from transgenic tobacco plants, were analyzed
in Northern blot hybridization experiments. Strand specific32P-labeled
RNA probes were used to demonstrate that transgenic plants expressed
transcripts of the expected size and "sense". A transcript of ca. 1,100
nucleotides (nt) was expected in RC and AS transgenic plants and a
transcript of ca. 1,350 nt was expected in the 2RC line. The expected RNA
transcripts were detected in the various transgenic plant lines examined.
Fig. IV.2, A and B, show Northern blot analysis of RNA samples from
various transgenic plants.
To quantify accumulated levels of the TEV-related transcript in the
different transgenic plant lines, slot blot analysis of transgenic plant RNA
was conducted. Various levels of transcript, ranging from ca. 1 to 20 pgCP
transcript per microgram total RNA, were found in the different transgenic
plant lines (Table IV.1.).
Inoculation of transgenic plants with virus
I sought to determine if these homozygous transgenic plant lines
would display a resistant phenotype to potyvirus infection. To examine
this, transgenic plants (ca. 15 cm in height) were challenged with sap extracts
from plants infected with one of four TEV isolates (TEV-H, N, OX, or S) or
with the potyviruses PVY-N or TVMV. Typically, N. tabacum cv. B49
plants inoculated with these viruses display symptoms approximately 7 days
after inoculation. In our studies some plant lines were resistant to TEV. In
replicated experiments, one AS line (AS #3) occasionally showed attenuated
symptoms when inoculated with TEV isolates (data not shown). Plants of
line RC #5 were generally resistant to TEV infection. However, a low86
Fig. IV.2. Northern blot analysis of transgenic plant RNA. Total RNA was
isolated from various transgenic plant lines and electrophoretically
separated on 1.2% agarose gels containing 6% formaldehyde. Varying levels
of RNA (between 1 and 5 gg) were loaded per lane so that bands could be
clearly seen in all samples.Filters were hybridized with a 32P-labelled RNA
probe specific for minus sense (A), or plus sense (B) CP transcripts. After
washing under stringent conditions (65 °C in 0.1X SSC, 2 hr), filters were
exposed to Kodak X-Omat film. Autoradiograms of the blots are presented.
Mobility and estimated length (in nt) of minus and plus sense marker
transcripts containing the TEV CP sequence (A and B, lanes 1 and 21,
respectively) are presented on the sides of the figure. Identity of transgenic
plant lines from which RNA was extracted are labelled above
autoradiograms. RNA from N. tabacum cv. Burley 49 (B49) is in lanes 2 and
20. Nomenclature for transgenic plant lines is as follows: (1) RC and AS
describe if the plant line is expressing a untranslatable sense or antisense
form of the TEV CP RNA, respectively, (2) the numbers following the AS
and RC designation refer to separate transformation events which gave rise
to transgenic plant lines.c
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percentage of such plants (less than 5%) did show symptoms when
inoculated with various TEV isolates (Tables IV.2 and IV.3). In several
experiments some plants of line RC #4 have not developed symptoms
(Table W.3). Transgenic plant lines RC #7 and 2RC #6 showed no
symptoms when inoculated with any of the four TEV isolates. All other AS
and RC transgenic plant lines exhibited wild type sensitivities to the TEV
isolates used. No AS or RC plant lines displayed symptom attenuation
when inoculated with PVY or TVMV (Table IV.2.). Experiments typically
were terminated 3-4 weeks post inoculation.
Mechanical and aphid vectored inoculation of young plants
After determining that large (ca. 15 cm in height) plants of selected
lines were resistant to mechanically applied inoculum, I sought to
determine if younger transgenic plants were resistant to mechanically- or
aphid-vectored TEV-H inoculum. To this end, I mechanically inoculated
transgenic and control germplasm as seedlings (two true leaves ca. 2 cm in
diameter) or as small plants (ca. 5 cm in height) with infected plant sap. I
also attempted to transfer TEV to small plants and seedlings using
viruliferous aphids. Results of these experiments were consistent with the
results of the mechanical inoculation experiments involving plants ca. 15
cm in height. An occasional RC #5 plant would become infected and some
RC #4 plants would not exhibit symptoms, while plants of lines RC #7 and
2RC #6 were completely refractory to TEV infection (Table W.3). The other
transgenic plant lines were susceptible to TEV infection.89
TABLE IV.2.
Susceptibility of transgenic plant lines to potyviruses.
a
Virus Inoculum
Plant
line TEV-HTEV-NTEV-STEV-OXPVYTVMV
B49 8/8 8/8 8/8 8/8 8/8 8/8
35S #4 8/8 8/8 8/8 8/8 8/8 8/8
FL #3 8/8 8/8 8/8 8/8 8/8 8/8
AS #3 8/8 8/8 8/8 8/8 8/8 8/8
AS #4 8/8 8/8 8/8 8/8 8/8 8/8
AS #5 8/8 8/8 8/8 8/8 8/8 8/8
AS #6 8/8 8/8 8/8 8/8 8/8 8/8
AS #7 8/8 8/8 8/8 8/8 8/8 8/8
AS #9 8/8 8/8 8/8 8/8 8/8 8/8
AS #10 8/8 8/8 8/8 8/8 8/8 8/8
RC #1 8/8 8/8 8/8 8/8 8/8 8/8
RC #2 8/8 8/8 8/8 8/8 8/8 8/8
RC #3 8/8 8/8 8/8 8/8 8/8 8/8
RC #4 8/8 8/8 8/8 8/8 8/8 8/8
RC #5 0/20* 0/20 0/20 2/20 8/8 8/8
RC #7 0/8 0/8 0/8 0/8 8/8 8/8
RC #8 8/8 8/8 8/8 8/8 8/8 8/8
RC #9 8/8 8/8 8/8 8/8 8/8 8/8
RC #10 8/8 8/8 8/8 8/8 8/8 8/8
2RC #6 0/8 0/8 0/8 0/8 8/8 8/8
a
Transgenic and wild type plants ca. 15 cm. tall (ca. 8 wks old) were mechanically inoculated
with 50 p.1 of a 1:10 dilution of infected plant sap extract. Data are presented as the number of
symptomatic plants (at 14 days post inoculation) over total number inoculated.
Viruses used in this study are as follows; TEV-H, TEV-highly aphid-transmissible isolate;
TEV-N, TEV non aphid-transmissible isolate; TEV-S, TEV severe isolate; TEV-OX, TEV oxnard
isolate; PVY, potato virus Y; TVMV, tobacco vein mottling virus. Plant line nomenclature is as
in Fig IV.1.
*A low percentage of the plants of line RC #5 show symptoms when inoculated with TEV
isolates. A larger sample size was used to demonstrate this non-uniform response.90
TABLE IV.3.
Susceptibility of transgenic plants to aphid (A) or
mechanically (M) transmitted TEV-H. a
Plant
Line
Seedlings
M A
5 cm tall plants
M A
B49 10/10 8/10 5/5 3/10
35S 10/10 4/10 5/5 5/10
FL #3 10/10 5/10 5/5 1/10
AS #6 10/10 3/10 5/5 1/10
AS #7 10/10 1/10 5/5 2/10
AS #9 10/10 6/10 5/5 5/10
RC #1 10/10 3/10 5/5 3/10
RC #4 6/10 3/10 3/5 2/10
RC #5 0/10 1/10 0/5 0/10
RC #7 0/10 0/10 0/5 0/10
RC #9 10/10 6/10 5/5 1/10
2RC #6 0/10 0/10 0/5 0/10
aData is presented as the number of symptomatic plants (at 14 days post
inoculation) over total number inoculated. Selected transgenic plant lines
were challenged at the seedling stage (two true leaves, ca. 2 cm diameter) or as
small plants (ca. 5 cm. tall) with either mechanically- (M) transmitted TEV (50
ixl of a 1:10 dilution of infected plant sap), or aphid- (A) vectored virus. For
seedlings, aphids were fasted and then fed on an in vitro transmission system
composed of purified PVY helper component and purified TEV-H (highly
aphid-transmissible isolate of TEV). Ten aphids were transferred to each test
plant. Alternatively, for 5 cm. tall plants, aphids were fasted and then allowed
a 2-5 min access time on a TEV-H infected N. tabacum cv. Burley 49 leaf (3
weeks post inoculation). Four feeding aphids were transferred to each test
plant. Plant line nomenclature is as in Fig. IV.1.91
Analysis of TEV replication in protoplasts derived from transgenic plants.
The resistance phenotype manifested by the RC and 2RC lines could
be a function of inhibition of virus replication or cell-to-cell movement.
An indirect test of this mode of action would be analysis of TEV replication
in protoplasts derived from the various transgenic backgrounds. Protoplasts
derived from wild-type and transgenic plants were electroporated in the
presence or absence of purified TEV RNA and later assayed for the
production of viral antigen (by Western blot analysis) and infectious
particles (by back inoculation to B49 seedlings). Protoplasts from N. tabacum
cv. B49 and transgenic plant line FL #3 support the production of viral
antigen, and infectious particles (Table IV.4. and Lindbo and Dougherty,
1992a). The Western blot analysis of protoplast extracts suggested virus
antigen (CP) accumulated to wild-type levels in protoplasts derived from
the various transgenic plants with four notable exceptions. AS #3 derived
protoplasts supported the production of viral antigen at a reduced level (Fig.
IV.3 lane 3), but still produced infectious particles (Table IV.4). Protoplasts
from resistant lines RC #5, RC #7 and 2RC #6 did not support production of
detectable levels of CP (Fig. IV.3, lanes 19, 20, 24) or infectious particles
(Table IV.4).92
TABLE IV.4
Production of TEV antigen and infectious particles
in transfected tobacco protoplasts a
Plant Viral Infectious
line antigen particles
B49 + +
35S + +
FL #3 + +
AS #2 + +
AS #3 + +
AS #4 + +
AS #5 + +
AS #6 + +
AS #7 + +
AS #9 + +
AS #10 + +
RC #1 + +
RC #2 + +
RC #3 + +
RC #4 + +
RC #5
RC #7 - -
RC #8 + +
RC #9 + +
RC #10 + +
2RC #6 - -
a
Protoplasts derived from wild type (B49) and transgenic plant tissue were
electroporated in the presence of 61.1.g of purifed TEV RNA. Protoplasts
were later assayed for production of viral coat protein by Western blot
analysis, and for the presence of infectious particles through back
inoculation experiments. In the above table, detectable levels of CP or
infectious particles are represented by a "+". Protoplasts transfected in the
absence of TEV RNA did not produce viral antigen or infectious particles
(data not shown).93
Fig. IV.3. Western blot analysis of TEV RNA transfected protoplasts.
Protoplasts were obtained from both transgenic and N tabacum cv. Burley49
plants. Protoplasts (lx 106) were electroporated in the presence of TEV
RNA (6 1.tg) and placed in incubation media. After 96 hr 2.5 x104 viable
protoplasts were assayed for production of viral coat protein by Westernblot
analysis. Protoplast proteins were extracted in 2X Laemmli runningbuffer,
separated on 12.5% polyacrylamide gels containing SDS and transferred to
nitrocellulose. Rabbit anti-TEV primary antibodies and goat anti-rabbit
alkaline phosphatase conjugated secondary antibody were used to detect
bound antigen. The source of each protoplast sample is indicated above
each lane. Transgenic plant nomenclature is as described for Fig IV.1. Lane
1 contains N. tabacum cv. Burley 49 (B49) plant extract with 10 ngof TEV
added. Lanes 12 and 13 (B49 healthy) contained uninfected whole plant and
protoplast samples, respectively. The migration of TEV CP is noted on the
sides of the figure. The identity of the high molecular weight cross reacting
bands is not known.t
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Discussion
Transgenic plant lines expressing untranslatable TEV RNA can show
high levels of resistance to TEV infection. I have developed a working
model based on the transgene expressed by the various transgenic lines and
my observations of the various germplasms in whole plant and protoplast
studies. Central to my hypothesis is the RC transcript containing the stop
codons immediately after the AUG initiator codon (Fig. IV.1) and the 3'
untranslated region of the transcript.I have considered models in which
the untranslatable RC transcript may participate in the resistance response
by (1) forming an RNA/RNA hybrid with the minus strand TEV RNA
species; (2) by binding factors (host or viral) essential for replication; or (3) by
a combination of both interactions. Alternatively the transgene could have
insertionally inactivated a host gene essential for TEV replication.
I do not favor the hypothesis involving the insertional inactivation
of a host gene for two reasons. First, I would expect any inactivated host
gene which affects TEV replication to also affect PVY and TVMV
replication. This is not the case. Second, the resistance phenomenon has
appeared in three independent transgenic plant lines with the transgene
inserted into distinct genome locations. Therefore, I suggest insertional
inactivation of an essential host gene would be unlikely.
I suggest the data are consistent with the RNA/RNA hybridization
hypothesis similar to the RNA/RNA hybridization mechanism proposed to
be involved in traditional cross protection (Palukaitis and Zaitlin, 1984). I
propose that the annealing of RC-type transcripts to minus-sense genomes
inhibits production of plus sense progeny RNA molecules by interfering96
with the procession of replicase complexes on the minus strand template.
During the course of a typical plus sense RNA virus replication cycle, sense
strand genomes grossly outnumber minus sense molecules. For this reason,
blocking the generation of plus sense genomes from minus sense templates
may be a particularly vulnerable step in the viral replication cycle.
I propose that the RNA transcript from RC constructs maximizes the
potential formation of an RNA/RNA hybrid. First, the three stop codons
immediately after the initiator AUG should prevent ribosomes from
translating the RNA. Second, there are no TEV 3' untranslated sequences
and the TEV replicase complex would not be likely to bind or transcribe this
RNA. Together, these features result in an RNA molecule which should
have limited RNA/protein interactions that could interfere with
RNA/RNA hybrid formation. In contrast, the FL gene construct produces
an RNA transcript that only differs from the RC transcript by five
nucleotides but is translated.I have never identified TEV coat protein
producing lines (Lindbo and Dougherty, 1992a; unpublished results),
including six different FL transgenic plant lines, which show the resistance
phenotype associated with select RC lines.I propose that when ribosomes
translate the RNA coding for TEV coat protein, they prevent RNA/RNA
hybrid formation. Although I have not tested RC constructs with an
authentic TEV 3' untranslated region, I would predict that TEV replication
complexes could bind, potentially transcribe the RC RNA and, in the
process, interfere with RNA/RNA hybrid formation.
The virus specific nature of the resistance is also consistent with the
RNA/RNA hybridization model. Because of the high degree of nucleotide
sequence homology between the four TEV isolates, the RC transcript would
be expected to anneal extensively to genome length minus strand RNA of97
these isolates. In the case of PVY and TVMV, however, the coat protein
nucleotide sequences share 62% and 60% homology, respectively, with the
TEV RC transcript. Therefore, the RC transcript would not be expected to
form a stable RNA/RNA hybrid with the minus-strand RNA of these viral
genomes and would not inhibit replication of these viruses.
Currently, I do not favor the model involving the transgene RNA of
either viral or host replication factors, for the following reasons: (1) The RC
construct lacks a TEV 3' untranslated region likely to contain some or all of
the signals detected by viral factors essential for replication; (2) RC and FL
lines only differ by five nucleotides yet the resistance phenotype has never
been observed in FL plant lines; (3) the resistance is quite virus specific.
However, the possibility of viral proteins binding to the CP ORF cannot
totally be discounted, as the presence of regions other than 5' and 3'
untranslated regions may also be involved in viral replication. In regards to
the specificity of the resistance, since the potyviruses TEV, TVMV, and PVY
are so closely related, we propose that these viruses would employ common
host factors during replication. Therefore, if the RC transcript is binding
such a host factor(s) and inhibiting replication of TEV, I would expect
replication of PVY and TVMV to be attenuated as well.
Not all RC transgenic lines express the resistance phenotype, and
resistance does not appear to correlate with RNA expression levels.
Therefore, I must qualify my model with other observations made in this
study. Additional undefined factor(s) must play a role in determining the
resistance phenotype. For example, cell-type specific expression levels or
subcellular localization of the untranslatable transcript may be important. It
may be that in order for a plant to be protected, a basal level of expression is
required in all cell types of that transgenic plant. All transgenic plants may98
not express the transgene in all tissues. For example, Barnes (1990) has
shown that different patterns of tissue specific expression can be obtained in
transgenic plants transformed with the same gene construct. This may
account for the difference in resistance observed with different RC lines.
Identification of the factors or cellular conditions required for the RC
transcript to function in resistance is the focus of our current studies.
My results differ significantly from the often-reported CP-mediated
resistance. Much of the information regarding CP-mediated resistance
involves the extensively studied TMV system (review, see Beachy et al.,
1990), though examples of CP-mediated resistance have been reported for
potyviruses as well (Stark and Beachy, 1989; Lawson et al., 1990; Ling et al.,
1991). The RC RNA-mediated protection results in plants which (1) do not
display symptoms, even at high virus inoculum levels (infected plant sap)
or when TEV RNA is used as inoculum; (2) show resistance in very young
plants; (3) are not protected against challenge inoculation with heterologous
viruses; and (4) mechanistically involves an attenuation of virus
replication. The high degree of resistance obtained by this method makes it
an attractive alternative to CP-mediated resistance.
Recently, other examples of transgenic plants expressing viral-
derived genes, but no detectable levels of protein, have been published.
These experiments have reported mixed results. Only one of these studies
(Powell et al., 1990) involved a gene construct designed to produce an
untranslatable RNA. In this case, Powell and colleagues (1990)
demonstrated that the TMV CP and not RNA was necessary for TMV
resistance in transgenic plants. In contrast, in an attempt to demonstrate
CP-mediated resistance to potato leaf roll virus (PLRV), Kawchuck and co-
workers (1991) could not detect the production of PLRV CP in their99
transgenic plants. However, these plants were resistant to PLRV vectored by
viruliferous aphids. Golemboski and co-workers (1990) reported that
transgenic plants expressing an RNA which would be translated into the
TMV (putative) 54 kDa protein were resistant to one isolate of TMV. An
RNA transcript from the transgene was present, but the 54kDa protein could
not be detected in transgenic plants. TMV replication, however, was
subsequently shown to be dramatically impaired in these plants (Carr and
Zaitlin, 1991). These workers have suggested that the transgene RNA may
be the basis of the resistance phenotype observed. However, in these
studies, the constructs were designed to produce translatable RNAs and it is
possible that undetectable levels of the expected protein may be responsible.
In my TEV RC study, the gene construct was designed to produce an
untranslatable RNA and, therefore, I suggest RNA is the effector molecule.
I suggest that this strategy will be successful, not only toward other
potyviruses but with other viral systems as well. If the hypothesis is correct,
multiple regions of viral genomes should be able to confer resistance,
though some genomic regions may be more effective than others. For
example, intramolecular base pairing of the untranslatable sense transcript
and/or that of the minus sense genome-length RNAs could limit efficient
hybridization between the two RNA species. Additionally, in selecting
regions of the minus sense genome to target, features which maximize
RNA/RNA hybrid formation should be emphasized. I suggest that 5' and 3'
untranslated regions, and internal promoter binding sites, all conventional
targets of antisense strategies, will not be effective. These regions of the
genome likely participate in extensive protein/RNA binding interactions.
Likewise, in virus systems which produce large quantities of subgenomic
mRNAs, regions of the minus sense genome which are actively transcribed100
during subgenomic mRNA production would not be favorable targets.
Heavily transcribed regions of minus sense genomes are likely to be
occupied by transcription complexes which would destabilize RNA/RNA
hybrids.
In summary, I have generated transgenic plants which express
untranslatable sense RNAs which interfere with viral replication.
Although I have not yet determined all the experimental parameters or the
exact mechanism of this inhibition I suggest this approach will complement
CP mediated strategies and other traditional resistance genes.101
CHAPTER V
INDUCTION OF A HIGHLY SPECIFIC ANTI-VIRAL STATE IN
TRANSGENIC PLANTS:
IMPLICATIONS FOR GENE REGULATION AND VIRUS RESISTANCE.
Abstract
Transgenic Nicotiana tabacum plants expressing either a full length
or an amino-terminally truncated form of the tobacco etch virus (TEV) coat
protein were initially susceptible to TEV infection and typical systemic
symptoms developed. However, 3 to 5 weeks after a TEV infection was
established, transgenic plants 'recovered' from the TEV infection and new
stem and leaf tissue emerged symptom- and virus-free. A TEV-resistant
state was induced in the 'recovered' tissue. The resistance was virus-specific.
'Recovered' plant tissue could not be infected with TEV, but was susceptible
to the closely related virus, potato virus Y (PVY). The resistance phenotype
was functional at the single cell level as protoplasts from 'recovered'
transgenic tissue did not support TEV replication. Surprisingly, steady state
transgene mRNA levels in 'recovered' tissue were 12- to 22-fold less than
transgene mRNA levels in uninoculated transgenic tissue of the same
developmental age. I propose that these two observations are mediated at
the cellular level by a cytoplasmic-based activity which targets specific RNA
sequences for inactivation and degradation.102
Introduction
The theory of pathogen-derived resistance (PDR) proposes that
pathogen resistance genes can be derived from a pathogen's own genetic
material (Sanford and Johnston, 1985). Numerous examples of PDR have
been reported for many different plant RNA viruses in a wide range of
plant species. Most examples of PDR involve transgenic plants engineered
to express a viral coat protein (CP) or a segment of a replicase gene(for
reviews see Beachy et al., 1990; Wilson, 1993). As a general rule, transgenic
plants accumulating one of these viral proteins are often resistant to that
particular virus and closely related viruses. While many examples of PDR
have been documented, in general the mechanism(s) underlying resistance
remains to be clearly defined.
I have been examining different PDR approaches to a member of the
Potyvirus genus. Potyviruses, assigned to the Picornaviral Super-family (for
review see Goldbach, 1987), comprise a large and economically important
group of aphid-transmissible plant viruses (for review see Reichmann etal.,
1992). Some general characteristics of potyviruses include: (1) flexuous rod-
shaped virions (ca. 18 X 750nm); (2) an RNA genome that has a protein
(VPg) covalently attached to the 5' terminal nucleotide and a 3'
polyadenylate sequence; (3) the genetic information is contained in a single,
large open reading frame on a single-stranded RNA genome (ca. 9500
nucleotides) of plus (message) sense polarity; and (4) individual gene
products are expressed by proteolytic processing of the genome-derived
polyprotein. Several examples of PDR to various potyviruses have been
reported (for review see Lindbo et al., 1993). In most cases, no correlation
between transgene product accumulation and the degree of potyvirus103
resistance was noted. This is in contrast to other PDR studies in other
virus/transgenic plant systems where resistance correlated with high
transgene expression. Thus, the exact mechanism underlying PDR for
potyviruses remains enigmatic.
I have previously described the construction of a series of transgenic
Nicotiana tabacum cv. Burley 49 lines producing different versions of the
tobacco etch virus (TEV) coat protein gene sequence (Lindbo and Dougherty,
1992a). Transgenic plant lines, expressing either a full length (FL plant lines)
or an amino- (N-) terminally truncated form (AN29 plant lines) of the TEV
CP, temporally developed typical systemic symptoms when inoculated with
TEV. However, FL- and AN29-transgenic plant lines outgrew TEV infection
approximately 3 to 5 weeks after inoculation (Lindbo and Dougherty, 1992a).
I refer to this phenomenon as 'recovery'. Other researchers have also noted
that selected transgenic plants expressing potyvirus coat protein sequences
display a similar response after inoculation with other potyviruses (Ling et
al., 1991; Fang and Grumet, 1993).
This study examined features of 'recovered' transgenic plant tissue.
Asymptomatic 'recovered' tissue did not support TEV replication, yet
supported replication of the closely related potyvirus, potato virus Y (PVY).
RNA and protein analyses of 'recovered' transgenic plant tissue
demonstrated that both transgene RNA and protein levels were markedly
reduced in 'recovered' transgenic plant tissue. I propose that the induction
of resistance to TEV, an RNA virus that replicates in the cytoplasm, and the
decrease in RNA accumulation of the nuclearly transcribed transgene are
mediated by a common cytoplasmically-based mechanism. Cytoplasmically-
based regulation of gene expression may have important implications for
(1) genetically engineered resistance to viruses, (2) classical cross protection104
and naturally occurring plant virus-resistance mechanisms, and (3)
transgene expression and selected examples of sense- (or co-) suppression.105
Materials and Methods
Construction of transgenic plants
Construction, selection, and analyses of transgenic plants used in this
study have been previously described (Lindbo and Dougherty, 1992a). The
transgenic plant lines used in this study accumulate either a full length or
N-terminally truncated (\N29) form of the TEV CP. The AN29 transgenic
plant lines express a form of the TEV CP missing the N-terminal 29 amino
acids (aa).
Virus Isolates
Tobacco etch virus strain H (TEV-H [highly aphid-transmissible]
strain) was originally obtained from Dr. Tom Pirone (Kentucky). The potato
virus Y (PVY) isolate used in this study was obtained from Dr. Guy Gooding
(North Carolina State University). Viruses were maintained in N. tabacum
cvs. Burley 49 or Burley 21. Virus was purified as described by Dougherty
and Hiebert (1980a). Potyviral RNA was obtained from purified virus
preparations by adding an equal volume of proteinase K solution (50 mM
Tris-C1, pH 8.0, 1 mM CaC12, 1% SDS, 100 gg/m1 proteinase K) to virus
preparations. The solution was vortexed, incubated at 45 °C for 10 min, and
then extracted with an equal volume of phenol:chloroform (1:1). RNAwas
precipitated as described in Sambrook et al. (1989) and resuspended in dH2O.
Whole plant inoculation experiments
Plant leaves were lightly dusted with carborundum and virus
inoculum (50111) was applied with a sterile cotton swab. Virus inoculum106
was at a 1:10 dilution (w/v) of virus-infected plant tissue in 100mM sodium
phosphate buffer (pH 7.8).
Grafting Studies
Rootstocks were prepared by removing the shoot of the rootstock
above at least two healthy basal leaves and making a vertical cut, 3 to 4 cm
long, in the center of the internode. Leaves larger than 4 cm in length were
removed from the scion and the base trimmed to a wedge. The cambia of
stock and scion were aligned along the length of the cuts, secured with
paraffin film and covered with a polyethylene bag for 7 d.
Protoplast preparation
Protoplasts were isolated from transgenic or wild-type N. tabacum cv.
B49 leaves by lightly abrading the abaxial surface of leaves with
carborundum and a cotton swab. Abraded leaf pieces were incubated
overnight (15-18 h) in 1.5% cellulase "Onozuka" R-10 (Yakult Honsha Co.,
Tokyo, Japan), and 0.2 % macerase in mannitol-MES (0.6M mannitol, 0.1%
(w/v) MES, pH 5.7). After enzyme treatment, protoplasts were floated on a
0.6 M sucrose cushion, collected and washed 2-3 times in mannitol-MES.
Protoplast transfection
The protocol of Jones et al., (1990) was used except that the PEG CaC12
solution was replaced with PEG-Mg/CMS solution (1 ml 50% [w/v] PEG
1500 in 75 mM HEPES, pH 8.01 [Boehringer Mannheim] to which 15 gl 1M
MgC12 and 100 gl 1M Ca(NO3)2, pH 7-9, had been added). After transfection
with 2 gg of viral RNA, protoplasts were transferred to incubation media
(Luciano et al., 1987).107
Analysis of transfected protoplasts
Protoplasts were analyzed by protoplast blotting as described by Jung
et al. (1992). Approximately 200 viable protoplasts were pipetted onto
nitrocellulose and air dried. Bound viral antigen was detected using
standard immunoblotting techniques with mouse anti-TEV monoclonal
antibodies, alkaline phosphatase conjugated goat anti-mouse antibodies and
the chromogenic substrates NBT (para-nitro blue tetrazolium chloride) and
BCIP (5-bromo-4-chloro-3-indoyl phosphate para-toluidine salt) (Biorad).
Back inoculation of transfected protoplasts to test plants was performed as
previously described (Lindbo and Dougherty, 1992b).
ELISA
The presence of viral antigen (CP) in wild-type and transgenic tissue
was examined by standard double antibody sandwich enzyme-linked
immunosorbent assay (DAS ELISA) procedures (Converse and Martin, 1990)
using rabbit anti-TEV polyclonal sera.
Northern and Western Blot Analysis.
Northern and Western blot analysis of plant tissues was performed as
previously described (Lindbo and Dougherty, 1992a, 1992b).
Aphid transmission experiments
Green peach aphids (Myzus persicae) were raised on mustard-spinach
plants. Prior to use in transmission experiments, aphids were collected,
fasted for several hours and then exposed to infected leaf tissue for 3 to 5108
min. After 3 min, feeding aphids were transferred to test plant seedlings
and allowed to feed overnight (8-12 hr). Aphids were then killed with an
insecticide. Symptoms on test plants were allowed to develop for 10 d.109
Results
Whole plant studies
All TEV-infected transgenic plant lines expressingan FL- or AN29-
truncated form of the TEV CP recovered from TEV infection. During this
process, initial infection and typical TEV-induced symptoms were succeeded
by progressively less symptomatic tissue in each newly emerging leaf. In
these emerging leaves, virus-induced symptoms were restricted to
interveinal areas. This progressive 'recovery' continued until leaves
emerged devoid of symptoms. As a result, the 'recovered' transgenic plants
had a distinct appearance compared to TEV-infected untransformed Burley
49 plants (Figure V.1).
Inoculation studies with viruses other than TEV demonstrated that
the recovery phenomenon was TEV-specific. These FL- and AN29-
transgenic plant lines were susceptible to the closely related potyviruses
PVY and tobacco vein mottling virus (TVMV) (Lindbo and Dougherty,
1992a), as well as a number of unrelated plant viruses (data not shown).
Inoculation of these transgenic lines with these viruses establisheda
systemic infection and no recovery was evident (data not shown). Aside
from the TEV-induced 'recovery' phenotype, plant height, weight, and
general morphology of transgenic plants used in this studywere similar to
untransformed plants.
The level of TEV in transgenic and untransformed N. tabacumcv.
Burley 49 plants was quantified in order to determine if infectious TEVwas
present in tissue displaying the 'recovered' phenotype. A DAS ELISA
(Converse and Martin, 1990) was used to indirectly quantitate TEV in the
various tissue types. The DAS ELISA conditions used detected only CP from110
Figure V.1. Tobacco etch virus (TEV)-induced symptoms in wild type and
transgenic tobacco plants. TEV-induced symptoms are shown for a
Nicotiana tabacum cv. Burley 49 plant (lower left), and for a plant from a
transgenic line (FL-44.4, upper left) expressing a full-length version of the
TEV coat protein. The transgenic plant has outgrown or "recovered" from
TEV infection; newly emerging leaves contain less virus and virus-induced
symptoms than older leaves of the same plant or than the corresponding
leaf from a TEV-infected B49 plant. Leaves from the bottom, middle, or top
segment (leaves 1, 2, and 3 respectively) of these plants are presented for
comparison on the right. Photographs were taken approximately 5 weeks
after inoculation with TEV.Figure V.1.112
replicating TEV, not TEV CP produced from the transgene. TEV CP levels in
symptomatic leaf tissue of infected transgenic plants were usually slightly
lower than those in infected untransformed Burley 49 (Table V.1).
However, this difference was most striking when comparing TEV CP levels
of TEV-infected Burley 49 tissue to levels found in the asymptomatic tissue
of plants displaying the 'recovered' phenotype. No TEV CP was detected in
asymptomatic leaf tissue (Table V.1).
I attempted to demonstrate the presence of infectious TEV in
transgenic tissue by bioassays involving both aphid-vectored transmission
experiments and back inoculation studies to a susceptible indicator host. In
general, lower TEV CP levels were correlated with lower aphid
transmission rates when TEV-infected transgenic tissue was used as an
inoculum source by aphids (Table V.1.). However, aphid transmission of
infectious virus from asymptomatic leaf tissue of the 'recovered' phenotype
or back inoculation of sap (data not shown) to N. tabacum cv. Burley 21
plants was unsuccessful. Therefore, by a variety of experimental approaches,
TEV could not be detected in asymptomatic tissue of leaves showing the
'recovered' phenotype.
These results suggested that TEV was excluded from or could not
replicate in 'recovered' transgenic tissue. Plants from the FL- and AN29-
lines were tested for their ability to support virus replication in a sequential
inoculation series. Plants from each of the lines were "pre-treated" in one of
four ways prior to a challenge inoculation with TEV or PVY. The four pre-
treatments were: (1) naive (receiving no initial treatment); (2) mock
inoculated with buffer and carborundum on a lower leaf; (3) inoculated
with tobacco mosaic virus (TMV); or (4) inoculated with TEV. No visible
plant symptoms were evident in pre-treatments 1 and 2, pre-treatment 3113
Table V.1. TEV concentration in TEV-infected plants
Plant lineaLeaf typeb ilg virusic
mg tissue
Aphid transmissione
rate
B49 1 1.45 6/6
B49 2 1.5 6/6
B49 3 1.35 5/6
FL-24.3 1 1.0 5/6
FL-24.3 2 0.4 1/6
FL-24.3 3 0.0 0/6
FL-44.4 1 1.4 3/6
FL-44.4 2 0.3 2/6
FL-44.4 3 0.0 0/6
FL-3.3 1 8.4 3/6
FL-3.3 3 0.0 0/6
N-8.1 1 1.0 3/6
N-8.1 2 0.5 1/6
N-8.1 2 0.2 2/6
N-8.1d 2 (symptomatic area) 5.5 3/6
N-8.1d 2 (asymptomatic area) 0.0 0/6
aPlant nomenclature used is as described in text.
bLeaf type 1, 2,or 3, are lower, middle or upper leaves, respectively, as shown in Fig V.1.
cVirus concentration was estimated using DAS ELISA. A standard curve (data not shown) was
produced by adding known quantities of purified TEV to uninfected B49 extracts. Tissue
extracts were analyzed by DAS ELISA procedures using alkaline phosphatase conjugated
rabbit anti-TEV antibodies. Infected plant samples (except d) were collected by randomly
removing 6 circular (10 mm dia., each) tissue samples from a leaf, combining them and then
preparing tissue extracts. DAS ELISA data is presented as ug TEV /mg tissue.
dSymptomatic and asymptomatic tissue samples from the same 'recovering' leaf (i.e. leaf
type 2, Figure V.1.) were analyzed.
eAphid transmission rate indicates the number of test plants that became infected with TEV
via aphid transmission over the number of test plants aphids were allowed to probe. Ten
aphids were applied to each test plant.114
resulted in the formation of local lesions on the inoculated lower leaf, while
pre-treatment 4 resulted in systemic TEV infection followed by recovery.
Four weeks after the original pre-treatment, upper leaves of these plants
were challenge inoculated with either PVY or TEV. Results are
summarized in Table V.2. All plants were susceptible to PVY infection.
Plants receiving pre-treatments 1, 2, or 3 were infected by TEV; however,
those plants which had 'recovered' from prior TEV infection were unable to
support a TEV infection in the 'recovered' tissue.
Further characterization of the induced resistant state involved
'recovered' scions from various FL- and AN29- transgenic plants and scions
from untransformed Burley 49 plants grafted on TEV-infected N. tabacum
cv. Burley 49 rootstock. Scions from transgenic plants displaying the
'recovered' phenotype remained symptom- and virus-free, while grafted
untransformed Burley 49 scions became infected and showed typical
systemic TEV symptoms within 10 to 15 days after the graft was established.
Resistance was absolute in the 'recovered' tissue and symptom
development was never observed in the 'recovered' scions of >50 grafted
plants. 'Recovered' FL- or AN29-scions grafted onto PVY-infected Burley 49
rootstock did become infected by PVY replication. Attempts were made to
induce TEV-resistance in unchallenged FL- and AN29-lines and in Burley 49
tissue. Various graft combinations were established, typically by grafting
untransformed Burley 49 tissue or an unchallenged FL- or AN29 scion onto
a 'recovered' FL- or AN29 rootstock. In nearly all cases, the scion became
infected within 10 to 20 days after grafting. This suggested that virus moved
readily through 'recovered' tissue and that a translocatable signal was not
involved in the induction of resistance.115
Table V.2. Induction of 'recovered' phenotype in transgenic plants
Pre-
treatmentbTreatment
a
Plant Line Symptoms on upper leavesc
Group 1
(Transgenic
plant lines)
Group 2
(Control
plant lines)
TEV none
PVY none
TEV TEV
TEV PVY
TMV TEV
TMV PVY
mock TEV
mock PVY
none TEV
none PVY
TEV none
PVY none
TMV TEV
TMV PVY
mock TEV
mock PVY
none TEV
none PVY
none
systemic PVY symptoms
none
systemic PVY symptoms
systemic TEV symptoms followed
by recovered plant phenotype
systemic PVY symptoms
systemic TEV symptoms followed
by recovered plant phenotype
systemic PVY symptoms
systemic TEV symptoms followed
by recovered plant phenotype
systemic PVY symptoms
systemic TEV symptoms
systemic PVY symptoms
systemic TEV symptoms
systemic PVY symptoms
systemic TEV symptoms
systemic PVY symptoms
systemic TEV symptoms
systemic PVY symptoms
aThe plant lines used in this study are presented as two groups based on
their identical response to the various challenge inoculations. Group 1
plants (FL-44.4, FL-24.3, AN-8.1, and AN-1.9) displayed the 'recovery'
phenotype. The nomenclature used is as described in the test. Group 2
plants were control lines that did not display the 'recovery' phenotype and
were Nicotiana tabacum cv. Burley 49 and 35S-4.7( a vector-only transgenic
control line containing no TEV sequences).
bne two sequential treatments were applied 4 weeks apart. Tobacco etch
virus (TEV), potato virus Y (PVY), or tobacco mosaic virus (TMV) were
mechanically inoculated onto leaf tissue dusted with carborundum using a
1:10 dilution of virus infected plant sap. For the mock inoculation studies, a
1:10 dilution of uninfected Burley 49 extract was used.
cSymptoms were observed daily for 30 days after the second inoculation
treatment.116
The TEV-resistance phenotype of progeny plants from TEV-recovered
AN29- and FL-lines were also examined. Plants showing the 'recovered'
phenotype were allowed to self-pollinate and set seed. Progeny plantswere
grown and then inoculated with TEV-infected plant sap. These plants
reacted to virus infection in a fashion identical to parental plants; plants
became systemically infected and then 'recovered' from TEV infection.
Therefore, progeny had not acquired the induced TEV-resistant state from
their parent, but had inherited the ability to recover after TEV inoculation.
Collectively, the results obtained in whole plant studies suggesteda
specific anti-TEV state had been induced in the 'recovered' FL- and AN29-
transgenic leaf tissue and TEV could not replicate in this tissue.
Protoplast studies
Studies were conducted to determine if the TEV-induced resistance
was functional at the single cell level. Protoplasts from both asymptomatic
tissue of TEV-infected plants displaying the 'recovered' phenotype and
unchallenged FL- and AN29-transgenic leaf tissue were transfected with
either PVY- or TEV-RNA. After incubation (ca. 24 to 48 hours), the
percentage of protoplasts supporting virus replication was determined by
analyzing transfected protoplasts in a protoplast printing assay (Jung et al.,
1992). Transfected protoplasts were also analyzed for thepresence of
infectious particles in back inoculation studies (Table V.3). Protoplast studies
correlated with whole plant studies; protoplasts from 'recovered' tissue did117
Table V.3. Analysis of TEV and PVY replication in protoplasts derived from
unchallenged or 'recovered' transgenic plant tissue.
ProtoplastPercent of protoplasts supporting Recovery of infectious
source virus replication" mv from protoplasts
infected with TEV RNAc
Inoculum
TEV RNA PVY RNA NO RNA
FL-24.3 88 59 0 +
FL-29.3 96 65 0 +
AN29-8.1 82 30 0 +
FL-24.3(r) 0 57 0
FL-29.3(r) 0 57 0
.N29 -8.1(r) 0 69 0
aResults from three different lines are presented. Transgenic plant nomenclature is as
described in text; (r), leaf tissue with the 'recovered' plant phenotype
bProtoplasts were transfected with purified TEV- or PVY-RNA or with no RNA, as described
in the text. Results are presented as percentage of protoplasts infected as determined in
protoplast printing assays. Monoclonal anti-TEV coat protein antibodies or anti-PVY
polyclonal antisera were used to detect viral antigen. Approximately 200 viable protoplasts
(per sample) were counted.
c Protoplasts which had been transfected with TEV RNA were pelleted, lysed, and extracts
were inoculated onto Nicotiana tabacum cv. Burley 49 leaves. Plants were examined 1 week
later for the appearance of TEV-induced systemic symptoms.118
not support TEV replication, while PVY replicated in protoplasts from
either 'recovered' or unchallenged leaf tissue (Table V.3). Therefore, both
the protoplast and whole plant studies suggested that the 'recovered'
phenotype was due to the inability of TEV to replicate in 'recovered' leaf
tissue.
Transgene expression
'Recovered' and unchallenged transgenic tissues were analyzed for
transgene transcript and translation product accumulation. Steady state
levels of transgene-encoded RNA and protein were examined by Northern
and Western blot analyses, respectively. Surprisingly, transgene coat
protein could not be detected in 'recovered' tissue (Figure V.2A) and
transgene mRNA levels from 'recovered' tissue were greatly reduced
(Figure V.2B). Quantitation of transcript levels revealed a 12- to 22-fold
reduction in transgene mRNA levels in 'recovered' tissue as compared to
transgene mRNA levels in unchallenged transgenic plant tissue at an
equivalent stage of development. As an internal control, actin mRNA
levels were also analyzed in these same RNA samples. This analysis
revealed that actin mRNA levels were approximately constant in the
different RNA samples (Figure V.2C).119
Figure V.2. Analysis of steady state levels of transgene RNA and protein
from the asymptomatic areas of 'recovered' leaves and from unchallenged
transgenic plant tissue. Extracts from the same tissues are in identical lanes
in A, B and C, except where noted. Protein (A) or RNA (B & C) samples
were used from the following tissues: lane 1, samples from N. tabacum cv.
Burley 49 tissue to which lOng of purified TEV (A) or 100pg of an RNA
transcript containing the TEV coat protein sequence was added (B); lane 2:
samples from N. tabacum cv. Burley 49 tissue; lane 3, samples from
transgenic FL-24.3 plant which was not challenged with TEV; lane 4,
samples from FL-24.3 transgenic plant which had recovered from TEV
infection; lane 5, samples from a transgenic FL44.4 plant which was not
challenged with TEV; lane 6, samples from a transgenic FL-44.4 plant which
had recovered from TEV infection; lane 7, samples from a transgenic AN29-
8.1 plant which was not challenged with TEV; lane 8, samples from a AN29-
8.1 transgenic plant which had recovered from TEV infection.
A. Western blot analysis of transgenic and B49 plant tissue isolated from
the plants described above. Total protein was extracted and electrophoresed
through a 10 % acrylamide SDS-PAGE gel and then transferred to
nitrocellulose membrane. The membrane was treated with rabbit anti-TEV
polydonal sera, goat anti-rabbit IgG (alkaline phosphatase conjugated) and
the chromogenic substrates NBT and BCIP to detect bound TEV CP
molecules. The position to which full length TEV coat protein migrates is
indicated by the arrow on the left. Proteins which cross-react with our anti-
TEV serum are present at the top and serve as an internal control for the
amount of protein loaded in each lane.
B., C. Northern blot hybridization analyses of Burley 49 and transgenic
plant tissue. Total RNA was extracted from plant tissues described above120
and analyzed. RNA samples were extracted, separated by electrophoresis on
denaturing (formaldehyde) agarose gel, and transferred to nitrocellulose.
TEV CP transgene transcripts (B) or tobacco actin sequences (C), were
detected by hybridizing filters with the appropriate 32P-labeled RNA probe.
Filters were exposed to X-ray film and photographs of the autoradiograms
are presented. Note that no sample was loaded in lane 1 of autoradiogram
in panel C.121
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Figure V.2.122
Discussion
I observed a unique, TEV-resistant state induced in transgenic plants
expressing an FL- or AN29-terminally truncated form of the TEV CP gene.
When initially challenged with TEV, these transgenic plants displayed
typical TEV-induced symptoms, but gradually outgrew infection by
approximately 3 weeks post inoculation.I refer to this process as 'recovery'.
As a result, 'recovered' transgenic plants consist of lower, symptomatic
leaves (which contain virus) and upper, asymptomatic leaves (which are
virus-free). Only TEV induced this phenotype, as mock inoculation or
inoculations with other viruses did not induce the 'recovered' plant
phenotype. Using a variety of approaches, I examined the ability of
'recovered' tissue to support TEV replication. In whole plant studies,
'recovered' tissue could not be infected with TEV but PVY, a related
potyvirus (displaying -47% total nucleotide sequence homology; -63% coat
protein gene sequence homology with TEV), established a normal systemic
infection. Comparable results were obtained in protoplast studies;
protoplasts from 'recovered' tissue did not support TEV replication, but did
support PVY replication.
The induced resistance observed in this report is distinct from the
phenomenon of systemically acquired resistance (SAR) (for review see Kuc,
1982). SAR can be induced by a variety of pathogens after the formation of a
necrotic local lesion, shows broad spectrum effects against different
pathogens (viruses, fungi, and bacteria), is active in untransformed
germplasm (does not require the presence of a particular transgene), and has
been linked to the induction of a number of genes with the involvement of123
salicylic acid as a translocatable signal (Ward et al., 1991). In contrast, the
induced anti-TEV state in FL- and AN29-plants that results from
'outgrowing' a systemic infection, is TEV-specific. The induced anti-TEV
state appears to require the presence of a TEV-derived transgene. An
endogenous signaling molecule does not appear to be involved, as the
phenotype could not be transmitted in grafted plants. The involvement of
endogenous host genes activated by viral or viral-induced signals has not
been determined in our system.
Coincident with the TEV-resistant state in 'recovered' plant tissues,
transgene mRNA and CP levels were significantly reduced. In 'recovered'
transgenic plant tissue, no transgene CP was detected and transgene mRNA
accumulation levels were reduced 12 to 22-fold compared to transgene
mRNA levels of unchallenged transgenic plant tissues of the same
developmental stage. These observations were surprising, as all of our
transgene constructions use the enhanced cauliflower mosaic virus 35S
promoter (Kay et a/., 1987), a regulatory element associated with constitutive
transcription in transgenic plants (Odell et al., 1985), though transcriptional
activity may vary in certain tissues (Williamson et a/., 1989; Barnes, 1990).
The only difference between these genetically-identical plants was whether
or not the plant had been infected by TEV; therefore, I anticipated no
difference in transgene expression between 'recovered' and unchallenged
transgenic tissue. One explanation for my observations was that the
decreased transgene expression and the induced anti-TEV state were
unlinked, induced by two separate mechanisms. In this scenario, specific
methylation of the transgene could be responsible for a reduction of
transcription with the induced anti-TEV state mediated by another cellular
process. While cognizant of this possibility, I propose that the two124
characteristics common to all tested 'recovered' tissue [i.e. a decreased
accumulation of a nuclear-encoded TEV mRNA transcript and the inability
of TEV, an RNA virus, to replicate in the cytoplasm] are linked. I have
developed a working model for our observations.
The model predicts that the molecular basis of the 'recovered'
phenotype is a cytoplasmic-based event, in which RNA sequences coding for
the TEV CP are specifically targeted, functionally suppressed, and eventually
eliminated from the cell. I propose that this activity is directly responsible
for both the decrease in transgene mRNA accumulation in 'recovered'
tissue as well as the inability of 'recovered' tissue to support TEV
replication. Mechanistically, the model suggests that a protein or nucleic
acid factor binds to a specific RNA sequence, rendering this RNA
functionally inactive and targeting it for elimination.
For the induction of the resistant state, I observed that the infecting
virus (TEV) must first establish a systemic infection. This suggested that
stimulation (or infection) of cells in the apical meristem was necessary. As
noted previously, I have never observed TEV-infected untransformed
plants to display this 'recovery' phenotype, and mock- or TMV-inoculated
transgenic plants also did not attain the TEV-resistant state. Therefore, a
specific interaction among TEV, the transgene, and the host plant was
necessary for the induction of the resistance phenotype. What is the
potential interplay between these factors?
A scenario I favor suggests that the transgene product contributes
two distinct components to the 'recovery' phenomenon. I propose that the
transgene transcript and the replicating TEV genome act additively to trigger
a natural cellular response which down-regulates or inactivates specific
RNAs in the cytoplasm. Stimulation of this system would result in a highly125
resistant phenotype to TEV as TEV RNA sequences are inactivated.
Normally, in an untransformed plant, the rapidly developing systemic viral
infection may overwhelm this defense response before it can be established
in a cell. However, in FL- and AN29-transgenic lines, the transgene protein
product provides a second function to impede virus movement, thereby
permitting cells to 'grow ahead' of the infection. This allows the anti-viral
state to be established in developing tissues. Protoplast studies indicate that
once established, the system functions at the single cell level.
The induction of cytoplasmic-based activity which inactivates and
eliminates specific RNA sequences from a cell may explain a number of
apparently disparate and unrelated phenomena. For example, I suggest that
certain examples of cross protection between infectious agents, sense or co-
suppression of transgenes, and the recently described examples of RNA-
mediated virus resistance may be explained by such a mechanism.
In a typical demonstration of cross protection (for review see Fulton,
1986), a plant is systemically infected with a mild isolate of a particular
virus. The infected plant, when challenged with a more virulent isolate of
that same virus, does not support replication of the second virus. As a
result, severe symptoms induced by the second virus do not develop. A
host response, similar to that proposed for 'recovered' trangenic plants [i.e.
enhanced viral RNA turnover], may be activated and prevent the second
challenging virus from replicating. Such a mechanism would not only be
functional for RNA viruses, but also could readily explain the cross
protection phenomenon observed with viroids (Nib lettet al.,1978; Branch
et al.,1988).126
I suggest that a cytoplasmic-based activity, similar to that proposed for
our virus-induced state, may be operational for some examples of sense- (or
co-) suppression. The phenomenon of co-suppression has been described for
a number of different genes in transgenic plants (Napoli et al., 1990; van der
Krol et al., 1990; de Carvalho et al., 1992; Smith et al., 1990; Hart et al., 1992).
Attempts to overexpress a particular gene product via the introduction of a
redundant transgene often results in suppression of both the endogenous
gene and exogenous transgene. In a number of cases, methylation of DNA
sequences correlates with reduced gene expression (Matzke et al., 1989;
Hobbs et al., 1990; Matzke and Matzke, 1991; Hobbs et al., 1993; Ottavianai et
al., 1993). However, in some cases, sense suppression appears to be
mediated post-transcriptionally (de Carvalho et a/., 1992) and a cytoplasmic-
based system may account for the suppression of transcript levels.
Finally, I suggest that the anti-viral state in RNA-mediated resistant
transgenic plants (Lindbo and Dougherty, 1992b; de Haan et al., 1992; van der
Vlugt et a/., 1992; Pang et al., 1993; Farinelli and Ma lnoe, 1993) and the
'recovered' CP-producing transgenic plants function by a similar
mechanism. I have previously described transgenic tobacco plants
containing a TEV CP gene modified by introduction of three stop codons
immediately downstream of the AUG start codon (Lindbo and Dougherty,
1992b). Such transgenic plant lines express an untranslatable TEV CP
mRNA. Approximately 40% of transgenic plant lines expressing this RNA
are highly resistant to TEV infection, but remain susceptible to PVY, TVMV,
and other viruses. The other ca. 60% of the transgenic lines express the same
untranslatable TEV CP mRNA, but are sensitive to TEV as well as other
plant RNA viruses. Results obtained with whole plants are reproduced at
the cellular level in protoplasts. I also observed that resistance to TEV did127
not correlate with transgene mRNA accumulation levels in these
transgenic plants.I propose that the highly resistant plants expressing the
untranslatable RNA have a cytoplasmic-based activity which functions
similarly to the TEV-induced system in 'recovered' FL and AN29 transgenic
plants. Activation of this RNA sequence-specific, cellular response renders
the plants completely resistant to subsequent TEV infection, but susceptible
to potyviruses with similar, yet distinct sequences. Activation of such a
system may also explain why resistance and RNA accumulation levels in
these plants are not correlated. Steady state levels of transgene transcripts
would be a function of RNA synthesis and turnover rates. In highly
resistant lines a sequence specific RNA degradation system would be
activated. Transgene RNA accumulation in these lines may be lower than
in susceptible transgenic lines where the system has not been activated and
only synthesis is being monitored. Hence one might expect to find a
negative or no correlation between RNA accumulation and resistance.
The working model proposed is far reaching in its implications and
may extend to mammalian cells.I believe this experimental system, which
examines specific nuclearly transcribed genes and a cytoplasmic replicating
RNA virus, will permit others to elucidate the biochemical basis of
resistance and this gene regulation in detail.128
CHAPTER VI
SUMMARY AND CONCLUSION
Summary
Research reports of 'coat protein-mediated resistance' (CPMR) to
potyviruses have described a variety of resistance phenotypes, both broad
spectrum and virus specific in nature. Several mechanisms have been
proposed for these resistance phenotypes including impaired virus movement
and/or replication. Additionally, virus resistance has been proposed to be
RNA- or protein-mediated. In most examples of potyvirus 'CPMR' no
correlation between steady state transgene RNA/protein levels and virus
resistance was found. As a result, a single unifying theory of potyvirus 'CPMR'
has not yet emerged. It is possible that no one single mechanism of resistance
does exist, and that a variety of factors (both RNA- and protein-mediated) are
involved in any example of resistance. Exactly why virus resistance occurs in
some, but not all, transgenic plants is not clear.
Recent work on transgenic plants which express full length (FL plants)
or amino-terminally truncated forms (6N29 paints) forms of the tobacco etch
virus (TEV) coat protein (CP) and are able to outgrow TEV-infection has
provided an interesting perspective on potyvirus 'CPMR'. In this transgenic
plant system, transgenic plant tissue which has outgrown (or recovered from)
TEV infection has attained an anti-TEV state and will not support TEV
replication. Concurrent with this virus resistant state is the dramatic reduction129
in transgene RNA and protein levels. Neither back inoculation experiments,
Northern blot analysis, nor ELISAs have demonstrated the presence of
infectious TEV particles, TEV RNA, or TEV protein in recovered transgenic
plant tissue. Thus it appears as though recovered tissue is virus free,
accumulates reduced levels of transgene RNA/protein and will not support
TEV replication. In this tissue, TEV resistance is inversely correlated with
steady state transgene RNA/protein levels. Recent preliminary experiments
have examined the transgene transcription rates in TEV-recovered transgenic
plant tissue, comparing them to transgene transcription rates in unchallenged
transgenic plant tissue. Nuclear run-on analysis suggests that transgene
transcription rates are roughly equivalent in these tissues. This result suggests
that in TEV-recovered transgenic plant tissue, transgene RNA levels are
regulated (by the host) post-transcriptionally. This regulation appears to
specifically target the TEV CP RNA sequence for degradation. If this post-
transcriptional regulation mechanism resides in the cytoplasm, where TEV
replicates, it is easy to imagine TEV genomic RNA also being subjected to this
same regulating mechanism.
All examples of potyvirus CPMR to date have focused on virus
resistance phenotypes and steady state transgene RNA/protein levels. TEV-
recovered transgenic plant tissue may explain why these two observations do
not correlate. In TEV-recovered tissue, it appears as though RNA stability
(RNA turnover rate) and not steady state RNA levels are critical for virus
resistance. Since steady state RNA levels are a balance between RNA synthesis
and degradation, a variety of different transgene RNA synthesis and
degradation rates could lead to equivalent 'steady state' levels of RNA in
different transgenic plant lines. We propose that in many examples of130
potyvirus CPMR, transgene RNA degradation rates and virus resistance will
be correlated; high transgene RNA degradation rates should positively
correlate with virus resistance.
This transgenic plant system implicates the host plant in the virus
resistant phenotype. For the most part, in discussions of potyvirus 'CPMR', the
response of the host plant to the transgene and its products have been largely
ignored. Steady state transgene RNA levels in TEV-recovered transgenic tissue
suggests that the response of the host plant may be critical for virus resistance.
It may be that under certain conditions, the host plant takes actions to
downregulate or reduce the amounts of transgene encoded RNA/protein in its
cells. These actions could operate at a transcriptional or post-transcriptional
level. In those cases where transgene transcript is regulated post
transcriptionally, by a cytoplasmically localized targetting and degradation
event(s), the probability of virus resistance is increased.
Though this discussion has presented some possible factors involved in
potyvirus CPMR, many questions still remain, including:
(1) Is transgene RNA stability critical for virus resistance in manyor all
examples of CPMR?
(2) Why or how could transgene RNA stability vary between transgenic
plant lines?
(3) In those cases where transgene RNA levels appear to be regulated
post-transcriptionally, what is the nature of the
recognition/degradation event?131
Is the transgene RNA specifically targetted for degradation?
How?
(4) Are plants able to target specific self/non-self RNAs for post-
transcriptional degradation? Could such a phenomenon be acting
in a some examples of co-suppression or virus cross protection?
Work on these and other intriguing questions is ongoing.132
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APPENDIX I
AGROBACTERIUM MEDIA1.1
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AB Minimal media
AB minimal plates (500 mls)
7.5 gms Agar
2.5 gms glucose
450 mls dH2O.
(Note: for AB minimal broth, omit agar).
Autoclave, cool to ca. 75 °C, then add:
25 mls 20X AB salts (see below).
25 mls 20X AB buffer (see below).
Cool to ca. 55 °C.
Add antibiotics (if desired.)
(Note: If adding antibiotics to minimal media, use 1/2
the concentration used on rich media plates).
Pour.
20X AB salts (1 L)
20 gms NH4C1
6 gms MgSO4 7H20
3 gms KC1
0.2 gms Ca C12
0.05 gms FeSO4 7H20
Sterilize by autoclaving.
20X AB buffer (1 L)
60 gms
20 gms
K21-1PO4 (dibasic)
NaH2PO4 (mono)
Sterilize by autoclaving.
Antibiotics:
For selecting Agrobacterium with pCIB 542 (Strepr, Spec') and
pPEV (Kanr) on minimal media use the following: 250 gg/m1
Streptomycin, 25 µg /ml Spectinomycin, 25 µg /ml Kanamycin.1.2.
MGY media
MGY media (1L)
10 gmannitol
2 gL-glutamic Acid (sodium salt)
0.5 g KH2PO4 (monobasic)
0.2 g NaC1
0.2 g MgSO4.7H20
1.0 gyeast extract
Add 800 mis of dH2O and adjust pH to 7.0 (with KOH or HC1)
Add 15 gms agar and water up to volume.
Autoclave.
(NOTE: glucose can be substituted for mannitol)
Cool to 55 °C.
Add antibiotics if desired.
Pour.
1461.3.
MG media
MG media
10 g Mannitol
2 g L-glutamic Acid (Sodium salt)
0.5 gICH2PO4 (monobasic)
0.2 gNaC1
0.2 gMgSO4.7H20
1 mlbiotin (211g/m1 stock)
Add H2O to 800 mis. Adjust pH 7.0 (with KOH or HC1)
Add 15 gms agar and autoclave.
Cool to 55 °C.
Add antibiotics if desired.
Pour.
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APPENDIX II
PLANT TISSUE CULTURE MEDIAILL
MS media
MS plates (1L)
4.3 gms MS basal salts (Sigma)
5 mis 200X B-5 vitamins (see below)
30 gms sucrose
800 mis dH2O
(Note: for MS broth, omit agar).
Adjust pH to 5.7 to 5.8 with IN and 0.1 N KOH.
Bring volume up to 1 L.
Add 7.5 gms plant tissue culture agar (Sigma).
Autoclave.
Cool to 55 °C.
Add antibiotics if desired.
Pour.
200X B-5 Vitamins:
2 gm myo-inositol
0.2 gms Thiamine HC1
0.02 gmsnicotinic acid
0.02 gms pyridoxine-HC1
Dissolve above in 100 mis sterile dH2O. Filter sterilize.
Store at 4 °C, protected from light.
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MSBN media
MSBN Agar (1L)
4.3 gms MS basal salts (Sigma)
5 mis 200X B5 vitamins (see II.1)
30 gms sucrose.
800 mis dH2O.
Add 100 1.1.1 BAP stock to 1L of media (see below)
(final concentration = 11.1g/m1).
Add 50 gl NAA stock to 1L of media (see below)
(final concentration = 0.1 µg /ml).
Adjust pH of media to 5.7 to 5.8 with IN or 0.1 N KOH.
Bring volume up to 1L.
Add 7.5 gms plant tissue culture agar.
Autoclave.
Cool to ca. 55 °C.
Add antibiotics, if desired.
(Example: add Carbenicillin to a final concentration of
500 gg/m1 and Kanamycin to a final concentration of 100-
300 gg/m1).
Pour.
BAP stock solution:
Dissolve 0.01 gms 6-benzylaminopurine (BAP) in 1 ml 1N
NaOH
Make up fresh for each use.
NAA stock solution:
Dissolve 0.01 gms a-naphthaleneacetic acid (NAA) in 1 ml
Et0H.
Slowly add 4 mis dH2O (while vortexing).
Make up fresh for each use.11.3.
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Protoplast incubation media
Reagents:
Stock solutions for Incubation media:
0.6 M Mannitol
109.3 gms/L
10% MES (pH 5.7),
10 gms MES/ 100 mis total volume.
Adjust pH with 1N KOH, filter sterilize.
80 mM KH21104 (pH 5.7 to 5.8)
1.088 gms per 100 mis. Adjust pH with 0.1M KOH.
Autoclave to sterilize.
400 mM KNO3
2.02 gms per 50 mis
40 mM MgSO4
0.493 gms per 50 mis
40 p.M CaC12
0.294 gms per 50 mis
2 mM KI
0.0166 gms per 50 mis
20 uM CuSO4
0.0005 gms per 100 mis
Incubation Media:
to 500 mis 0.6 M Mannitol add:
5 mis 10 % MES (pH 5.7)
2.5 mis 80 mM KH2PO4
2.5 mis 400 mM KNO3
2.5 mis 40 mM MgSO4
2.5 mis 40 uM CaC12
0.5 mis 2 mM KI
0.5 mis 20 I.LM CuSO4152
APPENDIX III
PLANT TRANSFORMATION PROTOCOLS153
Tri-parental mating
Reagents:
L-broth
L-agar plates
MGY broth (see 1.2)
AB minimal broth (see 1.1)
AB minimal plates (with appropriate antibiotics) (see I.1)
Nitrocellulose filters
Procedures:
Day one:
Grow up 2 ml cultures of :
(A) E. co/i/pRK2013 in L broth containing 50 µg /ml kanamycin.
(B) E. coli (HB101) with wide host range plasmid (ex. pCIB200) in L-
broth containing 50 gg/m1 kanamycin.
(C) Agrobacterium tumefaciens A136/pCIB 542 in MGY broth
containing 500 gg/m1 Streptomycin and 50 mg/m1
Spectinomycin.
Spin down 1 ml of each overnight culture and resuspend cells in 1 ml
of L-broth (or MGY broth for 'C') containing no antibiotics.
Place nitrocellulose (NC) filter disc onto L-Agar plate.
Pipette 50 Ill of each of the three above resuspended cultures onto the
surface of NC.
Mix by pipetting up and down 5-10 times.
Let plate sit at room temperature overnight.
Do not invert plate.
Day two
Resuspend bacteria on filter with 1 ml of AB minimal broth (no
glucose or antibiotics) and a P-1000 pipette.
Draw off resuspended bacteria and pipette into eppendorf tube.
Make serial dilutions of 10-2, 10 -3 and 10 -5 and 10-6.154
Plate 100, 10 and 1 gl of the dilutions onto AB minimal plates
containing 250 µg /ml Streptomycin, 25 p.g /ml
Spectinomycin and 25 µg /ml Kanamycin.
Grow cultures at room temperature.
(May take several days to see colonies).
Pick isolated colonies and restreak onto AB minimal plates
(containing antibiotics). Streak 5 colonies per mating for each
streak purification.
Incubate plates for streak purification at room temperature.
Streak purify selected Agrobacterium colonies a total of 3 times before
using for plant transformation.
Selected colonies can be stored as glycerol stock cultures as follows:
Add 0.5 ml overnight culture to 0.5 ml sterile glycerol.
Vortex to mix, and store at -70 °C.155
11L2.
Leaf 'disc' transformation of Nicotiana tabacum
Reagents:
MGY broth (see 1.2)
MS broth (see II.1)
MSBN plates (see 11.2)
MSBN (Kan/Carb) plates (see 11.2)
Sterile filter paper
70 % EtOH
25% Chlorox (with 2 or 3 drops of Tween 20 per 100 mis)
GA-7 vessels each containing (25-50 mis) MS agar (see 11.1)
Procedures:
Preparation of leaf tissue for transformation:
Surface sterilize Nicotiana tabacum seeds:
Work under hood and use sterile technique.
Place 50-100 N. tabacum seeds in 15 ml polypropylene tube.
Add 4 mis 70% EtOH. Swirl to mix.
Let stand 90 seconds.
Remove EtOH with Pasteur pipette. (Place tip of pipette firmly
against bottom of tube to avoid pulling up seeds with
liquid).
Add 4 mis 25% Chlorox solution.
Let stand 10 minutes, swirling occasionally.
Remove Chlorox solution with Pasteur pipette (as described
above).
Rinse seeds by adding 5 ml sterile dH2O. Let stand 1 min,
swirling occasionally.
Remove liquid with Pasteur pippette as previously described.
Repeat sterile dH2O wash 2X.
Growing plants under sterile conditions:
Using EtOH /flame sterilized forceps and scalpel, transfer 1 or 2
surface sterilized seeds from polypropylene tube into MS agar in
a GA-7 container.
Press seeds 1-2 mm below surface of agar with tip of sterile forceps.
Place lid on GA-7 and seal with parafilm.
Place under lights.
Let seeds sprout and grow under these sterile conditions.156
Seeds will sprout within a week. It will be several weeks (ca 6-8)
before plants will be big enough to use for leaf disc
transformation.
Subculturing plants in GA-7 containers:
(Work under hood, using sterile technique)
As plants get too large for containers, remove plants, cut off all
leaves and cut main stem at internodes.
Transfer one piece of stem into each new GA-7 with MS agar.
Push one cut edge of stem ca 1 cm down into agar. (Make sure the
apical end of the stem is pointing upwards).
Place lid on GA-7. Seal with parafilm. Place under lights.
Stem fragments will grow leaves and roots in a ca 2 weeks.
Infection of leaf discs with Agrobacterium:
(Work under hood, using sterile technique)
Inoculate MGY broth (500 µg /m1 Spec; 50 µg /ml Strep; 50 1.1g/m1 Kan)
with Agrobacterium colony containing suitable plant
transformation plasmid.
Incubate at room temp, 200 rpm for 24-36 hours.
Dilute 24-36 hr culture 10-2 to 10-3 into 10 mls MS broth.
Let Agrobacterium equilibrate to MS media for ca. 4-5 hours.
Excise leaf from a plant grown under sterile conditions.
Cut leaf up into lcm squares.
Place leaf 'discs' (pieces) into petri dish. Pipette Agrobacterium
(in MS broth) into dish with leaf discs.
Let leaf discs sit in media for 2 minutes.
Remove leaf discs and blot onto sterilized filter paper.
Place discs onto a piece of sterile filter paper overlayed on an MSBN
plate (NO antibiotics).
After three days, transfer discs directly onto MSBN with Kanamycin
(100-200 gg/m1) and Carbenicillin (500 gg/m1).
Transfer leaf discs onto new MSBN Kan/Carb plates ca every 2 weeks.
Callus forms in - 10 days to 2 weeks. Subculture callus as needed
(every two weeks or so).
As shoots form, excise them from the callus and place in MS plates
containing 100-200 µg /ml Kanamycin. Gently place cut end of
shoot into agar.
In about 1 week roots will begin to form on shoots.
About 2 weeks after rooting begins, plantlets can be transferred to soil.
Carefully remove all agar from roots with a gentle spray of water.
Transplant into soil and immediately transfer to greenhouse (no need
to "harden off").157
111.3.
Reagents:
Selection of Kan r transgenic tobacco seedlings
Sterile dH2O
70 % EtOH
25 % Chlorox with 2 or 3 drops of Tween-20 per 100 mis.
Seed Screening plates with Kan (per liter):
4.3 gms MS salts (Sigma).
Add 800 mls dH2O.
Adjust pH to 5.7 to 5.8 (with 1N or 0.1N KOH).
Bring vol up to 1L.
Add 7.5 gms agar.
Autoclave. Cool to about 55 °C.
Add 125 gg Kanamycin Sulfate per ml.
Pour plates.
Procedures:
Surface sterilizing seeds (See 111.2 for details).
Soak in 70% EtOH, 90 seconds.
Soak in 25% chlorox solution for 10 minutes.
Wash 3X in sterile dH2O.
Selection of Kanr seedlings:
Place seeds onto Seed Screening plates containing 125 ug/ml
Kanamycin (Kan).
After about 5 days seeds begin to germinate.
Kan sensitive plants will develop seed leaves, but not true leaves.
Kan sensitive plants will turn white and can usually be identified after
3 weeks.158
APPENDIX IV
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IV.1.
Reagents:
10 % SDS-PAGE minigel
10 % SDS (sterile)
1.0 M Tris (pH 8.8)
1.25 M Tris-Cl (pH 6.8)
10% (w/vol) Ammonium persulfate (made fresh)
30% Acrylamide, 0.8% Bis-acrylamide
TEMED
Laemmli Running buffer (1L, 10X):
Procedures:
30.25 gms
144 gms
10 gms
Tris
Glycine
SDS
Disolve in H2O, bring volume to 1L
10% Polyacrylamide (discontinuous) gel.
In two small beakers, mix all ingredients for Running and
Stacking gel except TEMED and Ammonium
persulfate.
Running Gel Stacking Gel
0.15 mis 10% SDS 0.05 mis 10% SDS
5 mis Acrylamide 0.9 misAcryl. mix
5.6 mis 1.0 M Tris ph 8.8 0.5 mis Tris-Cl (pH 6.8)
4.125 miswater 3.45 mis water
5 pi TEMED 5 IA TEMED
100 ill Amm Pers. 50 al Amm pers.
(10% w/v) (10% w/v)
Add TEMED and ammonium persulfate to running gel solution.
Swirl to mix.
Pour running gel into assembled plates. Overlay with dH2O.
After gel has polymerized pour off dH2O, rinse with dH2O.
Dry inside of plates with filter paper.160
Add TEMED and ammonium persulfate to stacking gel. Swirl to mix.
Immediately pour stacking gel and insert comb.
Run gel with 1X Laemmli running buffer.
Gel should be run at about 75 to 100 mAmps.
Notes: Run gel until bromophenol blue marker in sample (see
dissociation solution section IV.2) is almost off the gel (ca 3
hours) or until desired.
This recipe is enough for 2 SDS-PAGE minigels.161
IV.2
Reagents:
Western blot analysis
Towbin Transfer buffer (per liter)
3.03 gmsTris
14.41 gmsGlycine
200 mis Methanol
800 mis dH2O
Dissolve Tris and glycine in water first, then add methanol.
Store at 4 °C.
TBS (per liter):
50 mis 1M Tris-Cl (pH 7.5)
11.6 gm NaC1
1000 mis dH 20
TTBS (per liter):
TBS with 1 ml of Tween-20 per L.
Carbonate buffer (1L):
8.4 g NaHC 03
0.2033 g MgC12. 6H20
Dissolve in 800 mis H2O
Adjust pH to 9.8 with NaOH
Bring volume to 1L. Autoclave.
NBT stock solution:
30 mg p-nitro blue tetrazolium chloride
0.7 mis N,N-dimethylformamide (DMF)
0.3 mis dH20
Store at 4 °C, in dark.
BCIP stock solution:
15 mg5-bromo-4-chloro-3-indoyl phosphate p-toluidine salt
1 ml DMF
Store at 4 °C, in dark.162
Laemmli Running buffer (IL, 10X):
30.25 gmsTris
144 gms Glycine
10 gms SDS
Disolve in H2O, bring volume to 1L
3X dissociation solution (100 mis):
1.125 g Tris-HC1
3g SDS
15 mis glycerol
15 mis 2-mercaptoethanol
0.25 gmsBromophenol blue
Dissolve Tris in 50 mis dH2O. Adjust pH to 6.8.
Bring volume to 70 mis and add other ingredients.
Procedures:
Extraction of proteins:
Grind tissue in 10 vols (w/vol) of 2X Laemmli running buffer.
Clarify extracts with 10 min spin at 12.5 K in microfuge.
Remove supernatant into new tube and save.
Store supernatant (extract) at -20 °C.
Electrophoresis of proteins.
Add 5µl of 3X dissoc. solution to 10 pl extract.
Heat in boiling water bath 3 min. Spin down condensate.
Load all 15 gl onto gel (10 % acrylamide SDS-PAGE).
Run minigel at 75 mA constant current until dye front is within 1 cm
of bottom (ca. 3-4 hours).
Transfer of proteins to nitrocellulose
Assemble transfer apparatus, as follows:
Materials:
2 pieces of filter paper and 1 piece of nitrocellulose (NC), each
slightly larger than gel.
Note: Always wear gloves when handling NC.163
Prewet filter paper and nitrocellulose in Towbin buffer.
Place one piece of filter paper on sponge pad.
Place gel on top of this piece of filter paper.
Place NC membrane on top of gel. Make sure no bubbles are
under NC.
Place second piece of filter paper on top of NC.
Place another sponge pad on top of filter creating a "gel sandwich".
Place in plastic frame of blotting apparatus.
Place frame (containing gel) into transfer apparatus filled with
cold (4°C Towbin buffer).
Transfer proteins to nitrocellulose for ca. 45 min at 0.5 to
1.0 Amps. Remember, run to red. Proteins will migrate
to red (+) pole. Make sure the nitrocellulose is in between
gel and (+) pole.
After transfer is complete, disassemble "gel sandwich".
Gently remove NC and place in seal-a-meal bag.
Blocking of NC:
Block NC by adding 3% gelatin in TBS* (ca 15 mls solution per 60 cm2
of NC) to seal-a-meal bag containing NC.
Block at room temp for 2 hours (minimum).
Binding primary antibody:
Pour out blocking solution from bag.
Add primary antibody diluted in 1% gelatin in TTBS*.
(For detecting TEV CP use: 1:4000 of rabbit anti-TEV). Use same
volume of solution as used for blocking.
Bind primary antibody at room temperature for 4 hours to overnight.
Washing NC:
Remove NC from bag.
Place NC in dish or other suitable container.
Wash by adding enough TTBS so that NC is covered by a layer of
TTBS at least 2 mm thick.
Place on shaker (50 rpm) for 7 minutes.
Pour off TTBS.
Repeat washing with TTBS 2X.
Binding secondary antibody:
Place NC into seal-a-meal bag.164
Add second antibody, diluted in 1% gelatin in TTBS*.
(Ex; 1:1000 of Goat anti-rabbit Alkaline Phosphatase.) Use same
volume of solution as you used to block NC.
Bind second antibody 1-2 hours at room temp.
Remove NC from bag and place in suitably sized container.
Wash (as described above) in 3X in TTBS then 1X in TBS (7 min per
wash).
Color Reaction:
Place NC in new seal-a-meal bag. Add substrate solution and seal bag.
Use a volume of substrate solution (ca. 15 mis per 60 cm2).
Substrate solution:
Add 100 p.1 of BCIP and 100 p.1 of NBT stock to 10 mis carbonate
buffer.
Let color reaction develop at room temperature.
Stop reaction by removing NC from bag and rinsing blots in a dish of
distilled water.
Let blots air dry on filter paper. Store in seal-a-meal bag.
*Note: To dissolve gelatin in TBS /TTBS you will need to heat
solutions briefly in microwave. Let cool to room temp before
using.IV.3
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Enzyme-linked immunosorbent assay (ELISA)
Reagents:
5X PBS (2 L)
80 gms NaC1
11.5 gmsNa2HPO4.2H20
2.0 gms KH2PO4
2.0 gms KC1
2.0 gms NaN3
Disolve in 1900 mis dH2O. Adjust pH to 7.4.
Bring volume to 2L
Store at room temp.
Coating buffer (1L)
1.59 gms Na2CO3
2.93 gms NaHCO3
0.2 gms NaN3
Add 990 mis of dH2O. Adjust pH to 9.6.
Bring volume to 1L. Store at 4 °C.
Washing buffer (1L):
200 mis 5X PBS
800 mis dH2O
1 ml Tween 20
Store at room temperature.
Virus buffer (1 L):
200 mis 5X PBS
700 mis dH2O
20 gms polyvinyl pyrrolidone
2 gms ovalbumin
1 ml Tween-20
Mix ingredients. Adjust pH to 7.4. Bring volume to 1L.
If precipitate forms, filter through cheesecloth.
Store at 4 °C.166
Substrate buffer (1L):
97 mis Diethenolamine
800 mis dH2O
0.2 gms NaN3
Mix ingredients, adjust pH to 9.8. Bring volume to 1L.
Store at 4 °C.
para-nitrophenyl phosphate (substrate) tablets (Sigma).
Falcon brand ELISA plates
Alkaline phosphatase conjugated antibody
(anti-TEV alkaline phosphatase)
Partially purified anti-TEV IgG (coating antibody)
Procedures:
Coating ELISA plate:
Pipette 200 IA per well of rabbit anti-TEV IgG (coating antibody),
diluted 1:1000 in coating buffer.
Wrap plates tightly in saran wrap.
Place at 37 °C for 4 hours or at 4 °C overnight.
Pour out anti-sera from wells.
Fill wells with wash buffer. Dump out and re-fill.
Let plate stand 3 minutes then dump out. Tap (pound) wells dry on
paper towels. Make sure no liquid remains in wells.
Repeat this 3 min wash step 3 times, drying plate between washings.
Sample preparation and binding:
Collect tissue samples of interest.
In mortar and pestle, grind 0.5 gms tissue in 5 mis virus buffer.
Pour homogenate over glass wool into centrifuge tubes.
Dilute plant sap sample 1:100 in virus buffer.
Add sample dilutions (200 gl per well) to seperate wells in the ELISA
plate.
Wrap in plastic wrap.
Incubate at 4 hours at 37 °C or overnight at 4 °C.
Wash and pound dry as described above (3 washes of 3 minutes each,
3 times).167
Binding conjugate antibody:
Add 200 p.1 per well of conjugate antibody diluted 1:1000 in coating
buffer.
Wrap in plastic wrap.
Incubate 4 hours at 37 °C, or overnight at 4 °C.
Wash and pound dry as previously descibed (3 washes total).
Color generation:
Add para-nitrophenyl phosphate (PNP) to substrate buffer to give a
final [] of 1 mg/ml PNP.
Add 200 p.1 PNP solution per well.
Place plate in dark at room temp.
Read plates at 1 hour. May be necessary to let plates sit (in dark) for
several hours and then read again.
Note: This particular ELISA method is a double antibody sandwich
(DAS) method.IV.4
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In vitro translation: rabbit reticulocyte system
Reagents:
Translation kit stock solutions (see below)
Rabbit reticulocyte lysate
(purchased from Green Hectares, Oregon, Wisconsin).
Translatable RNA
Procedures:
Pretreatment of lysate (to remove endogenous mRNA):
[Final]
183.5 gl lysate
4.0 gl 1.0 M Tris-HC1 (pH 8.2) 20 mM
2.0 p.1 Creatine kinase (5 mg/ml) 50 µg /ml
2.0 p.1 0.1 M Ca C12 1 mM
1.5 41 4mM Hemin 30 p.M
1.0 p.1 2.0 M KOAc 10 mM
2.0 p.1 Micrococcal nuclease (1mg/m1) 10 µg /ml
Incubate 10 min at 30 °C.
Add:
4.0 IA 0.1 M EGTA 2 mM
18 gl 2.0 M KOAc 100 mM
12.5 p.1 0.5 M Creatine Phosphate 17.4 j.i/NA
12.0 pi tRNA (3 mg/ml) 3 pg
7.2 Ill Amino acids (- Met) 100 p.M
2.5 IA 0.7 M DTT 5 mM
3.0 p.1 RNasin (Promega)
30 IA 12 mM MgOAc 1 mM
Var. 35S Met (6 111 for 12 rxns) 2-5 p.Ci.
Var. di-120
300 111 Total volume (treated rabbit reticulocyte lysate)
In vitro Translation Reaction:
25 IA treated rabbit reticulocyte lysate
5 p.1 RNA sample
Incubate at 37 °C for 60 minutes.169
Analysis of translation products:
Remove 10 gl of translation reaction.
Add 5 gl 3X dissociation solution (see Reagents, IV.1).
Heat in boiling water bath, 3 min.
Load all 15 1.1.1 onto SDS PAGE gel and separate proteins by
electrophoresis.170
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In vitro transcription using T7
or SP6 RNA polymerase
Reagents:
Restriction enzyme
Restriction enzyme buffer
5X Transcription buffer (Promega)
100 mM DTT
4 mM (each) rNTPs (ATP, GTP, UTP, CTP)
RNasin (Promega)
SP6 or T7 RNA polymerase (Promega)
RNase free DNase (Optional), (Promega RQ1 DNase)
Procedures:
Linearize DNA:
Use a restriction enzyme which leaves a 5' overhang or a blunt
end.
Example:
5 1.1.g of DNA (or 15 pl of miniprep DNA).
5 pl of 10 restriction enzyme buffer
3 1.11 enzyme
water up to 50 IA
Digest at 37 °C for ca. 1.5 hours.
Remove 1 p.1 for analysis on a gel. If DNA has been cut completely
procede to next step. If not, continue digestion.
Phenol extract (1X) then ether extract (2X).
Precipitate DNA by adding:
20 p.1 5M NH4OAc (i.e. 0.4 volumes)
140 p.1 95 % EtOH (i.e. 2 volumes)
Invert to mix.
Place at -20 °C about 1 hour. Spin down (12.5 K, 10 min in microfuge).
Pour off supernatant (save pellet).
Wash by adding 0.5 ml 70% EtOH. Spin 12K, 1 min.
Pour off supernatant.
Air dry pellet, then vacuum dry.
Resuspend pellet in 20 p.1 dH2O.
Store at -20 °C until needed.172
Transcription Reaction:
6 IA5X buffer
6 glNTPs (4 mM, each, of ATP, CTP, UTP, GTP)
3 glDTT
0.5 gl RNasin
0.7 pi T7 or SP6 RNA polymerase
14 pl linearized DNA sample
Mix with pipette and place at 37 °C for 1 hour.
Optional: If for some reason you wish to degrade the input
plasmid DNA, you can now add 1 unit of RNase free
DNase per gg of DNA and let digest at 37 °C for 15-30 minutes.
Remove 1 gl and run on gel.
Immediately extract remainder of reaction with an equal volume of
phenol:CHC13.
Remove aqueous phase and place in clean tube.
To each of 30 IA of aqueous recovered add:
60 gl dH2O
60 IA 5M NH4OAc
400 IA EtOH
Invert to mix.
Store at -20 °C (30-40 min minimum).
Spin down in microfuge at 12.5 K for 5 min. Pour off supernatant.
Wash pellet by adding 0.5 ml 70% EtOH. Spin 12K, 1 min.
Pour off supernatant, save pellet.
Air dry pellet, then vacuum dry.
Resuspend pellet in 25 IA H20. Store at -20 °C until needed.173
V.2.
RNA extraction from plant tissue
Reagents:
RNA Ext. Buffer:
0.1 M LiC1
0.01 M EDTA
1% SDS
0.1MTris-Cl pH9.0
(Sterilize by Autoclaving)
4M LiC1 (sterilize by autoclaving)
Sterile 1.5 ml Eppendorf tubes
Ceramic mortar and pestle.
Liquid N2.
Phenol : CH13 (1:1)
5M NH4OAc
EtOH (95% and 70%)
Procedures:
In a mortar and pestle, grind piece of tissue (about the size of a 50 cent
piece) to a fine powder in the presence of liquid nitrogen.
Add 2.5 mis of RNA extraction buffer to powdered tissue and
homogenize tissue.
Remove about 2 mis of extract and pipette equally into 3 (1.5m1)
tubes each containing 600 Ill of (1:1) Phenol: CHC13.
Vortex for 30 seconds to 1 minute.
Spin tubes at 12.5 K for 10 minutes in microfuge.
Remove a total of two 700 pll aliquots (of aqueous layer) from the 3
tubes and add to an equal vol. of 4M LiC1 in 2 1.5 ml tubes.
Let RNA ppt. 4 hours to overnight on ice.
Spin down RNA at 12.5 K for 10 minutes in microfuge.
Pour off supernatant, save pellet.
Resuspend pellet in 100 to 200 p.1 dH2O.
Add 0.4 volumes of 5M NH4OAc and 2.5 volumes of cold 95% Et0H.
Invert to mix.
Precipitate RNA at -20°C for 2-4 hours. Spin down RNA with 12.5 K
10 min spin in microfuge. Pour off supernatant.
Wash pellet by adding 0.5 ml cold 70% EtOH. Spin 12 K, 1 min.
Pour off supernatant.
Air dry pellet, then vacuum dry.174
Resuspend pellet in 10-20 IA dH2O.
Quantitate RNA with OD readings:
Make 500 gl of a 1:500 dilution of RNA.
Record OD 260 and OD 280.
(1 OD 260 = 401.1g/m1 RNA.)
Final concentration of RNA is usually around 1-5 mg/ml.V.3.
RNA dot/slot blot protocol
Reagents:
20 X SSC (see V.5)
Formaldehyde
Nitrocellulose
3mm filter paper
Procedures:
RNA sample preparations (to denature RNA)
Mix reagents as follows:
Formaldehyde RNA
5 IA var.
Heat at 65 °C for 10 minutes.
Ice 10 minutes.
Add 30 ill 10X SSC.
Assembly of blotting apparatus:
175
10X SSC
to 30 11.1 final volume
Cut out one piece (each) of Whatman 3mm paper and nitrocellulose
to fit blotting apparatus.
Prewet filter paper and nitrocellulose in dH2O,then soak in 10X SSC
(15 min.).
Assemble apparatus with nitrocellose on top of filter paper.
Binding RNA to nitrocellulose:
Add denatured RNA samples to assembled apparatus.
Pull through apparatus with vacuum pump.
Remove filter from apparatus.
Place between Whatman 3mm paper to air dry.
Bake 30 min at 70 °C in vacuum oven.176
V.4.
Reagents:
Denaturing (formaldehyde) RNA gels
10X FF Buffer
200 mM HEPES (pH 7.8)
10 mM EDTA
Deionized Formamide
Deionize with Amber lite beads: Add about 250 Ill of Amber lite
beads to ca. 1 ml of formamide in a 1.5 ml tube. Vortex to mix.
Let sit about 15 min before using. Store in dark at room temp.
Formaldehyde (36%, reagent grade)
Agarose (electrophoresis grade)
Procedures:
Clean electrophoresis chamber, gel tray and gel comb:
Fill gel chamber (containing gel tray and comb) with 10% SDS
solution.
Let soak ca. 10 minutes. Rinse with sterile dH2O. Air dry or use clean
chem-wipes to dry.
Pour denaturing RNA gel
1.2 % Agarose gel (6% formaldehyde):
0.3 gm Agarose
2.5 ml 10X FF buffer
18.5 mls dH2O
Dissolve agarose by heating in microwave.
Cool to 55 °C. Then Add:
4.2 mls Formaldehyde.
(25 mls Total Vol.)
Pour gel (under hood) immediately after adding formaldehyde.
Let gel set and cool under hood.177
RNA Sample Prep (15 pl or 10 pl final volume):
RNA SampleFormamideFormaldehydeH2O10X FF buf.Vol.
3.5 41 (max) 7.5 pl 25 ill x µl 1.5 ul 15111
23 ul (max) 5µl 1.601 x 1.11 1 gl 101.11
Mix all components together.
Heat to 65 °C for 10 minutes.
Ice for 10 minutes.
Mix and load onto gel.
Add bromophenol blue (BpB) to (at least) one lane for marker.
Run gel at 10-20 mA until BpB is near bottom of gel.
Transfer to Nitrocellulose.178
V.S.
Reagents:
Transfer of RNA to nitrocellulose.
20 X SSC
175.32 g NaC1
88.23 g NaCitrate.
volume to 1L
Autoclave
Nitrocellulose
Whatman 3mm filter paper
Plastic (Saran) wrap
Procedures:
Set up
Cut 10 pieces of Whatmann 3mm filter paper, and one piece of
nitrocellulose (NC), each slightly larger (within a cm or 2)
than gel.
Soak NC in dH2O for 5 min., then in 20X SSC for 5 minutes.
Transfer:
On a piece of plastic wrap place 7 pieces of Whatman 3MM paper.
Saturate filter paper with 20 X SSC.
Place RNA gel on top of whatman paper.
Fold plastic wrap up to rest on the top of the gel on all 4 sides. This
"seals" the edges of the gel, on all sides.
Place pre-wetted nitrocellulose membrane on top of gel.
Remove all air bubbles by using a 5 or 10 ml pipette like a "rolling
pin".
Saturate remaining 3 pieces of filter paper with 20 X SSC. Place on top
of NC.
Place a stack of paper towels (about 5 inches high) on top of filter
paper.
Place a weight (about 500 gms) on top of towels.
Let transfer overnight.
Binding of RNA to Nitrocellulose (NC):
After transferring overnight, remove NC and place between 2 pieces
of dry 3mm filter paper.
Let NC air dry.
Bake at 70 °C in vacuum oven for 30 min to 2 hours.V.6.
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Hybridization of nitrocellulose filters
Reagents:
Pre-hyb buffer (500 mis):
87.66 gms NaC1
44.12 gms NaCitrate
2.0 gmsFicoll
2.0 gmsPVP
Volume to 500 mis with dH2O. Autoclave. Cool, then add
2.0 gmsBSA
(alternatively can add all ingredients and filter sterilize).
1 M NaPO4 (pH 6.5)
Denatured Salmon Sperm (10 mg/ ml)
10 % SDS
Formamide
20X SSC (see V.5)
Procedures:
Pre-hybridize:
Incubate baked filter for at least 2 hours (55-65° C) in a seal-a-meal bag
containing pre-hyb solution. Use about 20 mis pre-hyb solution
per 150 cm2 of nitrocellulose (NC).
Pre-hyb solution:
5 mis Pre-hyb buffer
0.4 mis NaPO4 (pH 6.5)
0.5 mis SS DNA (10 mg/ml) (boil 5 min before adding).
2.0 mis 10% SDS
2.1 mis dH2O
10 mis Formamide.
(Total vol = 20 mis.)
Hybridization
Cut open bag. Add RNA (ribo-) probe to pre-hyb solution and reseal
bag.
Hybridize at 65 °C for at least 4 hours.180
Wash conditions:
Cut corner of bag and drain out probe into suitable container (ex a 50
ml screw top plastic tube). Probe can be re-used several (2-3)
times, if stored at -20 °C.
Gently cut bag to release filter. Gently place filter in dish.
Wash filter by adding enough 2X SSC to cover NC filter with a layer of
liquid at least a couple of mm thick.
Wash (50 rpm on shaker) at room temp. for 15 minutes. Pour out 2X
SSC and repeat wash with fresh 2X SSC.
Pour out 2X SSC and wash filter in 0.1X SSC, on shaker (50 rpm), at 60-
65 °C for 1 hour.
Repeat 0.1X SSC wash.
Remove NC from final wash. Place on dry 3mm filter paper.
Air dry filter. Wrap in saran wrap and expose to X-ray film.V.7.
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Synthesis of riboprobe
Reagents:
5X transcription buffer (Promega)
100 mM UM'
RNasin (Promega)
ATP, GTP, UTP mix (2.5 mM each)
100 p.M CTP (cold)
T7 or SP6 RNA polymerase (Promega)
Linearized DNA template
a-32P CTP (800 or 3000 pCi/mmole)
Procedures:
Probe synthesis:
Add Reagents in the following order:
4 pl 5X buffer
2 pl DTT (100 mM)
0.5 IA RNasin
4 p.1 2.5 mM ATP, GTP, UTP mix
2.4 gl 100 I.LM CTP (cold)
1.0 pg Linearized DNA template
5.0 p.1 ( a-32P) CTP (50 pCi at 10mCi/m1)
1.0 pl 17 or SP6 Polymerase
var. dH2O
20 IA final vol.
Mix all ingredients briefly.
Let reaction procede at 37 °C for 1 hour.
Add 1 unit RNase free DNase (to destroy template).
Incubate 15 minutes at 37 °C.
Add (8 p.1) NH4OAc and (70 IA) EtOH to precipitate RNA.
Place at -20 °C (ca. 2 hours).
Spin down RNA (12.5 K, 10 minutes in microfuge).
Remove supernatant with a pipette.
Resuspend RNA in (50 pl) TE or dH2O.
Add directly to heated pre-hyb mix in a seal-a-meal bag already
containing nitrocellulose filter.182
APPENDIX VI
DNA METHODSVI.1.
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Oligonucleotide purification:
ethanol precipitation method
Reagents:
5M NH4OAc
EtOH (95% and 70%)
TE (10 mM Tris pH 8.0, 1 mM EDTA)
Procedures:
Resuspend 0.2 ;moles of lyophilized oligo in 1 ml TE.
Remove 200 gl. Store remaining 800 gl in freezer (-20°C).
To 200 p.1 sample add:
200 gl 5 M NH4OAc
800 gl 95% EtOH
Invert to mix.
Let sit at -20 °C for 15 minutes.
Spin 5 minutes at 12 K.
Pour off supernatant.
Air dry pellet.
Resuspend in 200 p.1 TE. Add:
200 pl 5 M NH4OAc
800 p.1 95% EtOH
Invert to mix.
Let sit at -20 °C for 15 minutes.
Spin down for 5 minutes at 12K.
Pour off supernatant. SAVE PELLET.
Wash by adding 0.5 ml cold 70% EtOH. Spin 12K, 1 min.
Pour off supernatant. Save pellet.
Air dry pellet, then vacuum dry.
Resuspend pellet in 200 p.1 TE.
Record OD 260 and 280 of 500 p.1 of a 1:100 dilution.
Use 1 OD 260 = 20 µg /ml oligonucleotide.184
VI.2.
Reagents:
Phosphorylation of oligonucleotides
10X kinase buffer
0.5 M Tris-C1 (pH 7.6)
0.1 M MgC12
50 mM DIT
1 mM spermidine
1 mM EDTA
100 mM ATP
T4 polynucleotide kinase
Procedures:
Mix the following reagents together in an eppendorf tube.
50 picomoles of oligonucleotide
3 Ill of 10X Kinase buffer
0.5 1.1.1 of 100 mM ATP
1 41 of T4 polynucleotide kinase
Sterile H2O to 30 pl
Incubate at 37 °C for 30 minutes.
Heat kill kinase at 70 °C for 10 minutes.
Final oligo [1 is 1.6 pmoles/p.l.
Phosphorylated oligo can be used directly for site directed
mutagenesis (Amersham kit).VI.3.
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Reagents:
STET:
Plasmid DNA miniprep (boiling method)
8% Sucrose
0.5 % Triton X-100
50 mM EDTA (pH 8.0)
10 mM Tris-Cl (pH 8.0)
Autoclave.
Lysozyme:
10 mg/ml in 10 mM Tris-Cl pH 8.0
Store stock at -20 °C.
L-broth (1L):
5 gms NaC1
5 gms Yeast extract
10 gms Tryptone
Autoclave.
Sterile 1.5 ml Eppendorf tubes
Phenol:CHC13 (1:1)
CHC13
5 M NH4OAc
EtOH (95% and 70%)
Procedures:
In large culture tube (ca 40 ml) inoculate ca. 5 mls of L-broth
(containing the appropriate antibiotics) with E. coli.
Culture at 37 °C, 250-300 rpm overnight.
Transfer ca. 1 ml broth culture into 1.5 ml Eppendorf tube.
Spin 4 min at 9K in Tomy microfuge.
Remove supernatant by aspiration.
Resuspend pellet in 325 ul STET.(Vortex hard).
Add 15 IA lysozyme stock (10 mg/ml)
Let stand at room temp. for 5 min.
Put in boiling water bath for 1 min.
Place tubes on ice until they cool at least to room temp.
Spin 10 min. at high in microfuge.
Vortex hard.
Spin 10 min at high.186
Remove pellet with a toothpick and throw pellet into the biohazard
waste.
Add 1 1.1.1 RNase to super and let sit 15 min. at room temp.
Extract with Phenol: CHC13 (1:1) 2x.
Extract with CHC13 lx. Place aqueous layer in clean tube and add:
125 IA 5M NH4OAc.
900 ill EtOH
Invert to mix.
Place at - 70° C for 30 min.
Spin 6 min at high in microfuge.
Pour off super.
Wash pellet with 0.5 ml 70 % EtOH. Spin 3 min at high in microfuge.
Pour off super. Air dry, then dry in speed vac.
Resuspend in 50p1 dH2O.
Run 2 ml on gel to analyze.VI.4.
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Extraction of DNA from plant tissue
Reagents:
2X CTAB buffer (Autoclaved)
2% CTAB (w/v)
100 mM Tris (pH 8.0)
20 mM EDTA (pH 8.0)
1.4 M NaC1
1 % PVP (polyvinylpyrrolidone) MW 40,000
5% CTAB solution (Autoclaved)
5 % CTAB
0.35 M NaC1
CTAB Precipitation buffer (Autoclaved)
1% CTAB
50 mM Tris (pH 8.0)
10 mM EDTA (pH 8.0)
**Note: CTAB = Hexadecyltri-methylammonium bromide**
High-salt TE buffer (Autoclaved)
10 mM Tris (pH 8.0)
1 mM EDTA (pH 8.0)
1M NaCl
0.1 X TE buffer (Autoclaved)
1 mM Tris (pH 8.0)
0.1 mM EDTA (pH 8.0)
RNase stock solution:
1 mg/mlRNase A
100 U/mlRNase T1
Heat in boiling water bath for at least 10 minutes (to destroy any
DNases.)
Store stock solution at -20 °C.
CHC13
Liquid N2
Mortar and Pestle
Sterile 1.5 ml Eppendorf tubes
EtOH (95% and 70%)
5M NH4OAc188
Procedures:
Prewarm 2X CTAB buffer and 5% CTAB solution in 65 °C H2O bath.
Also dilute some 2X CTAB buffer to lx (ca. 1 ml of lx CTAB
buffer per gm tissue to be extracted should be enough). Place 1X
CTAB buffer in 65 °C water bath too.
Weigh tissue.
Grind to powder in the presence of liquid nitrogen.
Add 1 vol (i.e. 1 ml buffer per gram tissue) 2X CTAB buffer (65 °C).
(Should be like thick soup. If too dry add lx CTAB buffer).
Transfer slurry to eppendorf tube (- 0.5 mis per tube).
Add equal vol chloroform. Vortex to mix.
Spin 30 seconds at 11K. If aq. vol is not as large as CHC13, add
1X CTAB buffer to bring up volume.
Transfer aq layer into new tube. Add 1/5 vol of 5% CTAB.
(eg. to 600 pl aq add 120 pl 5% CTAB)
Extract with CHC13. Spin 30 seconds at 11K.
Remove aq layer to new tube. Add equal vol of CTAB ppt buffer.
Invert gently to mix.
Spin 60 seconds at 11K. Pour off supernatant.
Resuspend pellet in high salt TE (ca. 200 p.1 per gram extracted tissue).
(may need to heat to 65 °C for 5-10 min. to get into solution)
Add 2 volumes cold 95% EtOH. Invert to mix. Place at -20 °C a
few minutes if you can't see DNA precipitate (ppt) form.
Spin 30 seconds at 11 K. Pour off supernatant.
Wash pellet in 0.5 mis 70% EtOH (spin at 11 K, 30 sec.)
Pour off super.Briefly vacuum dry pellet.
Resuspend pellet in 0.1X TE (ca. 200 p.1 per gm tissue extracted).
Add 1/10 vol RNase stock.
Digest RNA at 37 °C for 1 hour.
Extract with equal volume CHC13. Spin 11k, 30 sec.
Remove aqueous layer into new tube and add:
0.4 volumes 5M NH4OAc and 2.5 volumes 95% EtOH.
Invert to mix.
Place at -20 °C for at least 2 hours.
Spin at 12.5 K for 10 min. Pour off supernatant.
Wash pellet with 0.5 mis 70 % EtOH. Spin 12.5 K, 1 min.
Pour off supernatant. Save pellet.
Briefly vacuum dry pellet.
Resuspend pellet in dH2O.
Estimate DNA concentration by taking OD 260/280 readings of 500 p.1
of a 1:100 dilutions. (1 OD 260 = 50 µg /ml DNA)
Notes: As vortexing can shear large pieces of DNA, vortexing should
be kept to a minimum.
Yield should be about 50 -100 pg DNA per gm of tissue.VI.5.
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Restriction enzyme digestion and electrophoresis
of plant DNA
Reagents:
5 M NaOH
5M NaC1
2M Tris-Cl (pH 8.0)
1 M HC1
20 X SSC (see V.5)
6X DNA loading buffer
0.25 % bromophenol blue
30% glycerol
2X TPE buffer (per liter):
8.5 gm Tris
8.0 gm NaH2PO4 (monobasic)
0.6 gm EDTA
Add dH2O to 800 mls. Adjust pH to 7.7
Bring volume to R.
Plastic wrap
3mm filter paper
Nitrocellulose paper
Procedures:
Restriction enzyme digestion and electrophoresis of DNA
Digest 10 pg DNA (in 30p.1 vol. with 5 fold excess of restriction
enzyme) 4 hours to overnight.
Add 7 pl 6X DNA loading buffer and load onto 1% Agarose gel (in IX
TPE) and electrophorese in 1X TPE buffer.
Run gel at ca. 75 mAmps.
Stain gel with EtBr and photograph with ruler on UV
transilluminator.190
Transfer of DNA to nitrocellulose
Before transfer to nitrocellulose, pre-treat gel as follows:
Place gel in dish. Completely cover with the following
solutions and shake (50 rpm) at room temp. for the following
times:
20 min in 0.25 M HC1
1 hour in 0.5 M NaOH, 1.5 M NaC1
1 hour in 1 M tris (pH 8.0), 1.5 M NaC1
Cut 10 pieces of Whatmann 3mm filter paper and a piece of
nitrocellulose (NC) all slightly larger than gel.
Soak NC in dH2O for 5 min., then in 20X SSC for at least 5 min.
Assemble gel for transfer as follows:
On a piece of plastic wrap place 7 pieces of whatman 3MM paper.
Saturate filter paper with 20 X SSC.
Place DNA gel on top of whatman paper.
Fold plastic wrap up to rest on top of gel, on all sides. This will "seal"
the edges of the gel, on all sides.
Place pre-wetted nitrocellulose membrane on top of gel.
Remove all air bubbles by using a 5 or 10 ml pipette like a "rolling
pin".
Saturate remaining 3 pieces of Whatman 3mm paper in 20X SSC.
Place wet filter paper on top of NC.
Place a stack of paper towels (about 5 inches high) on top of filter
paper.
Place a weight (about 500 gms) on top of towels.
Let transfer overnight.
Binding DNA to nitrocellulose (NC).
Next day gently remove NC filter and place between 2 pieces of 3mm
paper to air dry.
After the filter has dried, bake at 70 °C in vacuum oven for 30 min.VI. 6.
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Southern blotting:
pre-hybridization, hybridization and washing conditions
Reagents:
Pre-hyb buffer:
87.66 gms NaC1
44.12 gms Na Citrate
2.0 gmsFicoll
2.0 gmsPVP
volume to 500 mls
Autoclave then add 2 gms BSA.
(Alternative method: add all ingredients and filter sterilize)
1M NaPO4 buffer (pH 6.5)
10 % SDS
Denatured salmon sperm DNA (10 mg/ml)
Formamide
Procedures:
Pre-hybridization:
Place baked nitrocellulose (NC) filter in a seal-a-meal bag with
Pre-hyb solution (ca. 20 mis per 150 cm2 nitrocellulose)
Incubate at 55 °C for at least 2 hours.
Pre-hybridization Solution: (20 mis)
5 mis Pre-hyb buffer
0.4 mis 1M NaPO4 (pH 6.5)
0.5 mls SS DNA (10 mg/ml stock) (boil 5 min before adding)
2.1 mls dH2O
2 mis 10% SDS
10 mls Formamide
Hybridization of filter:
Either add RNA (ribo-) probe directly to pre-hyb solution or replace
with hyb solution containing RNA probe.
Hybridize at 50-55 C for at least 4 hours, with shaking (50 rpm).192
Wash conditions:
Cut corner of bag. Drain out radioactive hybridization solution into
suitable container.
Gently remove filter from bag. Place filter in dish or other suitable
container.
Add enough 2X SSC to cover filter with at least 2 mm of liquid.
Wash in 2X SSC for 15 minutes at room temp on shaker (50 rpm).
Pour off 2X SSC.
Repeat wash procedure (described above) with 0.1X SSC for 40 minutes
at 55 °C with shaking (50 rpm).
Pour off 0.1X SSC wash. Check filter with counter. If too "hot" repeat
0.1X SSC wash.
Air dry filter on Whatman 3mm filter paper. Wrap with saran wrap
and press to film.VI.7.
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Preparation of single stranded DNA from (M13 ori) plasmids
Reagents:
20 % PEG (MW 8000), 2.5 M NaC1 (Autoclave).
L-broth with antibiotics
M13 K07 helper phage stock.
Sterile 1.5 ml Eppendorf tubes
Sterile corex tubes (15 ml)
Phenol
CHC13
3M NaOAc (pH 5.2) (Autoclaved)
EtOH (95% and 70%)
Procedures:
Day_l
Inoculate 8 ml of L-Amp (containing 8 gl 1% thiamine) with 40 1.1.1 of
overnight E. coli culture. Use large (ca 40 ml) culture tube.
Incubate at 37 °C, 250 rpm until log growth is reached (ca. 1.5 hours)
Add 50 pl helper phage stock (M13 K07). Incubate at 37°C, 100 rpm
1 hour.
Remove 1 ml of culture. Add to 5-10 mls L-Amp (in large culture
tube) with 0.001% thiamine and 70 gg/m1 Kanamycin.
Incubate at 37 °C, 250-300 rpm for 14-18 hours.
Day 2:
Transfer culture to 15 ml corex tube, spin 10 min at 8000 rpm.
Transfer supernatant to new 15 ml corex tube.
Add 2.5 mls 20% PEG, 2.5 M NaC1 per 10 mls liquid culture volume.
Invert to mix.
Ice 15 minutes.
Spin 10 K for 15 minutes. Pour off supernatant.
Resuspend pellet in 300 p.1 TE. Transfer solution to eppendorf tube.
Add 300 Ill phenol. Vortex. Spin 3 min at 10K.
Transfer Aq layer to new tube. Extract with CHC13.
Repeat if necessary.
Ether extract (1-2X).
Place aqueous layer in clean tube and add:
1/10th vol 3M NaOAc (pH 5.2) and 2 vols (95%) EtOH.
Invert to mix.
Precipitate at -20 °C ca. 2 hours.
Spin 5 min at 12.5 K in microfuge.194
Pour off supernatant.
Wash pellet by adding 0.5 ml 70 % EtOH. Spin at 12 K, 1 min.
Pour off supernatant.
Air dry pellet then briefly vacuum dry pellet.
Resuspend pellet in 20-40 gl TE.
Quantitate DNA concentration by recording OD 260/280 of 500111 of a
1:100 dilution. (1 OD 260 = 40 gg/ml ss DNA)195
APPENDIX VII
PROTOPLAST METHODSVII.1.
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Generation of protoplasts from Nicotiana tabacum
Reagents:
0.6 M mannitol (autoclaved)
0.6 M sucrose (autoclaved)
10 % MES (pH 5.7 filter sterilized)
Carborundum, cotton swabs, scalpel and forceps.
Sterile dH2O
70% EtOH
10% Chlorox with tween (2 drops per 100 mis).
Cellulase (Onozuka R-10, Yakult Honsha Co. Ltd, Tokyo)
Macerase (Calbiochem)
Procedures:
Surface sterilization of leaf tissue:
Remove mid-vein (use a razor blade) from leaf tissue.
Cut into ca. 1 inch squares with razor blade.
Weigh out 1 gm samples. Place 1 gm in 250 beaker.
Surface sterilize tissue in 200 mis 70% EtOH (90 sec.). Pour off EtOH.
Add 200 mis 10% Chlorox solution. Let stand 5 min.
Pour off Chlorox solution.
Add 100-200 mis sterile dH2O. Swirl to mix for ca 20 sec.
Pour off dH2O.
Repeat this dH2O wash procedure 3-4 X.
Place 1 gm tissue in petri plate.
Enzyme digestion of leaf tissue.
Lightly abrade undersurface of leaf with carborundum on a cotton
swab.
Place abraded side of leaf down. Cut into 1 cm. squares using a scalpel
and forceps.
Pipette 12 mis enzyme solution into petri dish. Seal with parafilm.
Enzyme solution
0.6 M mannitol, 0.1% MES (Mannitol/MES)
0.15 gms cellulase and 0.02 gms Macerase/ 10 mis.
Let digest overnight, in dark.197
Collecting protoplasts:
Next day swirl gently to release protoplasts.
Let digest another 30 minutes to 2 hours in dark.
Filter through sieve with 300 [tM diameter openings.
Gently pipette (use a 10 ml pipette) into 15 ml polypropylene tubes.
Underlay 0.6M sucrose cushion (ca. 2 cm thick) in each tube.
Use a sterile pasteur pipette to underlay sucrose.
Spin 400 rpm (1200 X G, room temp.) 4 min in swinging bucket rotor.
Remove all of the upper phase and the protoplasts at the interface
with a 10 ml pipette.
Transfer protoplasts to new 15 ml tube.
Spin as above. Protoplasts will pellet in this spin.
Washing protoplasts:
Remove as much of liquid as possible without disturbing protoplasts.
Gently swirl to resuspend protoplasts in remaining liquid.
Gently pipette in 8 mis of Mannitol/MES solution.
Spin as described above. Protoplasts will pellet.
Pipette off liquid with 10 ml pipette.
Swirl to resuspend protoplasts and repeat this wash procedure with
Mannitol/MES 2 more times.
Count protoplasts in hematocytometer before final spin.
Add 10-15 p.1 suspended protoplasts to hematocytometer and
observe under low power on compound microscope.198
VII.2
Reagents:
PEG-mediated transfection of protoplasts
50% PEG 1500 MW (Boehr. Mannheim)
1M MgC12
1M Ca(NO3)2 (pH 7-9 )
RNA to be transfected
Disposable glass tubes (Kimax 12 x 75 mm), autoclaved.
Mannitol/MES
0.6 M Mannitol, 0.1 % MES, pH 5.7
0.6 M sucrose
Protoplast incubation media (see 11.3)
Procedures:
Transfection:
Pipette 100K protoplasts (in Mannitol/MES) into sterile glass tubes.
Spin down 400 rpm (1200 x G) in swinging bucket rotor,
4 min at room temp.
Remove as much of supernatant as possible with pipette.
Gently resuspend protos by swirling.
Add RNA directly to protoplasts. Swirl gently.
Immediately add 100 gl PEG-MgCS
PEG-MgCs
1 ml 50% PEG 1500 MW (Boehr Mannheim)
15 Ill 1M MgC12
100 Ill 1M Ca(NO3)2 (pH 7-9 )
Swirl gently. Let stand 20 seconds.
Add 1 ml mannitol/MES in 0.33 ml aliquots.
Swirl gently (to dilute PEG) in-between aliquots.
Place tubes in ice 15 minutes.
Spin down (1200 x G, 4 minutes). Remove supernatant with pipette
and discard.
Resuspend pelleted protoplasts in ca. 0.5 mls incubation media
Transfer to incubation media in small petri dish. (ca. 2.5 mls
incubation media per 100-200 K protos).
Seal petri plates with parafilm.
Place under lights, cover plates with cheesecloth.199
To harvest protos:
Collect protos by gently swirling petri dish (to gently resuspend to
dislodge protoplasts).
Pipette protoplasts into 15 ml polypropylene test tube.
Underlay a cushion (ca. 2 cm in height) of 0.6 M Sucrose.
Spin at 400 RPM (1200 x G, swinging bucket rotor, room temp) for 5
minutes.
(Viable protoplasts will collect at and above sucrose/incubation
media interface).
With a pipette (10 ml) remove protoplasts in upper phase and at
interface. Transfer protoplasts to new tube.
Spin at 400 rpm, 5 min as previously described.
Protoplasts should pellet. Remove all liquid with pipette.
Gently swirl to resuspend. Add ca 5m1 Mannitol/MES.
Spin at 400 rpm, 5 min as previously described.
Protoplasts will pellet. Remove all liquid with pipette.
Resuspend protos by gently swirling. Add 0.5 to 1 ml Mannitol/MES.
Count protoplast suspension.
Add 10-15 ill of suspended protos to hematocytometer and
observe under low power on compound microscope.VII.3.
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Protoplast printing
Reagents:
Nitrocellulose
primary antibodies (monoclonal or polyclonal)
secondary alkaline phosphatase conjugated antibodies
TBS (see IV.2)
TTBS (see IV.2)
Procedures:
Binding protoplasts to Nitrocellulose:
Pipette ca. 200 protoplasts onto nitrocellulose.
Let air dry.
Detection of bound viral antigen:
Incubate nitrocellulose (NC) in a seal-a-meal bag containing 3%
gelatin in TBS* (ca 15 mis per 70 cm2 NC) for 2 hours at room
temp.
Pour out 3% gelatin solution. Replace with an equal volume of
primary antibody solution (diluted in 1% gelatin in TTBS*).
(example: 1:1000 mouse anti-TEV monoclonals)
Bind primary antibody for at least 2 hours, at room temp.
Washing NC filter:
Remove NC from bag. Place in dish, add enough TTBS to cover with
a layer of TTBS at least 2 mm thick.
Place on shaker (50 rpm) at room temp, 7 min.
Pour out TTBS and replace with fresh TTBS.
Repeat TTBS wash procedure 2X.
Binding secondary antibody:
Place NC filter in new seal-a-meal bag with secondary antibody
diluted (ex 1:1000) in 1% gelatin in TTBS*. (Use about 15 mis
solution/70 cm2 NC).
Bind secondary antibody at room temp for 1-2 hours.
Remove NC from bag. Place in dish and wash in TTBS as described
above (7 min per wash, 50 rpm, etc.). Wash 3X total.
Wash once in TBS on shaker (50 rpm) for 7 min.201
Color development:
Place NC in new seal-a-meal bag. Add substrate solution (15 mis per
70 cm2 NC).
Substrate solution:
100 ill (each) of NBT and BCIP stock solutions per
10 mis carbonate buffer.
Observe blot under binocular microscope (high power) as color
develops.
Negative controls should remain as green spots on blot.
Positive controls develop into purple spots.
Stop reaction by removing NC from bag and placing in a dish of dH2O.
Remove washed NC from dH2O, place on Whatman 3 mm filter
paper to dry. Seal dried NC in seal-a-meal bag to store.
*Note: To get gelatin into solution in TBS and TTBS, it will be
necessary to briefly heat the solution in microwave.202
APPPENDIX VIII
VIRUS-RELATED PROTOCOLS203
VIII.1.
Reagents:
TEV purification
20 mM HEPES (or 200 mM, or 1M stock). Autoclaved.
N-butanol
Sodium sulfite
TEV-infected plant tissue
PEG (MW 8000)
NaC1
Triton X-100
20 mM Tris (pH 8.0)
Sterile corex tubes (15 ml)
Procedures:
Extraction of infected tissue:
Collect Leaf tissue: (usually at least 1000 gms) gms.
Grind tissue in an ice-cold Waring Blendor with:
2X vol:wt 20 mM HEPES (pH 7.5) (1) ml
18% (final conc.) n-butanol (2) ml
[= (1) x 0.18]
0.1% (wt/vol) NaSulfite (3) gms
[= (1) x 0.001]
Grind on high for 1.5 minutes.
Express through cheesecloth.
Centrifuge in GSA bottles at 4500 RPM for 5 min.
Save supernatant and filter through glass wool. Combine all
supernatants.
Precipitation of virus:
Measure volume
volume = mls (4)
Transfer to large beaker, add triton, PEG and NaCl.
1.0% (wt/vol)Triton X-100 mls = (4) x 0.01)
4% (wt/vol) PEG 8000 gms =(4) x 0.04)
0.1M NaC gms =[5.68 x (4), in L]
Stir on ice for 2 hours.
Transfer to GSA bottles, spin 10 min at 8000 RPM.204
SAVE PELLETS.
Resuspend pellets well, in 1/4 original volume of buffer used
in 20 mM HEPES (pH 7.5) with the aid of a tissuegrinder.
Centrifuge in GSA rotor for 10 minutes at 8000 RPM.SAVE
SUPERNATANTS! Combine and measure volume.
volume = mis (5)
Transfer to chilled beaker and stir at 4°C for 2 hours after
adding:
8% (wt/vol) PEG gms = (5) x 0.08
0.1M NaC1 gms = 5.68 x (5) in L
Cenrifuge in GSA rotor for 10 minutes at 8000 RPM.
SAVE PELLETS!
Resuspend pellets in 9.0 mls of 20 mM HEPES (pH 7.5) with the
aid of a tissue grinder.
Purification on CsC1 gradient:
Make up a CsC1 solution of the following:
11.6 gms CsC1
27.0 mis 20 mM HEPES (pH 7.5)
To SW 50.1 tubes add:
3.5 mis CsC1 solution.
Overlay with 1.5 mls resuspended virus.
Spin at 36,000 RPM for 8-12 hours at 4 °C.
Isolation of virus from Cs gradient:
Virus band should be about 10 mm from the bottom.
(Four or 5 mm above this you should see a white
floculent band of "junk". Avoid this as much as
possible.)
Collect the bands with an 18 gauge needle and 1 ml syringe.
Combine volumes pulled in a 15 ml Corex tube.
Bring the volume to 12 mis with 20 mM HEPES Buffer (pH 7.5).
Centrifuge in an SS34 rotor for 10 minutes at 10,000 RPM.
SAVE SUPERNATANT!
Pour into 50 ml beaker and add PEG to 8% (wt/vol)
PEG gms (12 mls x 0.08)205
Stir on ice for 1 hour.
Centrifuge for 10 minutes in SS34 rotor at 10,000 RPM, 4°C.
SAVE PELLETS!
Resuspend pellet in 1-2 mls of 20 mM Tris (pH 8.0)
Quantitation of virus recovered:
Record volume of virus solution:
volume = mls
Dilute 1:100 into 500 IA dH2O
Record OD 260/280 of this dilution.
0D 260 =
OD 280 =
260/280 =
To estimate virus concentration:
(pure virus 260/280 = 1.18).
OD '60 x dilution factor = mg/ml
2.4VII.2.
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Purification of TEV RNA
Reagents:
Proteinase K stock solution:
50 mM
1 mM
1%
200 µg /ml
Tris-C1 (pH 8.0)
CaC12
SDS
Proteinase K
Phenol:CHC13 (1:1)
5M NH4OAc
EtOH (95% and 70%)
Procedures:
Proteinase digestion of virus sample:
Incubate proteinase K solution at 50 °C for 10 minutes.
To purified virus sample, add equal volume proteinase K solution.
Vortex briefly to mix.
Incubate at 45-50 °C for 10 minutes.
Precipitation of viral RNA:
Phenol:CHC13 extract 2X.
Remove aqueous phase and precipitate RNA by adding:
0.4 volumes 5M NI-140AC
2.5 volumes 95 % EtOH
Invert to mix
Place at -20 °C for 2 hours.
Spin down RNA at 12.5K for 10 minutes in microfuge.
Dump out supernatant. Save pellet
Wash pellet by adding 0.5 ml 70 % EtOH. Spin 12 K, 1 min.
Dump out supernatant.
Briefly vacuum dry pellet.
Ouantitation of RNA recovered:
Resuspend RNA pellet in dH2O.
Estimate concentration by taking OD 260/280 of 500 pi or a 1:100
dilution of RNA solution.
Note: Expect about 25 i.ig RNA per mg of virus.VII.3.
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Helper component extraction
(from PVY infected tissue)
Reagents:
Extraction Buffer ( per liter):
Final II per L
0.1M NH4 Acetate, pH 8.8, 7.7 gms
0.02M Nat EDTA 100 mis 0.2M Na2EDTA stock
0.02M NaDEICA 4.5 gms
To Ammonium acetate and EDTA solution add dH2O to bring
volume to 1L.
Adjust pH with acetic acid.
Chill at 4°C overnight.
Add Na diethyldithiocarbamate (NaDIECA)just before use.
TSM ( per liter):
Tris 12.1 gms
MgSO4. 7H20 4.93 gms
Dissolve in 800 mis dH2O and adjust pH to 7.2 with H2SO4.
Bring final volume to 1L. Autoclave.
40% PEG (wt/vol) solution:
200 gms PEG 6000
500 mis dH2O
Dissolve PEG in 500 mis dH2O.
Add 40 gms (8%) AG 501-x (Amberlite) mixed bed ion exchange
resin (Biorad). Stir overnight at RT. Filter out beads through
Whatman 541 filter in a Buchner funnel and vacuum flask.
Store at 4°C. (note: deionization is important for consistent
active HC preps).
PVY infected leaf tissue (10 gms ca. 2-3 weeks post inoculation).
Miracloth208
Procedures:
Collect PVY infected tissue:
Harvest 150g of leaf tissue from plants inoculated with PVY 14-21 days
before use.
Place in plastic bag. Chill leaves (4 °C, overnight).
Using a razor blade, Remove the mid-veins and cut into 2 inch
squares.
Vacuum infiltrate tissue with Extraction Buffer.
Submerge 100 gms tissue in 1L Buffer in a plastic bag.
Place in dessicator attached to vacuum pump.
Pull a hard vacuum. When the solution starts bubbling close off the
dessicator and detach the pump. Release the vacuum to
dessicator quickly and watch the water-soaking (darkening) of
the tissue.
Repeat this step until all the tissue has turned dark green.
Drain the extraction buffer into a graduated cylinder.
Extraction of HC from tissue:
Place 75 ml of extraction buffer into chilled Blender jar.
Grind the tissue on low speed until all the tissue has been added and
blendor runs smoothly.
Homogenize at high speed for 1 min.
Pour homogenized tissue through 4 layers of cheescloth.
Rinse blendor with 25 mls of extraction buffer. Pour rinse through
cheesecloth too. Transfer filtrate into GSA bottles.
Centrifuge for 15 min at 8000 g in a GSA rotor.
Pour supernatant through Miracloth (pre-wet with buffer).
Centrifuge filtered supernatant 1.5 hr at 21K in 21 Rotor (or 1 hr at
45 K in 50.2 Ti rotor).
Pour supernatant through wet Miracloth (save 0.5 ml sample for HC
activity assay. Store this 0.5 ml sample at -70 °C).
Precipitation of HC:
Save supernatant from above and measure volume.
Add 0.24 ml of 40% PEG Soln. per ml of supernatant
(final concentration = 8%).
Stir for 1 hr on ice.
Centrifuge 15 min at 8000g. Pour off supernatant. Save Pellets.
Resuspend pellet with glass tissue grinder in TSM
(use 1/10 High Speed Supernatant volume of TSM).209
Spin (clarify) for 15 min at 8,000g.
Transfer supernatant to clean beaker. (Remove 100 p.1 sample for
assay, store 100 p.1 sample at -70 °C.)
To remainder of supernatant add 0.24 volumes 40 % PEG.
Stir on ice 1 hour.
Pellet HC with 10 min, 10K spin (SS 34 rotor). Pour off supernatant.
Resuspend pellet in 1-2 mis TSM.
Spin 1 min at 5 K in microfuge to clarify.
Remove supernatant to clean tube and add (dry, powdered) sucrose to
a final [1 of 20%.
Store frozen (-70 °C) in aliquots (25 - 50 pl).
Test all samples in aphid transmission assay for HC activity (see VII.4).
If final sample does not give activity, use the other samples
collected along the way to help you identify at which step
activity was lost.VII.4.
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Potyvirus purification:
(for aphid transmissable virus)
Reagents:
Homogenization buffer:
0.5 M KPO4,pH7.5
1.0 MUrea
0.5%thioglycolic acid (TGA)
0.01 MNaDIECA
Prepare H., batches of phosphate buffer. Add other ingredients just
before use. Mix under hood.
(Note: NaDIECA = Diethyldithiocarbamic acid, sodium salt).
Resuspension buffer:
0.1 MKPO4,pH7.0
1.0 M Urea
1 % Triton X-100
20 mM Tris-ClpH 7.5
53%CsSO4 (wt /wt)
5.3gmsCsSO4
4.7mis 0.02 M Tris-Cl (pH7.5)
Potyvirus infected tissue (ca. 2-3 weeks post inoculation).
Procedures:
Collect virus infected tissue the night before. Store at4°C overnight
in plastic bag.
Extraction of virus from infected tissue:
Homogenize tissue in blendor in 1.5 ml homogenization buffer
per gm (fresh wt) of tissue.
Initially add about1/3of buffer and then add tissue gradually.
Add rest of buffer and homogenize on high ca. 1 min.
Add cold chloroform (1m1 chloroform per gm tissue).
Homogenize in blendor 1 minute at low speed.
Transfer slurry to GSA bottles. Spin15min at7K.
Pour aqueous layer through glass wool into chilled graduated cylinder.211
Precipitation of virus:
Record Vol: Vol = m 1 s
Add NaC1 to 0.25 M and PEG (8000) to 4%.
0.0146 X vol = gms NaC1
0.04 X vol = gms PEG
Stir gently at 4 °C for 1 hour.
Transfer to GSA bottles. Spin for 15 min at 7K.
SAVE PELLETS!!
Resuspend pellets in Resuspension buffer.
(Use about 120 mis for 200 gms tissue).
Use glass rod to break up pellets.
Stir gently at 4 °C for 1.5 - 2 hours (make sure all green material is
resuspended-- the white junk may never resuspend.)
Transfer to GSA bottles.
Spin 15 min at 7K.
SAVE SUPERNATANT.
Transfer 20 mis of supernatant into 60 Ti tube. Underlay with 5m1
sucrose pad (30 % sucrose in 20 mM Tris-CL pH 7.5).
Centrifuge 60 min at 45 K.
SAVE PELLETS.
Resuspend in 0.02 M Tris-Cl pH 7.5 with tissue homogenizer.
(8 mis buffer for 100-200g virus preps).
Transfer to corex tubes. Spin 10 K for 10 min.
Transfer supernatant to new tube.
Separation of virus on Cs gradient:
Record Vol. Add 0.23 gms CsSO4 per ml.
Mix gently to dissolve Cs.
Layer onto 0.8 ml 53% wt/wt CsSO4 pad in 4 ml cellulose nitrate tubes.
(Use P1000 to load onto pad).
Centrifuge 16 hr at 32 K in SW 50.1 rotor.
Isolation of virus:
Pull virus band with large needle and syringe (18 Ga).
Resuspend pulled virus (gently) in ca. 8 mis 20 mM Tris-Cl pH 7.5.
Transfer to corex tube. Spin 10 min at 10K.
SAVE SUPERNATANT.
Transfer super to cellulose nitrate tubes.
Spin in SW 50.1 for 60 min at 45 K, 4 °C.
Resuspend pellets in 0.5 ml 20 mM Tris-Cl (pH 7.5) at 4 °C for 2-4 days
with gentle mixing.
Store at 4 °C.212
VIII.5
Reagents:
In vitro potyvirus aphid transmission system
Purified PVY helper component (HC)
Purified virus
TSM (with 20% sucrose)
Procedures:
Mix purified HC, virus and TSM (20% sucrose):
Try various ratios of HC and virus to optimize transmission
system.
(Ex: Try 1-10% HC, 20-80% virus).
Collect aphids:
Grow aphids on mustard-spinach plants ( cv. Tendergreen) in growth
chamber with 14 hour photoperiod and 22°/20° (C) day/night
temps.
Tap aphids off of leaves into glass dish. Pick up aphids with small
paint brush and place into small bottles. Place caps on
bottles.
Fast aphids for ca. 1-2 hours.
Aphid feeding:
Stretch parafilm membrane over aphid feeding chambers.
(Feeding chambers are 2 cm lengths of 2 cm diameter glass
tubing with black electrictrical tape on outside of tubing.)
Place 10-20 aphids on a glass microscope slide.
Place open end of aphid feeding chamber over aphids.
Pipette ca. 20 1.11 of virus-HC mix on top of parafilm membrane.
Place glass coverslip on top of virus-HC solution.
Let aphids feed on virus-HC solution for 1-2 minutes.
Lift up aphid feeding chamber, remove feeding aphids with a small
paint brush.
Place ca. 10 aphids on each test plant (i.e. tobacco seedling).
Let aphids feed overnight then spray with insecticide.
Let virus symptoms develop for at least one week.